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Every new life starts with a single cell, which is formed by the fusion of two 
gametes in case of sexual reproduction. Some organisms exist as just one 
singe cell throughout their lives. These organisms are called unicellular. Other 
organisms have bodies composed of many different cells and celltypes, which are 
often specialized towards specific functions and work together to give rise to a 
multicellular individual. 
The cells of multicellular and of many unicellular organisms enclose their genetic 
material in a specialized organelle, called the nucleus (figure 1). These organisms 
are named eukaryotes. The nucleus is the cell’s ‘safe’ and stores the genetic material 
in a highly organized fashion, protects it from harmful influences and maintains an 
army of guardians to repair any damage that might occur.
The genetic material of every eukaryote is composed of DNA and contains all 
the information for an organism to function and reproduce. The basic unit of 
the information is the gene, which encodes for the ‘workmen’ of a cell, called 
proteins. In order to convert the information of a gene into a protein, there are 
two basic steps required (figure 1). First, the DNA is copied into an RNA molecule 
in a process of transcription. The DNA will remain safely in the nucleus, while the 
RNA copy will move away from the nucleus to protein-producing ‘factories’ called 
ribosomes. These ribosomes can subsequently read the information embedded 
in the RNA copy and translate this into the appropriate protein in the process 
of translation. Since every cell of a single organism harbours the same genetic 
material, the determining factor in cellular development (e.g. progression towards 
a different life cycle stage) or differentiation (e.g. specialization towards a specific 
function) is which subsets of the thousands of genes are converted into proteins 
(expressed). Therefore, many different processes and molecules have evolved to 
tightly regulate the expression of genes in a certain cell at a given time and ensure 
that the appropriate proteins are formed to exert the specific tasks required from 
this cell. Of key importance to this regulation are several mechanisms instructing 
the correct packaging, accessibility and recognition of genes. These processes 
are called epigenetic mechanisms and they are essential for viability of organisms 
ranging from the unicellular malaria-parasite Plasmodium to trillion-cell individuals 
such as humans.
This thesis describes the study of epigenetics in the human malaria parasite 
Plasmodium falciparum and embraces some of the fundamental molecular 
players that organize this parasites epigenome.
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Figure 1: General Introduction
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figure 1: The fl ow of information from genotype to phenotype. DNA is stored in the nucleus of 
a cell, where it is subject to various mechanisms of regulation. Depending on the accessibility of a 
particular gene and the availability of numerous regulatory factors, such gene can be transcribed into 
an RNA copy. This RNA molecule will translocate to the cytoplasm, where it can be translated into a 
protein. Depending on the gene set being transcribed, diff erent sets of proteins will be present in a cell 
resulting in distinct cellular functions.
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WHAT is “ePigeneTiCs”? 
All cells in the human body rely on the same genome sequence, yet different 
cell types express distinct sets of genes and have distinct protein compositions, 
morphologies and functions. Still, upon cell division, they pass these characteristics 
on to their progeny. So how are these characteristics transmitted, if they are not 
caused by changes in the DNA sequence? Which mechanisms provide cells with a 
memory extending from the genetic code? The answer is epigenetic mechanisms. 
These mechanisms do not work directly on the DNA sequence, but work on top 
of the underlying DNA. Consequently, epigenetic traits are defined as “stably 
heritable phenotypes resulting from changes in a chromosome without 
alterations in the DnA sequence” 1. The molecular definition of epigenetics is 
somewhat broader and covers all mechanisms acting on our chromatin, including 
those that are not transmitted to the next generation.
 
epigenetic glossary 
This box is an assembly of abbreviations and terms used throughout this general introduction. 
•	 epigenome: consist of a DNA component and the collection of proteins and RNAs that 
are associated with this DNA. Cells of one individual contain the exact same genome, 
while the composition and location of associated factors varies, giving rise to distinct 
epigenomes
•	 Chromatin: the complex of DNA and protein which forms a chromosome
•	 Cpg: the di-nucleotide combination of a cytosine (C) followed by a guanine (G) in the 
5’ to 3’ direction
•	 nucleosome:  the complex of DNA and histones that forms the basic repeat unit of 
chromatin. A ‘standard’ nucleosome is composed of 2 copies each of the core histones 
H2A, H2B, H3 and H4, surrounded by ~147bp of DNA
•	 Canonical histones: histones which are synthesized solely during the S-phase of the 
cell cycle and constitute the ‘standard’ octameric nucleosome core 
•	 Histone variant (replacement histone): histone with a similar, but not identical, 
amino acid sequence compared to canonical histones. Histone variants can bear 
different modifications, have distinct functions and can be incorporated into the 
genome in a replication-independent manner
•	 nucleosome dyad: the midpoint of the DNA wrapped around the histone octamer 
(indicated in figure 2)
•	 Histone PTMs: post-translational modifications such as acetylation (ac), mono- 
(me1), di,- (me2) and tri-methylation (me3), phosphorylation (p), ubiquitination (ub), 
polyADP-ribosylation (ADP-r), sumoylation (sumo)
•	 Modified amino acids residues: residues frequently modified by PTMs are lysine (K, 
ac, me and ub), arginine (R, me), serine (S, p) and tyrosine (Y, p)
•	 Histone PTM nomenclature: includes the histone involved, name and position of the 
modified amino acid and the type of modification. For example H3K9me3 refers to tri-
methylation of the lysine at position 9 of histone H3
•	 Writer protein: a protein that places a PTM at specific residues of a histone tail
Hoeijmakers.indd   13 20-04-12   14:41
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•	 Reader protein: a protein which recognizes a certain histone mark and binds it
•	 eraser protein: a protein that removes a specific PTM from a histone tail
•	 HAT: histone acetyltransferase – an enzyme which places acetylation marks
•	 HDAC: histone deacetylase – an enzyme removing acetylation marks
•	 HMT: histone methyltransferase – an enzyme placing methylation marks
•	 HDM: histone demethylase – an enzyme which removes methylation marks
•	 nucleosome occupancy: the amount of nucleosomes present at a certain genomic 
region at a specific time. Nucleosome occupancy is influenced both by 1) the density 
of nucleosomes (e.g. the length of the linker between adjacent nucleosomes) and 
2) the stability of these nucleosomes (e.g. the frequency/probability with which the 
nucleosome is displaced from the DNA).
•	 non-coding RnAs: RNA molecules that do not encode proteins (contrary to messenger 
RNAs)
•	 Chromosome territories: chromosomal DNA is not randomly distributed throughout 
the nucleus, but DNA from a single chromosome remains in close proximity and seems 
to occupy a specific nuclear location called territory
The building blocks of chromatin
A human cell contains about 2 meters of DNA, which is stored in a nucleus of only a 
few micrometers in diameter. Therefore, to fit the DNA into this tiny nucleus it has to 
be tightly packaged. Furthermore, DNA is stored in a highly organized fashion that 
allows clustering of functional entities, for example clustering of ribosomal DNA 
arrays into the highly active nucleolus (2 and figure 3D) or gathering of inactive 
regions into heterochromatin (3 and figure 3D). The structure of DNA and protein 
that ensures this organization and packaging is called chromatin. Chromatin forms 
the scaffold on which vital processes such as transcription, replication and DNA 
repair unfold and therefore is one of the structures that stands at the cradle of 
eukaryotic life (reviewed in 2).
The basic unit of chromatin is formed by the nucleosome 4. Each ‘standard’ 
(canonical) nucleosome (figure 2) is composed of about 147bp of DNA, which is 
wrapped around a protein core by nearly 1.7 helical turns 5. Typically, one histone 
H3-H4 protein tetramer and two copies of a histone H2A-H2B dimer together form 
the octameric nucleosome core. The eight N-terminal histone-tails that protrude 
from this core are vital for nucleosome function and can be post-translationally 
modified on various residues. These modifications can influence nucleosome 
properties and recruit effector proteins, which, amongst other things, can influence 
the degree of nucleosome compaction. Furthermore, binding of linker histone 
H1 to DNA close to the nucleosome dyad results in higher-order packaging of 
chromatin into more compact structures (reviewed in 2, 4, 5). 
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Figure 2: General Introduction
dyad
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figure 2: The nucleosome. The nucleosome consists of a protein core surrounded by about 147bp of 
DNA (grey). Two copies of each of the core histones H2A (yellow), H2B (red), H3 (blue) and H4 (green), or 
variants thereof, comprise the protein component of the octameric nucleosome. The N-terminal protein 
‘tails’ that protrude from the core can be modifi ed at multiple positions. The dyad position is indicated 
by an arrow. This image was modifi ed and reprinted from Richard Wheeler, with permission (The Sir 
William Dunn School of Pathology, University of Oxford, UK, http://en.wikipedia.org/wiki/Nucleosome).
The layers of epigenetic regulation
There are several intertwined processes that aff ect chromatin structure and 
function. In this paragraph I will introduce many of these fascinating mechanism 
and I will structure them according to the level at which they work (separated as 
the DNA-level, the nucleosome-level, the chromatin-level or the higher organization-
level). However, as most of these mechanisms are tightly interconnected, this 
separation is inevitably artifi cial. For example, histone variant incorporation will 
aff ect nucleosome stability and might ensure recruitment of several chromatin-
associated proteins thereby infl uencing chromatin compaction and remodelling. 
Nonetheless, I feel this separation to be necessary to step-wise introduce the 
diff erent ways in which chromatin infl uences key nuclear processes and composes 
our epigenomes. I hope that reading this description of the fundamental epigenetic 
mechanisms will ignite some of the admiration I feel when studying the wonderful 
complexity of epigenetic regulation. 
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Figure 3: General Introduction
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figure 3: epigenetic layers of regulation. Epigenetic mechanisms function at diff erent levels 
of organisation to regulate all DNA-associated processes. Although these mechanisms are highly 
interconnected, four primary levels can be distinguished: the DNA level, the nucleosome level, the 
chromatin level and the higher organisation. The main processes working at each level are schematically 
depicted in this fi gure. 
The “DNA-level”. Modifi cations of the building blocks of DNA (composed of adenine 
(A), thymine (T), cytosine (C) and guanine (G)), constitutes the fi rst level of epigenetic 
regulation (figure 3A). Cytosine methylation of CpG dinucleotides is the most 
frequently occurring DNA modifi cation 6 in eukaryotic organisms. Additionally, 
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cytosine methylation of non-CpG dinucleotides has been detected mainly in 
fungi 7 and plants 8, 9, but also in a human embryonic stem cell line 10. Furthermore, 
methylation of adenine is frequently observed in bacteria 11, archeabacteria 11 
and several protozoa 11, 12 and other infrequent base-modifications (such as base 
‘J’ found in the genome of the parasite Trypanosomes brucei 13) are reported to 
incorporate into the DNA of specific organisms 11, 14.
CpG methylation plays a critical role in imprinting and X-inactivation and is 
involved in gene silencing (reviewed in 15-18) by recruitment of silencing complexes 
and subsequent compaction of DNA. In healthy human beings, most CpG 
dinucleotides (~70-80% of all CpGs) are methylated 19. However, CpGs residing 
in the CpG-dense regions of gene promoters, called CpG-islands, are generally 
unmodified 15. Targeted methylation of such CpG-islands results in silencing of the 
downstream gene and has been reported to silence essential tumor suppressor 
genes in cancer 20, 21, whereas demethylation of methylated CpG-promoters in 
oncogenes can be involved in cancer aetiology by upregulating their expression 
22. Recent studies revealed hydroxylation of methyl cytosine into hydroxymethyl 
cytosine by TET enzymes 23 and high abundance of this modification in mammalian 
cells 24. Although the exact role of this DNA modification is currently unclear, it is 
believed to play a crucial role in DNA demethylation 22, 23 and was speculated to be 
involved in DNA repair 23.   
The “nucleosome-level”. This next level of regulation affects individual nucleosomes 
with respect to their composition, properties and/or placement on the DNA. In 
principle, five processes can be distinguished that act at the nucleosome-level and 
they are involved in histone modification, histone exchange, nucleosome stability, 
nucleosome positioning & eviction (figure 3b). However, I would like to emphasis 
again that these processes should not be seen as separate entities, as many 
influence each other. 
Properties of nucleosomes are greatly influenced by the placement of various 
post-translational modifications (PTMs) mainly on the N-terminal histone tails. 
These include acetylation, methylation and phosphorylation amongst others and 
can occur on various amino acids at numerous positions on the histone tail (see 
box 1 for examples). They can potentially influence chromatin structure directly. 
For example, acetylation of histone tails neutralizes the positive charge of lysine 
residues, thereby directly decreasing the interaction with negatively charged DNA 
and the compaction of chromatin 25. 
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box 1: The post-translational histone modifications  (PTMs)
A plethora of histone post-translational modifications (marks) have been identified, some 
specific to canonical or variant histones, and for many PTMs the exact role is still unclear. 
Below, I will list some of the best-characterized marks together with their genomic 
localization, to illustrate the diversity of this mode of regulation and its role in indexing 
functionally distinct elements of the genome. As localization and/or function of these marks 
might have diverged during evolution, I will focus on features that are conserved between 
commonly used model organisms (yeast, Drosophila, human and mouse amongst others):
•	 H2AXs139p (gH2AX): marks sites of DNA double-strand breaks 28
•	 H3ac: marks promoters of active genes 29-32
•	 H3K4me1: marks (active) enhancers 32
•	 H3K4me2: marks coding bodies of active genes 30, 31, 33
•	 H3K4me3:  marks promoters of active genes 29, 32
•	 H3K9me3: marks silent heterochromatic domains and imprinted loci 34
•	 H3K27me3: marks silent heterochromatic domains 34, 35
•	 H3K27ac: marks active enhancers 36, 37
•	 H3K36me3: marks coding bodies of active genes 34, 38
•	 H3K79me2: marks coding bodies of active genes 33
•	 H4ac: marks active genes 30, 32
•	 H4K20me1: marks coding bodies of active genes 34
Characteristics of these (and other) marks are described in more detail in some excellent 
reviews 39-42. 
Nonetheless, their main effect is believed to result from recruitment of specific 
‘reader’ protein complexes 25. PTMs are placed and removed by opposing 
enzymatic activities (figure 3b) such as histone acetyltransferases (HATs) and 
histone deacetylases (HDACs) or histone methyltransferases (HMTs) and histone 
demethylases (HDMs). An almost unlimited combination of modifications could 
in principle be generated and cross-talk between different marks on the same 
histone tail might further complicate interpretation of PTMs, however, many of 
these histone marks co-occur and share similar functions (see box 1). Among 
the best-studied modifications are lysine acetylations and methylations. While 
lysine-acetylation is generally associated with transcriptional activity of genes, 
methylations have more diverse functions and correlate both with gene activity 
and repression as well as marking of specific functional DNA elements such as 
enhancer regions (reviewed in 2, 25)
Besides dynamic modification of histone N-terminal tails, nucleosome properties 
and composition can be altered by the exchange of canonical (‘standard’) core 
histones by variant histone proteins (figure 3b). Histone variants (or ‘replacement’ 
histones) are often highly similar but not identical in amino acid sequence as 
compared to canonical histones 26, and they display different characteristics and 
functions 27 (see box 2 for more details).
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box 2: Variant histones add more flavours to the epigenome
Besides the canonical histones, several variant histone proteins were identified in many 
different organisms. The literature on histone variants is extensively covered in chapter 5 
(H2A.Z), 6 (H2Bv) and 7 (CenH3) of this thesis and in some excellent reviews 26, 27, 40 :
Histone H2A   
•	 macroH2A – marks the inactive X chromosome in female cells 43 and is involved in 
silencing of gene expression 26  
•	 H2AbbD – colocalizes with H4K12ac and is associated with active chromatin 26, 27
•	 H2AX – signals double-strand breaks when phosphorylated and recruits the DNA 
repair machinery 28
•	 H2A.Z – possesses diverse functions and localizations, including marking of 
heterochromatin boundaries and promoters of active or repressed genes 26, 27 and 
occupies ‘nucleosome free regions’ at transcription start sites of active genes 44
Histone H2b, although most eukaryotes encode a single H2B, lineage-specific variants 
have been described 27, of which examples are included below:
•	 TsH2b & H2bfWT – 2 testis / sperm-specific H2B variants 45, 46
•	 H2bv – protozoan-specific H2B variant which forms a double-variant nucleosome 
subtype together with histone variant H2A.Z (47, 48 and chapter 6 of this thesis)
Histone H3
•	 CenH3 / CenPA – exclusively demarcates centromeres and is involved in kinetochore 
assembly  49
•	 H3.3 – incorporated in coding regions during active transcription 50
Histone H4, although most eukaryotes encode a single H4, a histone H4 variant has been 
identified in the protozoan parasite Trypanosoma brucei 27:
•	 H4V – localizes to putative transcription termination sites (TTS) 48
In addition, they often acquire PTMs that do not occur on canonical histones, or 
lack PTMs that are present on their canonical counterparts, due to differential 
recognition by epigenetic enzyme complexes. Contrary to PTMs, which are 
placed on existing nucleosomes by enzymatic activity, incorporation of histone 
variants requires the disassembly and reassembly of nucleosomes 26. Histone 
chaperones and chromatin remodelling enzymes are involved in this process and 
target variants for incorporation at specific locations (see box 3 for examples of 
histone chaperones). Although the classical separation between canonical and 
variant histones is their time of assembly onto the genome (canonical histones 
are incorporated in a strictly replication-dependent manner, whereas variants can 
be incorporated both during and after replication) 26, this might be a much too 
simplistic view. 
The above information demonstrates that there is evidently not one ‘building 
block’ of chromatin, but different ‘flavours’ of nucleosomes exists, each with distinct 
properties and functions. Together, they give rise to a diverse assembly of different 
‘tastes’ that functionally index an organism’s epigenome.
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box 3: Histone chaperones guide histone deposition on the genome
Incorporation of canonical and variant histones into nucleosomes and their correct 
placement onto DNA is guided by factors called histone chaperones. Various chaperones 
have been identified with specificity for certain canonical histones or histone variants. Some 
of the best characterized chaperones are listed below (reviewed in 26, 51) :
• swr1 – the SWR1 complex (or orthologs thereof ) deposit histone variant H2A.Z onto 
the genome of yeast, animals and plants 52
• CAf1 – the best-studied histone chaperone to date 26, involved in deposition of 
canonical H3/H4 tetramers in a replication-coupled process 53
• HiRA – deposits histone variant H3.3 in a replication-independent manner 50
• scm3 – exhibits chaperone activity towards the yeast histone variant Cse4 (e.g. CenH3) 54
One of the properties greatly influenced by nucleosome composition is the stability 
of the histone octamer on the DNA. This is called nucleosome stability (figure 
3b) and determines the residence time of the nucleosome on the DNA, thereby 
influencing the accessibility of the underlying DNA sequence. Some nucleosome 
subtypes were identified that display reduced stability and easily dissociate from 
the DNA, including the H2A.Z/H3.3- 55 and the H2A.Z/H2Bv- (48 and chapter 5 & 6 
of this thesis) double variant nucleosome subtypes. These nucleosomes seem to be 
preferentially enriched on regions that require high levels of accessibility for their 
function. For example, the enrichment of ‘instable’ H2A.Z/H3.3- 44 or H2A.Z/H2Bv-
nucleosomes  (48 and chapter 5 & 6 of this thesis) at promoters and transcription 
start sites of genes might result in increased transcription initiation by displacement 
of the octamers by transcription factors 44 or directly by temporal ‘exposure’ of 
these regions toward the transcription machinery because of a rapid turnover of 
these nucleosomes 56 (also discussed in some excellent reviews on nucleosome 
stability by Henikoff and colleagues 57-59). Hence, nucleosome stability/turnover 
might prove to be one of the key mechanisms mediating the biological output of 
histone variant incorporation and post-translational modification.   
The placement of a nucleosome onto the genome will limit the accessibility of the 
underlying DNA sequence to other factors, for example to transcription factors 
or the transcription initiation machinery. Therefore, the exact positioning of 
nucleosomes on the DNA will determine which sites are accessible towards various 
processes, and which are not. Removal of histone octamers (nucleosome eviction, 
figure 3b) at specific positions will expose these regions for binding by other 
factors. Similarly, movement of nucleosomes to place them directly on top or just 
adjacent to a transcription factor binding site (nucleosome positioning, figure 3b), 
will result in inaccessibility or exposure of this sequence, thereby regulating the 
transcriptional status of the downstream gene (reviewed in 60). The factors involved 
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in repositioning of nucleosomes are called chromatin remodellers 61, 62. They are key 
factors in chromatin biology and often occur in large protein complexes that also 
include cofactors for targeting and various other epigenetic activities (see box 4 
for an example of such a complex).
box 4: nucleosome Remodelling and histone Deacetylation complex (nuRD)
Chromatin-associated proteins and epigenetic enzymes often reside in large multi-subunit 
complexes that bring together various epigenetic activities. One such silencing complex is 
the Nucleosome Remodelling and histone Deacetylation (NuRD) complex, which recruits 
silencing factors to sides of methylated CpGs, resulting in gene silencing. Epigenetic 
activities assembled in the MBD2-NuRD 63 complex are:
•	 MbD2 – methyl-DNA binding activity 64
•	 Mi-2 – ATP-dependent chromatin remodelling activity 65
•	 HDAC1 / HDAC2 – histone deacetylase activity 66
•	 PRMT5 – (histone) arginine methyltransferase activity 63
 Furthermore, cooperative actions of chromatin remodeller complexes, transcription 
factors, RNA polymerase and certain histone chaperones are involved in eviction of 
nucleosomes from the DNA 40, where, by destabilization of histone octamers, they 
counteract the activity of histone chaperones that place the nucleosomes 58. 
In conclusion, nucleosome composition, stability and positioning cooperate in an 
intriguing and intricate manner to expose sequences that need to be accessible, 
mask those that need to be ‘closed’ and to provide a scaffold to recruit or repel 
specific epigenetic activities to orchestrate the desired biological function at this 
genomic location.
The “chromatin-level”. Chromatin remodellers are involved in the positioning and 
potential eviction of nucleosomes, and thereby directly influence nucleosome 
occupancy (figure 3C) and the higher-order packaging (figure 3C) of our DNA. 
Active chromatin is generally loosely spaced by nucleosomes in a so-called ‘beads-
on-a-string’ formation. These regions display low nucleosome occupancy. On the 
contrary, inactive regions are densely occupied by nucleosomes and can even 
be further compacted into a tight structure such as the 30nm fiber by addition 
of linker histone H1 (reviewed in 2, 67). A logic inference is that the lowly occupied 
regions are relatively accessible to various factors (e.g. transcription initiation 
machinery), whereas densely packaged and higher-order folded regions are rather 
inaccessible. Historically, these two types of chromatin were identified cytologically 
as dark staining nuclear regions 68 and regions that stain poorly. Consequently, 
these were called heterochromatin (meaning ‘different chromatin’) and euchromatin 
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(meaning ‘true chromatin’, reviewed in 69). Both eu- and heterochromatin are fairly 
well-defined in their molecular composition and the histone marks found at those 
regions are generally categorized as ‘active’ or ‘repressive’, depending on their 
localization towards either type of chromatin (reviewed in 39, 41 and see box 1 for 
examples).
Most epigenetic activities are brought about by recruitment of effector-proteins 
(figure 3C), which are formed by a diverse group of different types of chromatin-
associated proteins (reviewed in 41, 70). These include, writer, reader and eraser 
proteins (that place, recognize and remove histone PTM marks respectively) in 
addition to the chromatin remodeller machinery and structural components. One 
of the best characterized example of a ‘reader’ is the heterochromatin protein 1 
(HP1), which recognizes and binds H3K9me3 marks on silent chromatin 71 and 
recruits other factors required for further compaction of these regions into ‘closed’ 
heterochromatic structures (reviewed in 72). In general, chromatin-associated 
proteins do not work alone, but function in large, multi-protein complexes where 
various activities come together (see box 4 for an example of the silencing 
complex nuRD). Many of these complexes are characterized and the specificity 
of most writers and erasers is established. Furthermore, recruitment of these 
complexes towards specific marks acts via well-characterized ‘reader’ domains (see 
box 5). 
box 5: Reading the epigenome
Many reader proteins have been identified with different specificities towards the various 
histone PTMs. These readers are essential to target epigenetic activities towards these marks 
and exert their biological function. Reader protein binding is brought about by a number 
of protein domains that display specificity towards certain types of modifications. The most 
common ‘reader domains’ are:
•	 Chromodomain – an evolutionary conserved reader domain that recognizes 
methylated lysine residues on histone tails
•	 Tudor domain – related to chromodomain and binds methylated lysine and arginine 
residues
•	 PHD finger – recognize tri-methylated lysine residues, specifically H3K4me3 marks 
•	 bromodomain – a very commonly used domain involved in recognition of acetylated 
lysine residues
•	 beT – a specific family of bromodomains binding to acetylated lysine residues on 
histone tails 77 
Reviewed in 41, 70, 73, 78. 
Nevertheless, we still know very little about the combinatorial effect of different 
PTMs and how the recruited activities work together to bring about the desired 
biological outcome (reviewed in 73, 74). Similarly, although histone PTMs locations 
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are extensively studied and correlations with functional elements in the genome 
have been widely established, the causal relationship that is responsible for this 
association is very poorly understood (reviewed in 73, 74). Are histone PTMs the 
cause or the consequence of a biological process? For example, is the enrichment 
of H3K4me3 and H3K9ac at promoters of active genes an initiating event in gene 
activation or merely a consequence of ongoing or initiated transcription and 
subsequent recruitment of histone writers? Although these questions are still 
largely unanswered, a recent breakthrough by Vermeulen and colleagues lifts the 
tip of the vial 74-76 by directly linking H3K4me3 to transcription 75. In their study, the 
authors provide a causal relationship where H3K4me3 marks directly recruit TFIID, 
a core component of the transcription machinery, and consequently promote 
transcriptional activation. In addition, they uncover antagonistic and synergistic 
effects of H3R2me2 and H3K9/K14ac either compromising or enhancing TFIID-
H3K4me3 interaction, thereby (for the first time) providing direct evidence 
for combinatorial effects of different PTMs. Although it is still unclear whether 
H3K4me3 recruits the first RNA polymerase to the gene of interest thereby initiating 
the transcription process, or whether it merely functions to promote transcription 
of already activated promoters, this study clearly shows that H3K4me3 is not just a 
consequence of the transcriptional process 75.
Besides various effector proteins, short and long non-coding RNAs were found to 
associate with chromatin (figure 3C). These long non-coding RNAs (lncRNAs) were 
shown to localize both in cis, by acting on the DNA molecule they were transcribed 
from, and in trans, by acting on different chromosomes, and seem to play crucial 
roles in various epigenetic processes, especially in silencing. Although the exact 
mechanisms of lncRNA function still needs to be further explored, a picture 
emerges in which the lncRNAs create repressive environments by functioning as 
a scaffold to recruit repressive histone modifier complexes to their site of action 
(reviewed in 79-81). One of the best-characterized examples of lncRNA action is the 
RNA molecule Xist, which plays an essential role in X-inactivation by ‘coating’ the 
inactive X 82, repelling of RNA PolII and transcription factors 83 and subsequently 
recruiting the Polycomb repressive complex 2 (PRC2) to tri-methylate H3K27 
and stably silence the inactive X-chromosome 84, 85.  Besides repressive functions, 
lncRNAs have been reported to be involved in various processes, including gene 
activation, involvement in higher-order chromatin looping (see below) and the 
formation of nuclear structures and subcompartments (see below) (reviewed in 79). 
The higher organisation-level. Chromatin is not just stored in the nucleus in a 
random fashion. On the contrary, the 3D location of chromosomes in the nucleus is 
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highly organized 86, 87 and this seems to be crucial to their function. Chromosomes 
occur in so-called ‘territories’ 86 and chromatin looping mediates the translocation 
to distinct nuclear structures or subcompartments to allow sequences of similar 
function to gather into a single functional unit (88 and figure 3D). For example, 
silent chromatin is tethered to the nuclear lamina, possibly by the interaction of 
methylated H3K9 with laminar proteins 3, 39. Active genes can loop out of these silent 
domains (figure 3D) to localize to ‘transcription factories’ within euchromatin that 
ensure their expression 39, 89. Additionally, actively transcribed ribosomal clusters 
present on different chromosomes gather in the nucleolus 90, a specialized nuclear 
structure dedicated to the production, processing and assembly of ribosomal 
RNA (reviewed in 91). Moreover, a recent study mapping the 3D interactome of the 
insulator-binding protein CTCF revealed that CTCF potentially facilitates promoter-
regulatory element interactions and separates the genome into insulated functional 
domains which localize to distinct nuclear (sub)compartments 89. However, despite 
these pioneering studies 3, 87-89, the processes involved in higher-order packaging 
and the nuclear 3D organisation are still largely unexplored.  
indexing the (epi)genome 
I indicated earlier that two types of chromatin were recognized almost 100 years 
ago by microscopy 68, being the ‘open’, accessible euchromatin and the compact, 
inaccessible heterochromatin. Today, these are still considered to be the two 
major chromatin states, although a subdivision can be made for constitutive 
heterochromatin (hallmarked by the presence of H3K9me3 and HP1) and facultative 
heterochromatin (characterized by H3K27me3 and polycomb group (PcG) 
proteins) 26, 72, 92. However, a recent landmark study by Filion and colleagues urges 
us to further polish these categories 92. Genome-wide profiling of 53 chromatin-
associated features in Drosophila cells led to the identification of 5 different types 
of chromatin, thereby refining the categorisation of chromatin states. These types 
include the previously identified constitutive and facultative heterochromatin 
in addition to a third type of silent chromatin that covered about half of the 
Drosophila genome and did not bear any of the classical heterochromatic marks. 
Additionally, two different types of active chromatin were identified which included 
different types of genes (one being enriched in housekeeping genes and the other 
in developmentally regulated genes). Certainly, within these broadly defined 
domains, distinct features will bear different epigenetic signatures, as is already 
recognized for transcription start sites, coding bodies of active genes or enhancers, 
just to name a few (see box 1 for hallmark PTMs correlated with these features). 
Therefore, genome-wide profiling approaches present an extraordinary powerful 
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tool in the identification of functional genomic DNA elements or domains and 
generate a treasure trove for hypothesis-driven research to unravel the working 
mechanisms of epigenetic processes 39.
Toolbox: Chromatin immunoprecipitation (ChiP) & RnA-seq
This thesis is built on two applications of state-of-the-art deep sequencing 
technology, namely chromatin immunoprecipitation followed by deep sequencing 
(ChIP-seq) and transcriptome analysis by deep sequencing (RNA-seq). As RNA-seq 
is the relatively straightforward sequencing of messenger RNA molecules and is 
extensively discussed in chapter 4 of this thesis, I will not describe this technology 
in details here. Below, I will elucidate the ChIP procedure and highlight the 
advantages brought about by using deep sequencing as a read-out.
Chromatin immunoprecipitation is a multi-step procedure, which aims at 
precipitation of DNA and associated proteins (chromatin) using specific antibodies 
93, 94. These antibodies can either recognize a particular histone or histone variant, 
a specific histone modification, a chromatin-associated protein or an epitope-
tagged variant thereof (if no specific antibodies are available) 95. When studying 
chromatin-associated proteins, cross-linking of protein-protein and protein-DNA 
interactions is mandatory for the procedure 96, 97. However, when the interactions 
between the DNA and associated proteins (such as histones) are sufficiently strong 
and fragmentation of the chromatin is achieved by non-destructive means (e.g. 
micrococcal nuclease digestion), chemical cross-linking is not required and a 
procedure called native ChIP (nChIP, illustrated in figure 4) can be applied 93, 96, 
97. One of the main advantages of nChIP is that it fragments the genome to mono-
nucleosomes and, when combined with deep-sequencing, gives single-base 
resolution of DNA-nucleosome interactions 98. Moreover, due to a lack of chemical 
crosslinking, only direct interactions on the chromosome will be detected and 
artefacts resulting from cross-linking of three-dimensional structures will not occur.
The nChIP procedure (outlined on figure 4) starts with the isolation of nuclei from 
the cell population of interest (1). Subsequently, the chromatin will be digested 
to mono-nucleosomes (2) using the enzyme micrococcal nuclease (MNase), 
which removes all DNA that is not protected by nucleosomes (e.g. the linker 
DNA between neighbouring nucleosomes) or DNA-binding transcription factors. 
Next, the nucleosomes containing a specific modification or histone variant are 
immunoprecipitated using antibodies that specifically recognize this variant 
or PTM (3). All unbound chromatin is washed away and the DNA component of 
the immunoprecipitated nucleosomes is purified (4) 97, 99. The identity of the 
immunoprecipitated DNA can then be determined using different read-outs (5).
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Figure 4: General Introduction
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Relative enrichment of a specific region of interest can be analysed using PCR. In a 
simple endpoint PCR, a band of the expected size is observed in case the protein 
of interest localized to this DNA sequence, while the absence of such interaction 
results in the lack of a band. However, this binary readout is very error prone. To 
obtain more quantitative information, a quantitative PCR (qPCR) reaction can be 
performed using the same primer pairs. A clear disadvantage of both PCR-based 
methods is that the analysis is limited to the specific (suspected) regions that are 
figure 4: native Chromatin 
i m m u n o P r e c i p i t a t i o n . 
The nChIP procedure is 
outlined and key steps in 
the procedure are numbered 
(1-5). As ChIP results can 
be assayed using different 
methods, the most common 
assays are included in this 
figure (a-d). The positions 
of primers used for PCR 
are indicated by arrows in 
the top figure. Micrococcal 
nuclease (MNase) used to 
digest the unprotected 
DNA is depicted as scissors. 
Histone variants are included 
as coloured quarters of a 
nucleosome, histone PTMs 
are indicated by circles 
placed on the nucleosome. 
Antibodies against histone 
variant H2A.Z (green) are 
indicated by Y, and isolated 
pieces of DNA by black lines.
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tested in the PCR reaction. To obtain genome-wide localization profiles, microarray 
(ChIP-on-chip 100, reviewed in 95) or deep sequencing (ChIP-seq 34, 101, reviewed in 98) 
technology can be employed. Both yield a tremendous increase in resolution over 
endpoint and qPCR methods 95, 98. Microarray-based methods, nevertheless, are 
restricted to analysis of known sequences, suffer from cross-hybridization issues 
and have, amongst others, a limited dynamic range resulting in substantial noise 
in the data. On the contrary, deep sequencing technology provides an in principle 
unlimited resolution, which is only restricted by the number of sequenced reads 
and the efficiency of the antibody used for ChIP. Furthermore, it does not suffer 
from hybridization artefacts, is not dependent on a priori knowledge of the 
sequence composition, offers single-base resolution and can provide almost 
complete genome coverage (depending on the read length, organism under 
investigation and the extent of repetitive sequences in its genome) (reviewed in 98, 
102, 103). Therefore, ChIP-seq provides superior data and better resolution compared 
to array-based technology and is the method of choice for the experiments 
described in this thesis.
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PlAsModiuM, THe CAusATiVe AgenT of MAlARiA
The global impact of malaria 
Malaria is one of the most threatening infectious diseases, placing almost half of 
the world-population at risk 104. A shocking number of 225 million clinical cases of 
malaria were documented in 2009 alone 105, resulting in the death of almost 800,000 
people 105, the majority of whom are children and pregnant women 106. Malaria is 
a disease of poverty, prevalent in tropical and subtropical regions of our globe 
and places a major hindrance for economical growth in developing countries 107. 
Despite intensive research on various levels of malaria intervention 106, 108 (including 
vector control 109, transmission-blocking strategies 110, 111, vaccine development 
112-114 and drug discovery 115, 116), an effective malaria-vaccine is still lacking 113, 114 
and drug resistance is spreading against our current, and only available, line of 
medication 117, 118. Therefore, there is an urgent need for alternative strategies to 
fight this devastating disease. 
Parasites of the Plasmodium genus 
The eukaryotic unicellular parasitic organisms that are causative for malaria, 
belong to the evolutionary phylum of the Apicomplexa and the genus Plasmodium 
119. Apicomplexa are parasites and besides Plasmodium, this phylum includes 
Toxoplasma gondii 120. However, unicellular parasites that do not belong to the 
Apicomplexa do exist and can also cause human disease. An example of such 
non-apicomplexan parasites includes species of the genus Trypanosoma that are 
causative for sleeping sickness 121. Plasmodium, Toxoplasma and Trypanosoma 
are collectively often refered to as Protozoan parasites (a poorly defined group 
of unicellular eukaryotic parasites). Although they are evolutionarly not closely 
related, they posses common features and therefore literature on epigenetic 
processes in both latter species will often be used as a reference to findings in 
Plasmodium presented in this thesis.
Approximately 200 different parasite species belong to the Plasmodium genus (see 
box 6 for examples). Most of these either infect reptiles, birds, rodents or primates 
and maintain strong host specificity 122. As of today, five main species are known 
to infect humans: P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi 122. They 
can be distinguished based on their morphologies and disease characteristics. 
For example, P. vivax and P. ovale cause periodic fever every 48 hours, whereas the 
periodicity of patients infected with P. malariae is about 3 days 123. P. falciparum 
infections are generally non-synchronous and do not often results in periodic 
fever 123, whereas P. knowlesi infections in humans are relatively infrequent and 
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therefore not well characterised. Of all Plasmodium species infecting humans, P. 
falciparum is responsible for the most life threatening form of the disease 123. P. 
falciparum parasites evolved a unique strategy to evade host immune responses 
by sequestration in internal organs, thereby preventing clearance by the spleen 
(reviewed in 124). However, sequestration can result in organ failure by diminishing 
the blood flow through vital organs, thereby leading to death of the patient 123. 
P. falciparum malaria is most prevalent in Africa, hence, over 85% of all malaria-
victims originate from this continent 125.
box 6: Plasmodium spp.: facts and figures
Of the ~200 Plasmodium species, most are highly adapted to a specific host. Switching 
to a different host is observed only occasionally and might represent a speciation event 
(reviewed in 122). Below I list some of the more renowned Plasmodium spp. and indicate their 
preferred host(s) and other characteristics: 
•	 P. falciparum – infects human, ~48h asexual cycle. P falciparum is responsible for ~40% 
of clinical malaria cases and (almost) all malaria-associated deaths 122. It is the most 
deadly human malaria parasite because of its sequestration in vital organs 124. It locates 
primarily to Sub-Saharan Africa, but is also commonly found in Southeast Asia and 
occasionally in South-America  126.
•	 P. vivax – infects human, ~48h asexual cycle. P. vivax is responsible for another ~40% 
of clinical malaria cases 122 and has been reported to be (occasionally) responsible for 
severe malaria and malaria-deaths 127. It locates mainly to Asia and South-America 118. 
A special characteristic of this parasite species is the formation of dormant liver stage 
infections, called hypnozoites, which can reactivate years after primary infection and 
give rise to delayed disease 123.
•	 P. malariae – infects human, ~72h asexual cycle.
•	 P. ovale – infects human, ~48h asexual cycle. Like P. vivax, P. ovale can produce liver 
hypnozoites, which can reactivate years after primary infection 123.
•	 P. knowlesi – infects monkeys, but has been reported to also infect humans in 
Southeast Asia 128 and is currently considered to be the 5th human malaria parasite 122. 
P. knowlesi has a ~24h asexual cycle and is used as the simian model system.
•	 P. cynomolgy – infects monkeys, also reported to (occasionally) infect human 104.
•	 P. reichenowi – infects apes, ~48h asexual cycle. In morphology this parasite closely 
resembles P. falciparum 129.
•	 P. berghei – infects rodents, ~24h asexual cycle.  Commonly used rodent malaria 
model, because it is highly amendable for genetic manipulation and provides the 
possibility to study every stage of host infection in situ (which is impossible for human 
malaria infections) 130.
•	 P. yoelii – infects rodents, ~18h asexual cycle. Commonly used rodent malaria model, 
similarly to P. berghei. 130.
•	 P. chabaudi – infects rodents, ~24h asexual cycle. 
•	 P. gallinaceam – infects birds.
•	 P. mexicanum – infects reptiles/lizards.
Reviewed in 107, 122
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The Plasmodium life cycle
Plasmodium parasites have a complex life cycle involving two hosts (figure 5), 
which vary depending on the specific parasite species. Transmission of P. falciparum 
occurs when an infected female mosquito vector of the Anopheles genus takes a 
blood meal on a human being. Starting her blood meal, she will inject some saliva 
into the human skin and with it few sporozoites of P. falciparum. The sporozoites 
will rapidly migrate to the human liver, where they take residence in liver cells. This 
so-called liver-stage of infection lasts for about 14 days, is asymptomatic, but will 
result in formation of thousands of new parasites from a single sporozoite. Once 
the infected liver cell bursts, thousands of so-called merozoite stage parasites are 
released into the blood stream where they will rapidly invade human red blood 
cells (RBCs). This is the beginning of the infected red blood cell (iRBC) cycle (also 
called intraerythrocytic or asexual cycle) of development, which takes ~48 hours 
and is responsible for all disease-associated symptoms and mortality. Once a 
merozoite invades the RBC, a so-called ring parasite will form, which remodels the 
red blood cell. After ~24 hours, the parasites progress into the trophozoite stage, 
which presents the metabolic and transcriptional ‘peak’ of the cycle and lasts for 
~12 hours. During this phase all preparations are made for massive replication 
and reproduction during the latest stage of the cycle, the schizont stage. In the 
schizont, DNA replication is followed by the formation of 8 to 32 new merozoites. 
Once these are matured, the RBC will rupture and the merozoites will re-invade 
fresh RBCs, resulting in the next asexual infection cycle and rapid expansion 
of the parasite load. In addition to participation in this asexual developmental 
cycle, parasites can commit to asymptomatic sexual development, leading to the 
production of male and female gametocytes in ~12 days. Once another female 
Anopheles mosquito takes a blood meal on the infected human, the gametocytes 
will be taken up and end up in the mosquito midgut. Here, the male gamete will 
exflagellate from its surrounding RBC and fertilize a female gamete that already 
escaped her RBC, resulting in the production of a zygote. The zygote undergoes 
rapid meiosis followed by mitosis and develops into a single tetraploid ookinete, 
which traverses through the mosquito midgut wall where it matures into the 
oocyst. Within 10-22 days, sporozoites will develop within the oocyst. Once these are 
mature, the oocyst will rupture, releasing thousands of sporozoites that migrate to 
the mosquito salivary glands and develop into infective salivary-gland sporozoites. 
Now, the female mosquito has become infectious and can spread the disease to 
another human being on her next blood meal thereby closing the parasite’s life 
cycle (reviewed in 107, 124, 131, 132).
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Figure 5: General Introduction
figure 5: The P. falciparum life cycle. P. falciparum has a complex life cycle involving a mosquito vector 
and a human host. The various host cells infected by this parasite, and the numerous morphological 
forms it engages are indicated in the figure. A description of the cycle is included in the main text. This 
figure is reprinted from 131 with permission from the publisher (Elsevier). 
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The extreme genome of Plasmodium falciparum
The genetic blueprint of an organism is encoded in its DNA, which contains all 
information for the organisms to function and reproduce. Therefore, all information 
required to progress through the complex life cycle of Plasmodium falciparum 
described above is encoded in its genomic DNA. The genome of P. falciparum 
consists of about 23 millions bases (Mb) divided over 14 chromosomes and is 
haploid (e.g. it contains only a single copy of each chromosome) 133. It encodes 
almost 6300 protein coding genes 133, 134 of which 54% is predicted to contain one 
of more introns 133. With an average gene size of ~2.3kb, over half of the 23Mb 
genome is covered by coding sequences 133. It is comparable in size and structure to 
the genome of the budding yeast Saccharomyces cerevisiae, which contains about 
12 Mb spread over 16 chromosomes, encodes for ~5800 protein coding genes and 
consists of about 70% coding sequence 135. However, contrary to the yeast genome 
which displays a more or less even distribution of the 4 bases (62% adenine 
+ thymine and 38% cytosine + guanine), the composition of the P. falciparum 
genome is extremely biased and contains more than 80% A+T 133. Remarkably, this 
is the highest AT-content detected for the genome of any organism sequenced 
to date 133, 136 exposing substantial challenges to molecular biologist. First of all, 
molecular techniques (such as polymerase chain reaction (PCR) and cloning) are 
inefficient on DNA with such high AT-content 137. Second, sequence comparison 
to reveal conserved sequences in for example protein-coding genes is severely 
complicated by the deviating genome composition. And third, algorithms to de 
novo detect specific sequence motifs in for instance transcription start sites (TSS) 
of genes, function poorly due to the relatively limited information content of 
sequences consisting mostly of 2 instead of 4 bases. Consequently, TSS have been 
characterized for only part of the genes 138 and ~60% of genes in the genome are 
still catalogued as ‘conserved Plasmodium protein of unknown function’ 139.
Based on AT-content, 4 distinct regions can be differentiated in the P. falciparum 
genome (figure 6). The GC-richest domains (~73% AT) can be found at the 
heterochromatic subtelomeres and chromosome-internal islands that encode 
for antigenic variation genes. Second are the euchromatic genes containing on 
average ‘only’ 76% AT. They alternate with euchromatic intergenic regions of ~86% 
AT. However, the ~2kb putative centromeres that can be detected on almost all P. 
falciparum chromosomes contain a remarkable 97% adenine and thymine bases 
(133 and figure 6).
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Figure 6: General Introduction
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figure 6: gC-content of a typical P. falciparum chromosome. The complete Pfchromosome 12 is 
depicted on top and a zoom-in of the centromeric region of chr12 is included below. Genes or the 
forward (above 0) and reverse (below 0) strands are indicated as blue blocks. GC-content per 35bp 
window is depicted in grey. The genome can be divided into 4 distinct regions based on the GC-content: 
GC-rich subtelomeric and chromosome-internal islands (light pink), genic regions of lower GC-content 
(dark pink), intergenic regions with even lower GC (purple) and extreme GC-poor centromeric domains 
(blue).
Plasmodium gene expression
One of the surprising conclusions after sequencing and annotation of the P. 
falciparum genome sequence was the severe underrepresentation of (recognizable) 
specifi c transcription factors to regulate gene expression 133, 140. Nevertheless, gene 
expression during intraerythrocytic development appears to be tightly regulated 
with ‘waves’ of functionally related RNAs and proteins that are expressed when 
they are required for invasion, growth or replication (139 and figure 7). Although 
co- and post-translational processes were identifi ed in the regulation of specifi c 
groups of genes 141, 142, mechanisms acting at the level of transcription initiation 
are still believed to be the predominant regulators of RNA and protein abundance 
143, 144. Even though specifi c transcription factors were identifi ed in Plasmodium 
recently 145-147, we still have very limited understanding of how they infl uence 
expression of genes and which other mechanisms might be at play. In addition 
to gene regulation via transcription factor binding, epigenetic processes may play 
a dominant role in regulation of transcription initiation. Indeed, components of 
the epigenetic machinery are well represented in the Plasmodium genome (140 
summarized in box 7).
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Figure 7: General Introduction
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Nonetheless, even the ‘basic’ distribution of epigenetic features over the P. falciparum 
genome is just starting to be explored and mechanistic insights are largely lacking. 
Therefore, we have a long road ahead to unravel the epigenetic processes at play 
in this important human pathogen and to dissect their contribution to the tight 
regulation of its gene expression program. This thesis adds to this daunting task by 
revelation of the genome-wide localization of some epifeatures, thereby providing 
a solid basis for hypothesis-driven studies to functionally dissect the mechanisms 
underlying this fascinating epigenome.   
figure 7: gene expression during 
the intra-erythrocytic cycle. The 
intraerythrocytic developmental cycle is 
characterized by a highly synchronized 
‘wave’ of gene expression, where most 
genes peak in expression once during 
the cycle exactly when they are required 
for growth and development. Few 
genes are highly expressed during early 
developmental stages (top), whereas 
more genes become expressed as the 
cycle progresses (middle-bottom). This 
pattern suggests that a highly regulated 
gene expression program is underlying 
intraerythrocytic development. This 
figure is modified from 161.
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box 7: epigenetics in Plasmodium, what are the basics?
The components of the epigenetic machinery are well represented in the Plasmodium 
genome. Below, I list the distinct epigenetic levels and the absence or presence of such 
processes in the malaria parasite:
•	 DnA methylation: NO, neither DNA methylation nor a methylation machinery have 
been detected in the Plasmodium genome 148
•	 Canonical histones: YES, H2A (MAL6P1.249) 149, H2B (PF11_0062) 150, H3 (PFF0510w) 151 
& H4 (PF11_0061) 152 are present
•	 Histone variants: YES, H2A.Z (PFC0920w) 153, H2Bv (PF07_0054) 153, CenH3 (PF13_0185) 
153 & H3.3 (PFF0865w) 154 have been detected
•	 linker histone: NO, linker histone H1 has not been identified 140
•	 Histone Post-translational modifications: YES, over 40 histone PTMs have been 
uncovered 153, 155, 156
•	 epigenetic enzymes, chromatin remodellers & other chromatin-associated 
proteins: YES, many homologues of histone modifiers and chromatin remodellers were 
identified 140 and chromatin associated-proteins such as HP1 have been characterized 157
•	 non-coding RnAs: non-coding RNAs have been detected in Plasmodium spp. 158, 159, 
although their role is currently unclear and a (functional) RNA interference machinery 
is lacking from this parasite 160
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AiM & ouTline of THis THesis
The Plasmodium epigenome harbours four canonical histones, four histone 
variants and a multitude of histone post-translational modifications (PTMs), which 
together result in a myriad of distinct nucleosome subtypes, each with specific 
localizations, functions and properties. The aim of this thesis is to get a first taste 
from the ‘flavours’ of this rich epigenome by the genome-wide localization of three 
histone variants, two key histone PTMs and their potential correlation with gene 
expression throughout Plasmodium falciparum intraerythrocytic development. 
Chapter 2 reviews the state-of-the-art in Plasmodium epigenome research at the 
start of this thesis and highlights the very first genome-wide characterization of 
few histone PTMs and chromatin-associated proteins.
At the start of this PhD project, next-generation-sequencing technology just 
became available to the general research community, but had not yet been applied 
to the extremely adenine- and thymine-rich genome of P. falciparum. Chapter 
3 describes the adaptation of next-generation-sequencing protocols towards 
applicability on ‘extreme’ genomes and forms the technological cornerstone of this 
thesis.
Chapter 4 entails a detailed, step-wise protocol for application of NGS for 
transcriptome profiling (RNA-sequencing) in Plasmodium spp. and makes use of 
the newly developed linear amplification for deep sequencing (LADS) protocol 
described in the previous chapter.
The genome-wide localization of histone variant PfH2A.Z, acetylation of histone H3 
lysine 9 (H3K9), tri-methylation of H3K4 and their dynamic correlation to parasite 
development and gene expression is uncovered in Chapter 5.
In Chapter 6, the genome-wide localization of histone variant PfH2Bv, its co-
localization with PfH2A.Z and their association with highly AT-rich, intergenic 
domains in the P. falciparum genome is explored.
Chapter 7 reports the identification of all Plasmodium falciparum centromeres 
by genome-wide localization of the universal centromeric histone variant CenH3 
and describes centromere gathering at the replicative-stages of intraerythrocytic 
development.
The experimental data described in this thesis is placed in the context of ongoing 
studies in the field of Plasmodium epigenomics and their contribution to 
generation of driving-hypothesis and new insights on the molecular mechanisms 
of Plasmodium epigenetics is discussed in Chapter 8. 
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AbsTRACT
The epigenetic contribution to the regulation and maintenance of gene expression 
patterns by histone modifications is well established in eukaryotes. In Plasmodium 
falciparum, the mechanisms and factors regulating gene expression during 
progression through its infected red blood cell cycle (iRBC) and underlying 
mutually exclusive expression of antigenic variation genes involved in immune 
evasion are far from understood. Recently, the first comprehensive analyses of the 
P. falciparum chromatin landscape at different iRBC stages have been performed. 
These studies uncovered the existence of well-defined heterochromatic regions 
within a generally euchromatic epigenome. Notably, silencing of genes encoding 
for virulence determinants such as var genes, appears to be orchestrated by the 
concerted action of the Sir2 and HP1 orthologs and the presence of the histone 
mark, H3K9me3. Epigenetic speciation could make the parasite exquisitely 
vulnerable to epigenetic drug treatment, unless this deadly parasite still has a 
number of tricks up his sleeves.
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inTRoDuCTion
The World Malaria Report 2009 announced 243 million cases of malaria, which led 
to death of an estimated 843,000 people in 2008. Malaria is thus still one of the 
most threatening diseases around the world. It is caused by species of a protozoan 
parasite of the genus Plasmodium, which infects human and mosquito. Underlying 
the virulence of P. falciparum, responsible for the most severe and lethal forms 
of the disease, are sophisticated mechanisms that enable the parasite to modify 
the RBC surface by expressing cell adhesion molecules such as PfEMP1. PfEMP1 
is encoded in the genome by the family of 60 var genes that are expressed in a 
mutual exclusive manner. Switches between var family members allow the parasite 
to display different antigenic forms and thus survive, prolong and repeat infection 
of its human host 162.
During P. falciparum infection of erythrocytes, parasites multiply and establish 
the clinical disease. Development in RBCs from rings, through trophozoites to 
schizonts and release of merozoites requires the expression of different sets of 
proteins, which is enabled by a precise and timely program of gene regulation 
139. The molecular machinery for control of gene expression is conserved to some 
extent in Plasmodium (reviewed by 144). However, transcription factors (TFs) and 
their binding sequences are less conserved and therefore more difficult to identify 
145. The epigenetic component of gene regulation in Plasmodium has gained a lot of 
attention in recent years. The epigenome is the sum of all chemical modifications 
and protein factors associated with the genome. Epigenomes are established 
and modulated at distinct levels such as DNA methylation, non-coding RNAs, 
nucleosome density and remodeling, histone post-translational modifications 
(PTMs) and incorporation of histone variants. Extensive surveys confirmed that 
the Plasmodium genome lacks DNA methylation 148 and the RNA interference 
machinery 160. Chromatin remodellers and histone modifying enzymes appear 
however well represented in the genome 163. Their contributions to the control of 
the developmental program during iRBC and to the parasite’s ability to evade the 
immune response are just beginning to be deciphered. In this review we will focus 
on the genome-wide aspects of epigenetic regulatory mechanisms in P. falciparum 
and will only briefly mention the control of antigenic variation that has been 
extensively reviewed in 164, 165.
Posttranslational modifications and variants of malaria histones
The core unit of the epigenome is the nucleosome, around which approximately 
150bp of DNA is wrapped. Each nucleosome consists of two copies of histones 
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H2A, H2B, H3 and H4. Histones are subject to numerous covalent PTMs that affect 
chromatin properties or serve as interaction platforms for chromatin modifying and 
transcription regulatory factors. Accurate characterization of the full complexity of 
histone PTMs is an ideal first step towards an understanding of their role in cellular 
events. P. falciparum histones have been identified by mass spectrometry (MS) 
153, 155. Most major types of PTMs identified on histones of evolutionary distinct 
eukaryotes are also found in Plasmodium (figure 1). 
Figure 1: chapter 2
figure 1. P. falciparum histone PTMs. The size of the bars indicates the relative abundance of each 
PTM based on extracted ion counts. Part of the figure is published at 156. The numbering of the H2AZ 
acetylated lysines has been updated from 155 by removing the –N-terminal Met. 
H3 and H4 PTMs related to the transcriptional permissive or active state of genes 
(i.e. H3K4me3, H3K9ac, H3K14ac and H4ac) were predominant over silencing 
related marks (i.e. H3K9me3 and H4K20me3) 155. Notably, the repressive H3K27me 
and the transcription-linked H3K79me were not detected. PTMs relevant for 
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heterochromatin formation (H3K9me3) and DNA replication (H3K56ac) in other 
eukaryotes are only found on H3 but not H3.3 155. Histone variants can further 
expand the epigenetic regulatory potential but their functions in Plasmodium 
are completely unknown. In the protozoan parasite Trypanosoma brucei, H2AZ 
and H2Bv are deposited at nucleosomes surrounding the transcription start site 
of polycistronic units providing a demarcation system that “compensates” for the 
lack of classic TFs binding motifs 48. In Plasmodium, the histone variants H2AZ and 
H2Bv are expressed in iRBCs and display heavily modified N-tails, contrasting with 
their canonical counterparts (155, figure 1). It is tempting to speculate that different 
chromatin environments are made up by associations of histone variants and fulfill 
specific functions in gene regulation.
Roles of epigenetic modifications in defining euchromatic regions
Plasticity in the epigenome is brought about by the dynamic activity of enzymes 
that place and remove histone PTMs. Deciphering the presumed correlation 
between histone modifications and the parasite’s global transcription program 
would greatly facilitate the development of drugs to fight the disease. Exploratory 
surveys of asynchronous iRBCs revealed defined heterochromatic regions, marked 
by H3K9me3, within a general euchromatic epigenome depleted of H3K9me3 
156, 166 (figure 2). At euchromatic regions, a rather homogenous enrichment of 
H3K4me3 and H3K9ac is present in intergenic regions. The PTMs are enriched 
towards the 5’ and 3’ end of genes and are at lower levels within gene bodies 156. 
Although this pattern of PTMs distribution did not reveal a correlation with the 
level of expression of genes, it was the first indication that the chromatin is in an 
open configuration for the greater part of the (epi)genome. Accordingly, recent 
quantitative transcriptome analyses using Next Generation Sequencing increased 
the fraction of transcribed genes in iRBC to 90% (167, our unpublished data). Such 
open chromatin may facilitate, but is unlikely to instruct, the swift changes in gene 
expression during the iRBC cycle.
Analysis in synchronous parasites led to the notion that epigenomic marking is 
indeed subject to changes during the iRBC. In ring stage parasites, active and 
inactive genes display a homogeneous pattern of H3K4me3 and H3K9ac over the 
gene body. In schizonts, however, active genes are more extensively marked at 
their 5’ end 156 (figure 2). These observations imply that the correlation between 
these histone PTMs and transcription hitherto universally observed 168 may not 
hold for all stages of Plasmodium iRBCs. It will be of interest to detail PTMs changes 
at more points throughout the cycle to uncover possible epigenomic “check 
points” (erasure and marking) and interfere with the underlying mechanism. 
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Interestingly, the lack of active gene marking in rings 156 coincides with the very low 
transcriptional activity found at this stage 169. The peak in transcriptional activity at 
late trophozoite and schizont stages may eventually relate to the extensive 5’ end 
gene marking.
Figure 2: chapter 2
 
figure 2. Plasmodium falciparum chromatin landscape. A. Nuclear architecture studies have shown 
that in P. falciparum heterochromatin domains are clustered in chromatin dense regions at the nuclear 
periphery (dark brown), while transcriptionally engaged euchromatic regions locate more centrally 
(light brown). B. At the chromosomal level, these heterochromatic and euchromatic structures can be 
distinguished by the localization of histone PTMs and associated proteins. Subtelomeric and intra-
chromosomal heterochromatic domains are characterized by elevated H3K9me3 (blue), HP1 (green) 
and depletion of H3K9ac (red). C. Zooming to the molecular level, to the transcriptional silent chromatin: 
Sir2A and Sir2B and possibly other HDACs are likely candidates to remove acetylation (red) from H3K9 
which in turn can be tri-methylated (dark blue) by a lysine methyltransferase (KMT) (predicted as SET3). 
This mark is subsequently recognized by effector proteins (i.e. HP1 and likely by histone modifying 
complexes) that orchestrate the compaction of the chromatin. When and how the formation of these 
heterochromatic domains is initiated is unknown but may involve PfSIP2. Boundaries between dense, 
antigen variant family encoding, to open chromatin are indicated by a purple square that could be 
“nailed down” by DNA elements and associated factors or could be loosely defined by opposing 
enzymatic activities. d. H3K9ac (red) and H3K4me3 (blue) localize to euchromatic intergenic regions 
established by the opposing activities of histone acetyltransferase (HATs, GCN5) and deacetylases 
(HDACs) or lysine methyltransferase (KMT) and demethylases (KDM). Intergenic regions of both 
expressed and silent genes harbor increased H3K9ac and H3K4me3 levels with somewhat clearer 
marking of the 5’ end of active genes at schizonts. 
The nucleosomal packaging of DNA influences the accessibility of the underlying 
DNA for transcription and every other nuclear process. Recently, it has been 
reported that in P. falciparum nucleosome positioning is dynamic through the 
cycle with increased relaxation through the ring and trophozoite and compaction 
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at schizont 170. Moreover, a relative depletion of nucleosomes at intergenic regions 
has been reported as opposed to transcribed regions 170, 171. These findings are 
puzzling considering the clear enrichment of H3K4me3 and H3K9ac at intergenic 
regions reported by Salcedo-Amaya and coworkers 156, 171. It is however possible that 
a less stable, but heavily modified, nucleosome subtype is positioned at intergenic 
regions, enabling a distinction between coding and non-coding sequences. Indeed, 
nucleosomes with reduced stability have been reported in other organisms and 
were found to associate with gene promoters 44.
Roles of epigenetic alterations in heterochromatin and antigenic variation
In eukaryotes, transcriptional dormant heterochromatic domains exhibit a 
number of hallmarks: DNA methylation, histone hypoacetylation, H3K9me3 
and H3K27me3. These marks facilitate the recruitment of factors, such as 
heterochromatin protein 1 (HP1) that initiate and spread chromatin compaction 
(reviewed in 168). H3K9 hypoacetylation, H3K9me3 156, 166 and HP1 157, 172 have been 
described to play a role in heterochromatin formation in Plasmodium, which is 
confined to subtelomeric regions as well as to a number of sharply separated intra-
chromosomal islands (figure 2). The H3K9me3-HP1 marked regions encode var 
genes and other multicopy gene families such as rifin, stevor and pfmc-2tm, which 
undergo expression switching. Notably, the region upstream of the single actively 
transcribed var gene is typically marked by histone PTMs such as H3K4me2, -me3 
and H3K9ac while H3K9me3 marks the stably repressed var genes 173. Importantly, 
in P. falciparum H3K9me3 is exclusively present on canonical H3 155. Its variant, H3.3 
has been reported to replace H3 at actively transcribed genes in many organisms 
(see i.e. in Tetrahymena, 174). It is tempting to speculate that the activation of a 
single var gene in the midst of a repressive heterochromatic environment is at least 
in part facilitated by H3 exchange and consequently the removal of H3K9me3- HP1 
from an inactive var gene. The almost perfect colocalization of (over)expressed HP1 
protein with the H3K9me3 sites suggests that the spreading of heterochromatin 
is tightly controlled 157 but DNA sequences and factors that maintain eu- and 
heterochromatin boundaries are elusive in P. falciparum. Recently, it was shown that 
an ApiAP2 DNA-binding protein, coined PfSIP2, binds to tandem repeats present 
at subtelomeric regions and could be involved in heterochromatin formation and 
chromosome end biology via recruitment of other factors (e.g. KMTs, HDACs, SNF2L) 
175. The general lack of PfSIP2 at intrachromosomal heterochromatic domains 
suggests that PfSIP2 is not the only candidate that could initiate heterochromatin 
formation. Although some factors required for heterochromatin formation and/or 
maintenance have been identified, we still lack insights in the sequence of events 
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orchestrating the silencing of antigenic variation genes. 
Var genes are situated in the nuclear periphery at chromatin dense regions where 
also the Silencing Information Regulator Sir2 is localized. Recently, a direct role of 
PfSir2 in virulence gene silencing has been shown. Different subsets of var and rifin 
genes displayed increased transcription in knock-out parasite lines lacking either 
one of the two Sir2 paralogs 176. Sir2A has been shown to deacetylate H3K9, H3K14 
and H4 N-tail 177. Thus, it is likely that in vivo the hypoacetylated status of the var and 
rifin gene families 156 is maintained by the deacetylase activity of PfSir2A and PfSir2B. 
However, H3K9me3-HP1 also decorate P. falciparum-specific multigene families 
whose expression was not altered by the Sir2 knock-outs. Whether their function 
is somehow related to antigenic variation and pathogenicity remains subject of 
investigation. Furthermore, P. falciparum genes that are inactive in iRBCs such as 
mosquito- and hepatocyte-specific genes are not associated with H3K9me3-HP1, 
indicating that H3K9me3 is not a general mark of gene silencing 156, 157. Likely other 
PTMs or transcriptional co-repressors are involved in maintaining their very low 
level of expression in iRBCs.
ConClusions & PeRsPeCTiVes
In light of the emerging resistance against currently employed anti-malarials, 
there is an urgent need for new strategies to combat the parasite. Enzymes 
involved in epigenetic regulation are likely drug targets as epigenetic changes are 
readily reversible. Although the Plasmodium enzymes share their overall domain 
structure with their human counterparts, they are not identical at the aminoacid 
level and thus (epi)drugs that selectively target the malaria enzymes could be 
developed. Evidence that HDAC inhibitors are effective anti-malarials in mice or 
cultured parasites has been reported (reviewed by 178). Moreover, the mechanism 
of action of a cyclic tetrapeptide HDAC3 (PfHDAC1) inhibitor has been deciphered 
in the closely related Toxoplasma gondii 179. The enzymes involved in the distinct 
heterochromatic marking of chromosomal regions encoding antigenic variation 
genes and the dynamic epigenetic patterns throughout the iRBC cycle may provide 
good targets for epidrugs. The variety of histone types and the multiplicity of 
histone PTMs utilized by P. falciparum stress the need to elucidate their function. In-
depth analysis of corresponding enzymes (complexes) will be essential to identify 
key pathways to be deregulated via administration of epidrugs. While much 
remains to be uncovered, our current knowledge suggests that the epigenome is a 
“weak spot” unless the parasite has additional tricks up his sleeves.
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AbsTRACT
Linear amplification for deep sequencing (LADS) is an amplification method that 
produces representative libraries for Illumina next generation sequencing within 
2 days. The method relies on attaching two different sequencing adapters to 
blunt-end repaired and A-tailed DNA fragments, where one of the adapters (B) is 
extended with the sequence for the T7 RNA polymerase promoter. Ligated and size-
selected DNA fragments are transcribed in vitro with high RNA yields. Subsequent 
cDNA synthesis is initiated from a primer complementary to adapter A, ensuring 
that the library will only contain full-length fragments with two distinct adapters. 
Contrary to the severely biased representation of AT- or GC-rich fragments in 
standard PCR-amplified libraries, the sequence coverage in T7-amplified libraries 
is indistinguishable from that of non-amplified libraries. Moreover, in contrast to 
amplification-free methods, LADS can generate sequencing libraries from a few 
nanograms of DNA, which is essential for all applications in which starting material 
is limited.
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inTRoDuCTion
Rationale
In recent years next generation sequencing (NGS) technology revolutionized the 
analysis of complex RNA/DNA samples and became an essential tool for nearly 
all fields of research, ranging from genome (re)sequencing, clinical studies and 
population biology 180. It enables parallel sequencing of millions of small DNA 
fragments for low per base costs in a short time. Besides de novo sequencing, NGS 
provides accurate information on the composition of complex (c)DNA samples, 
making it the method of choice for most, if not all, genomic applications (e.g. 
transcriptome analysis (RNA-Seq 181), profiling of methylated DNA 182, 183 or DNA-
associated proteins (ChIP-Seq 76, 98, 184)) and new applications for NGS appear 
frequently (e.g. single cell transcriptome analysis 185, directional RNA-Seq 186-188, 
GRO-seq 189, ribosome footprinting 190). Furthermore, NGS applications are under 
intense scrutiny to produce even more and better quality data 191-193.
Currently, the Illumina Genome Analyzer (GA) is the most widely used among the 
available NGS platforms 180. Libraries are prepared by ligation of specific bifurcated 
adapters to the ends of DNA fragments, which facilitate their capture on the surface 
of a flow-cell. Subsequently, each fragment is locally amplified to generate a cluster 
of identical sequences, which are subjected to reverse terminator sequencing (for 
more information see 194 or http://www.illumina.com/technology/sequencing_
technology.ilmn). Typically a single lane contains 25-30 million DNA fragments 
(clusters) that can be sequenced for up to 150 bases from one or both ends of the 
fragment. As in most applications the amount of starting material is limited, a PCR 
amplification step (18 cycles) is an inherent part of the manufacturer’s protocol 
(supplementary figure 1A).
This leads to a paradoxical problem, since PCR amplification is known to introduce 
strong bias in sample composition and fragments with high AT- or GC-content 
become under-represented or are completely lost during library preparation 
161, 188, 191, 195-197 (figure 1). These PCR-mediated changes introduced during 
sample preparation severely compromise the quality of the data, complicating 
data quantitation and representation (coverage), which can only be partially 
compensated for by deeper sequencing. This bias is especially detrimental 
to sequencing of ‘extreme’ genomes, like that of a human malaria parasite (P. 
falciparum, average AT-content ~80% 133), slime mold (D. discoideum, average AT-
content ~78% 198) and herpes B virus (average GC-content ~75% 199) or profiling of 
highly GC-rich CpG islands of cancer genomes. Therefore, development of a method 
resulting in linear amplification of NGS libraries is indispensable for sequencing 
of ‘extreme’ genomes and accurate quantification of all applications of NGS.
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Figure 1: chapter 3
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The linear amplification for deep sequencing method (LADS 161), described here 
in detail, utilizes the T7 linear amplification system, which has previously been 
successfully employed for linear amplification of DNA for array hybridization 156, 
200, 201. T7 amplification requires addition of the T7 promoter to DNA fragments 
enabling T7 RNA polymerase-mediated transcription in an in vitro reaction. T7 
RNA polymerase transcribes the same fragment multiple times yielding many RNA 
transcripts, hence amplifying the template in a linear rather than an exponential 
manner. The resulting RNA fragments are subsequently converted to cDNA in 
which the representation of different DNA fragments is highly similar to that of the 
original sample 200.
In LADS (figure 2) the T7 promoter is incorporated via adapter (B) ligation, which 
required synthesis of two separate adapters (A and B, Table 1) corresponding to 
the two strands of the Illumina adapter. These adapters are ligated to blunt-end 
repaired and ‘A’-tailed DNA, resulting in fragments with either two identical (A-A, 
B-B) or two distinct (A-B, B-A) adapters (figure 2). Since only fragments containing 
two different adapters can be sequenced on the Illumina platform, selection of 
fragments with both adapter A and B is key to LADS. This is achieved in two steps: 
figure 1: Comparison of 
different library preparation 
methods for illumina 
sequencing. Distribution of 
sequence reads in relation to GC-
content in shotgun sequencing 
data obtained from P. falciparum 
(A) and M. tuberculosis (b) 
genomic DNA prepared by 
different amplification methods. 
Note that overrepresentation 
of fragments with 40-60% GC-
content in PCR amplified P. 
falciparum library is a relative 
overrepresentation due to the 
severe underrepresentation of 
AT-rich sequences comprising 
about 40% of the genome 
(grey area highlights deviation 
from expected coverage in PCR 
amplified libraries). Normalized 
read density is plotted as log2 
ratio of expected read density 
per 150bp window for different 
GC-content. figure 1a has been 
modified from ref. 161. For details 
about preparation and analysis 
of M. tuberculosis samples see 
supplementary figure 2. 
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i) due to the presence of the T7 promoter on adapter B, only fragments bearing 
adapter B (A-B, B-A, B-B) are transcribed into RNA during in vitro transcription 
(A-A type fragments are not transcribed to RNA and lost during subsequent 
RNA purifi cation). ii) subsequent cDNA synthesis is initiated from a primer 
complementary to adapter A (P5, figure 2 and Table 1) resulting in the exclusive 
conversion of fragments with A-B/B-A adapters (B-B type fragments are not 
converted into cDNA and removed by RNA degradation) (figure 2). The resulting 
library can be directly used for Illumina deep sequencing. 
Figure 2: chapter 3
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figure 2:  Workfl ow of lADs. Double stranded DNA fragments are fi rst blunt-end repaired, 
phoshorylated and A-tailed (Steps 1-8). Subsequently, T-tailed adapters, containing sequences used 
during cluster formation (P5 and P7) and sequencing (S1-2) on the Illumina platform or for in vitro 
transcription (T7 promoter in adapter B), are ligated to each fragment (Steps 9-11). After removal 
of excess adapters and size selection (Step 12), adapter B containing fragments (A-B, B-A or B-B) are 
subjected to in vitro transcription resulting in multiple RNAs per template DNA (Steps 13-17). First 
and second strand cDNA synthesis (Steps 18-29) are initiated by adapter specifi c primers (P5 or P7, 
respectively) ensuring that only fragments with two distinct adapters will be present in the library. 
Proof-of-principle for this method was provided by sequencing of genomic DNA 
from the extremely AT-rich genome of the malaria parasite Plasmodium falciparum 
161 and the very GC-rich genome of Mycobacterium tuberculosis (average GC-
content ~65% 202) (figure 1b and supplementary figure 2). This analysis showed 
that, contrary to PCR amplifi ed libraries in which sequences with more than 80% 
AT-content were severely reduced or even completely absent, the T7 amplifi ed 
library enabled sequencing of the up to 100% AT centromeres of P. falciparum and 
preserved the original sample composition (see figure 1 in ref. 161, and figure 
1A). On the other side of the spectrum, M. tuberculosis DNA fragments with more 
than 80% GC-content were reduced upon PCR amplifi cation, but maintained in the 
LADS library (figure 1b and supplementary figure 2). Therefore LADS results 
in robust and quantitative data and thus superior analysis for a plethora of NGS 
applications.
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Table 1: Oligos required for LADS
Name Sequence (5’-3’)
Adapter-A-For & AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC*T
Adapter-A-Rev & PGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCGTATCATT
Adapter-B-For & GAATTTAATACGACTCACTATAGGGACAAGCAGAAGACGGCATACGAGATCGGTCTCG-
GCATTCCTGCTGAACCGCTCTTCCGATC*T
Adapter-B-Rev & PGATCGGAAGAGCGGTTCAGCAGGAATGCCGAGACCGATCTCGTATGCCGTCTTCT-
GCTTGTCCCTATAGTGAGTCGTATTAAATTC
P5 # AATGATACGGCGACCACCGA
P7 CAAGCAGAAGACGGCATACGA
& Adapter oligos should be minimally PAGE purified, but ideally prepared by double purification (e.g. 
double PAGE, HPLC-PAGE) (CRiTiCAl!)
# Should be synthesized and kept RNase-free (CRiTiCAl!)
P 5’ phosphate group (CRiTiCAl!)
*  phosphorothioate linkage that can stabilize the overhanging thymidine (OPTIONAL)
T7 promoter sequence is underlined, P5 primer sequence is red, P7 primer sequence is blue, sequencing 
primer 1 is green,  sequencing primer 2 is orange
Applications of lADs
In principle, LADS can be applied to all types of NGS applications in which the 
starting material for sequencing is double stranded DNA and it is particularly 
beneficial when the starting material is limited and amplification is inevitable. 
However, directionality is not maintained in this protocol, complicating its 
application to directional transcriptome analysis (see “Limitations of LADS”, below). 
So far we successfully applied LADS for three different applications (shotgun 
genome (re)sequencing, ChIP-seq and transcriptome analysis) on the highly AT-
rich genome of the human malaria parasite, Plasmodium falciparum 161. Shotgun 
sequencing following LADS yielded a much more uniform coverage of the malaria 
genome compared to PCR amplified samples (see figure 1 in ref. 161). Such uniform 
coverage makes sequencing more cost efficient and allows complete genome 
sequencing from limited DNA samples (for example non-cultivatable field isolates 
or forensic samples). LADS also enabled the accurate genome-wide localization 
(ChIP-seq) of histone marks/variants that associate with highly AT-rich parts of 
the malaria genome (see figure 3 in ref. 161). Similarly, LADS should improve 
quantitation when profiling CpG dense promoters for DNA methylation (MeDip, 
MethylCap) or transcription factor binding (ChIP-seq). Finally, LADS enabled highly 
quantitative analyses of the P. falciparum transcriptome during intraerythrocytic 
development (see figure 4 in ref. 161) and improved coverage of the AT-rich 
untranslated regions (W.H, R.B & H.S. unpublished data). With slight modification 
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of adapter A (see supplementary Table 1 for a small set of “barcoded” adapters 
as an example) LADS can be applied for parallel sequencing (i.e. multiplexing) of 
multiple samples in a single lane (R.B. unpublished data).
Comparison to other bias-prevention strategies
LADS was developed to circumvent severe sequence bias resulting from PCR 
amplification of Illumina sequencing libraries (supplementary figure 1A). 
Previously, Kozarewa and colleagues 191 reported an amplification-free method 
(supplementary figure 1b), which efficiently tackles this problem but only if 
several hundred nanograms of DNA is available for library preparation. However, 
the method cannot be used when only limited amount of starting material is 
available. Therefore, LADS will provide a solution for many applications where 
material is limited, such as sequencing of clinical isolates, ChIP-seq, RNA-seq and 
ribosome footprinting. Alternatively, true single molecule sequencing technology, 
such as Helicos Genetic Analysis System (Helicos BioScience Cooperation 195) or 
Pacific Bioscience SMRT technology (www.pacificbiosciences.com, 203) could allow 
sequencing of small amounts of DNA/RNA without amplification. However, Helicos 
Genetic Analysis System is no longer available to the general marketplace, while 
SMRT technology just became available to the research community. Therefore, 
unbiased library amplification is still indispensable for most applications of NGS.
T7 in vitro transcription is not the only linear amplification technology available. 
Another well-known alternative is rolling circle amplification (RCA) 204, 205, in which 
a highly processive DNA polymerase generates hundreds of concatenated copies 
from a circularized template. Similar to T7 in vitro transcription, RCA has very 
high replication fidelity and results in linear amplification of the input material 
206. Therefore, during development of LADS we also considered this method, but 
finally decided to use T7 amplification, as it was easier to adapt to the Illumina 
sequencing platform. RCA, however, could be considered for selective enrichment 
of the template 207 followed by amplification-free library preparation or LADS.
limitations of lADs
Similar to the standard library preparation protocol, strand information is not 
maintained in LADS (i.e. the sequence read obtained can correspond to the 
sense/Crick or antisense/Watson strand of the original DNA/RNA fragment with 
equal probability). Accordingly, if directionality needs to be maintained, it has to 
either be introduced before adapter ligation or requires modification of the LADS 
protocol. For example, directional RNA-seq is directly compatible with LADS if a 
‘barcode’ is incorporated on the reverse strand during first strand cDNA synthesis 
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while generating the ds cDNA to start LADS.
A known limitation of the T7 amplification system is caused by the premature 
termination of T7 RNA polymerase on certain low complexity sequences 208. 
Accordingly, we observed a reduction in signal in the LADS library compared to 
amplification-free control for a set of ~100 regions of the Plasmodium falciparum 
genome. Since, these sequences were found to comprise short telomeric 
repeats or long homopolymeric polyA or polyT stretches we assume that the 
underrepresentation of these sequences resulted from such premature termination 
events. Given that ~50% of these regions are located in difficult to map/assemble 
repetitive regions and they comprise a minuscule fraction of the genome 
(~0.07%) we believe that this limitation is negligible compare to the advantages 
brought about by LADS. Moreover, if needed, this premature termination can be 
circumvented by lowering the temperature during in vitro transcription 209, but at 
the cost of a lower yield.
experimental design
LADS involves many steps (summarized in figure 3), but rather few at which 
efficient processing of the sample can be monitored. Therefore we recommend 
the use of a control sample to set up the entire protocol first. This can be useful to 
pinpoint problems (see Table 2 for details) and could prevent wasting precious 
experimental material. Such control sample should contain a DNA fragment of a 
distinct size (~200bp) that has been prepared by restriction enzyme digestion. 
Any representative PCR fragment of distinct size could be used as control and 
restriction sites can be incorporated via the primers. The restriction enzyme needs 
to be a non-blunt cutting enzyme that does not leave a 3’ A-overhang, so that both 
end-repair (Steps 3-5 in PROCEDURE) and A-tailing (Steps 6-8 in PROCEDURE) are 
required for efficient adapter ligation. Using 40ng of control fragment, efficiency 
of adapter ligation can be easily monitored on the gel (fragments with only one 
A-adapter, fragments with only one B-adapter and fragments with an adapter on 
each side will give distinct size-shifts on the gel and will reveal the efficiency of 
adapter ligation).
The Illumina sequencing platforms give maximum performance with fragments 
of a distinct size (e.g. ~300bp including adapter sequences). Accordingly a size 
selection step is included in the LADS protocol (see PROCEDURE Step 12) and it 
is advisable that the majority of the fragments in the starting material is around 
150-200bp long (the adapters add 145bp to the fragment). This can be achieved 
by numerous means depending on the type of starting material: i) for genomic 
DNA or for cross-linked chromatin we use sonication 161, but other mechanical 
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or enzymatic methods can also be used 197  ; ii) native chromatin can be digested 
to mononucleosomal DNA fragments using MNase 97, 161 ; iii) while for RNAseq 210 
hydrolysis of the RNA 211 followed by random primed cDNA synthesis worked best 
for us 161. 
Table 2: Troubleshooting table  
 
Step Problem Possible reason Solution
12 Two distinct bands 
corresponding to 
the adapters (~58 
and 87 bp) are not 
visible.
Lack of either or 
both adapters in the 
ligation reaction.
Ensure that the adapters are appropriately 
prepared and added to the ligation reaction. 
No sample visible on 
the gel besides the 
adapters.
Too low amount of 
starting material.
Try to increase the amount of starting material. 
Make sure that most of your starting DNA is 
double stranded, in a confined size range and not 
denatured.
Unexpected ladder 
visible at the sample 
lane
Concatenation of 
the adapters
Ensure that only reverse adapter oligos carry the 5’ 
phosphate group. Use the ligase described in this 
protocol and not ligase from a different source.
Lack of size shift 
(~150 bp) for 
samples at a distinct 
size or control 
fragment.
Inefficient ligation Ensure that all reactions including and prior 
to ligation are optimally set up. (The use of a 
positive control fragment of distinct size (see 
“Experimental Design”) can be helpful to visualize 
and troubleshoot this problem.)
17 Low RNA yield RNase 
contamination
Use RNase free solution and labware. Keep your 
bench and surrounding area clean. Change gloves 
regularly during these steps. 
Inefficient in vitro 
transcription
Make sure that adapters are efficiently ligated 
to the sample fragments (see above). Follow the 
instruction of the MEGAscript T7 Kit closely.
Inefficient retrieval 
from gel
In case of the E-gel system (Step 12A) include 
more collection steps by running the gel (program 
8) and collecting every 10 sec followed by reverse 
running (program 5) and collecting every 10 sec, 
to increase the amount of material retrieved from 
the gel.
In case of using ‘regular’ gel electrophoresis 
(Step 12B) excision of a broader fragment might 
increase yields after size selection. Otherwise, 
changing to E-gel system might increase yield.
26 Low cDNA yield RNase contamina-
tion during first-
strand synthesis
Use RNase free solution and labware. Keep your 
bench and surrounding area clean. Use new 
gloves for setting up this reaction. 
Inefficient first- or 
second-strand syn-
thesis
Ensure that the reaction is set up and incubated 
according the protocol. Make sure that the primers 
are used at the correct order (P5 during first-
strand and P7 during second-strand synthesis).
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Figure 3: chapter 3
Preparation of starting material
1 hour
Steps 1-2
Purification and quantitation of starting material.
End repair
1.5 - 2 hours
Steps 3-5
This step ensures that DNA ends are blunt and
phosphorylated.
‘A’-tailing
1.5 - 2 hours
Steps 6-8
This step adds an adenine to the 3’-end of each DNA  
fragment and enables ligation to the
adapters (containing a ‘T’-overhang) later on.
Adapter ligation
1.5 - 2 hours
Steps 9-11
This step covalently joins adapters (either one  A-type and 
one B-type, or two  A- or B-type) to the ends of
each DNA fragment.
Size selection
1 - 3 OR >2 hours
Step 12
This step removes the excess of adapter oligos and
selects a narrow size range of fragments for optimal 
sequencing results. 
In vitro  transcription
12 - 16 hours
Steps 13-17
In this step all fragments containing at least one B-type 
adapter will be translated to multiple RNAs resulting in 
amplification.
cDNA synthesis
3 - 4 hours
Steps 18-28
This step converts the amplified RNA to cDNA.  The use of 
adapter- A specific primer in the first strand synthesis 
reaction ensures that only fragments with 2 different 
adapters get converted
figure 3: flowchart of experimental procedure. The flowchart summarizes the main stages of LADS, 
explains the purpose of each, indicates the time required and the corresponding steps of the protocol. 
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It is pertinent that all DNA fragments in the starting material are in a double 
stranded state. Therefore, care must be taken to avoid denaturation of DNA 
fragments during the preparation of starting material (e.g. heat-inactivation 
of enzymes after cDNA synthesis) or the library itself (e.g. gel extraction 193). For 
example, for decross-linking of formaldehyde cross-linked chromatin samples from 
P. falciparum, we recommend 45°C O/N incubation in the presence of 500mM NaCl 
as this better preserves the representation of high AT-rich sequences (shown by 
qPCR in supplementary figure 3). 
QC of the starting material: Given that preparation and sequencing of LADS 
libraries is rather expensive, it is important to perform quality controls (QC) 
minimally at the beginning and at the end of the procedure. Samples must be free 
from any contaminants (e.g. salt, phenol, enzyme). Therefore, in most cases, we 
recommend column purification of the starting material (see PROCEDURE Steps 
1-2). Accurate quantification of the starting material is also critical as for optimal 
sample preparation each sample should contain a minimum of 3 (although 
less might work), but not more than 40 nanograms of double stranded DNA in 
a maximum volume of 40 ml to start Step 3 of PROCEDURE (for samples with a 
broad size range starting from <10ng is not recommended). For quantification we 
recommend the use of a highly sensitive fluorescence based technology that can 
differentiate between double stranded DNA and ssDNA/RNA (e.g. Quant-iT dsDNA 
HS Assay Kit from Invitrogen).
QC after library preparation: For proper estimation of the cluster number on 
the sequencing platform it is essential to accurately quantify the concentration 
of the LADS library. For this purpose we found the Quant-iT dsDNA HS Assay Kit 
(Invitrogen) to be most accurate. It is also essential that most fragments in the library 
are full-length and contain two distinct adapters (A+B). The size distribution of the 
library can be checked on an Automated Electrophoresis System (e.g. Bioanalyzer 
from Agilent Technologies or Experion from BioRad) and should be comparable to 
that of the fragments excised during size selection (PROCEDURE Step 12) minus 
the length of the T7 promoter (26 bp). The presence of the adapters can be tested 
by performing qPCR on a fraction of the library using adapter-specific P5 and P7 
primers (Table 1, Steps 27-28 PROCEDURE). The Ct value for 50 fg library on the 
MyIQ real time PCR machine (BioRad) in our hands is very consistently in the range 
of 16-17.5 for P. falciparum, but it is likely to differ depending on the insert length, 
the species to be sequenced or the setup used.  
Finally, undesired changes in sample composition could be monitored by 
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comparing the representation of a handful of fragments (e.g. exon, ChIP enriched 
region) in the original material and in the LADS library by qPCR. However, care must 
be taken when selecting primer-sets, as amplicons approximating the library insert 
size will give poor signals in the qPCR of the size selected, but not the starting 
material (For example a 250bp amplicon will show a relative depletion in a size-
selected library with an average insert size of 200bp when compared to the non-
selected starting material).
MATeRiAls
Reagents
Reagents
T4 DNA polymerase (New England Biolabs; www.neb.com; cat# M0203L or M0203S)
DNA Polymerase I, Large (Klenow) Fragment (New England Biolabs; www.neb.com; cat# 
M0210L or M0210S)
Klenow Fragment (3´→5´ exo–) (New England Biolabs; www.neb.com; cat# M0212L or 
M0212S) including NEBuffer 2
T4 polynucleotide kinase (New England Biolabs; www.neb.com; cat# M0201L or M0201S)
T4 DNA ligase buffer (Promega; www.promega.com; cat# C1263)
LigaFast™ Rapid DNA Ligation System (Promega; www.promega.com; cat# M8221 or 
M8225) containing T4 DNA ligase and 2x rapid ligation buffer CRiTiCAl: Use of DNA ligase 
from another source may cause concatenation of the adapters when removal of adapter 
T-overhangs occurs due to contaminating exonuclease activity. This potential exonuclease 
activity is only problematic if the adapters do not contain the phosphorothioate-bond for 
stabilization of the overhanging T.
Certified Low Range Ultra Agarose (BioRad; www.biorad.com; cat# 161-3107) 
GelStar® Nucleic Acid Gel Stain (Lonza; shop.lonza.com; cat# 50535) CAuTion: Potentially 
mutagenic and carcinogenic. Handle with care, wear double gloves and eye protection.
50x Tris/Acetic Acid/EDTA (TAE; BioRad; www.biorad.com; cat# 161-0743)
Orange G (Sigma-Aldrich; www.sigmaaldrich.com ; cat# O3756-25G or O3756-100G)
Ultrapure glycerol (Invitrogen; www.invitrogen.com; cat# 15514-011 or 15514-029)
100 bp DNA Ladder (Invitrogen; www.invitrogen.com; cat# 15628-019 or 15628-050)
MEGAscript® T7 Kit (Ambion; www.ambion.com; cat# AM1333, AM1334 or AMB1334-5) 
containing 10x T7 reaction buffer, 10x T7 enzyme mix, ATP, CTP, GTP and UTPs CRiTCAl: Use 
of alternative kits, e.g. MEGAshortscript T7 kit (Ambion), may result in truncated products 
and/or lower yield
Quant-iT Assay Kits for double stranded DNA (HS) and RNA (Invitrogen; www.invitrogen.
com; cat# Q32851 or Q32854 and Q32852 or Q32855) CRiTiCAl: Only highly quantitative 
technologies (e.g. Quant-iT, Picogreen) enable precise quantification of the final DNA yield. 
Use of inferior measurement methods (e.g. Spectrophotometer) might result in under-/
overloading of the flowcell.
SuperScript® III Reverse Transcriptase (Invitrogen; www.invitrogen.com; cat# 18080-044 or 
18080-085) including 5x first stand buffer and DTT
Nuclease-free water (e.g. Ambion; www.ambion.com; cat# AM9930, AM9932, AM9937, 
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AM9938, AM9939 or 4387936)
14.3M β-mercaptoethanol (e.g. Merck; www.merck-chemicals.com; cat# 444203-250ML) 
CAuTion: Toxic by inhalation, ingestion and through skin contact. Handle with care, wear 
gloves and eye protection. Preferably handle in a hood.
100% Ethanol (e.g. Merck; www.merck-chemicals.com; cat# 1009831000) CAuTion: highly 
flammable liquid and vapor. Keep away from fire.
RNasin® Plus RNase Inhibitor (Promega; www.promega.com; cat# N2611 or N2615)
Ribonuclease H, E. coli (Ambion; www.ambion.com; cat# AM2292 or AM2293)
Ribonuclease A (Ambion; www.ambion.com; cat# AM2274)
dNTP mix (Invitrogen; www.invitrogen.com; cat# 10297-018) 10mM mix of dATP, dTTP, dCTP 
and dGTP
QIAquick PCR purification kit (Qiagen; www.qiagen.com; cat# 28104 or 28106)
QIAquick Gel extraction kit (Qiagen; www.qiagen.com; cat# 28704 or 28706)
MinElute PCR purification kit (Qiagen; www.qiagen.com; cat# 28004 or 28006)
RNeasy MinElute cleanup kit (Qiagen; www.qiagen.com; cat# 74204)
equipment
DNase/RNase-free filter tips (available from several suppliers, we obtained ART® Aerosoal 
resistant tips from Molecular BioProducts; www.mbpinc.com; cat# 2139, 2149P, 2069 and 
2279)
1.5ml reaction tubes (e.g. Eppendorf; www.eppendorf.com; cat# 0030-123.328)
Temperature controlled benchtop centrifuge (e.g. Eppendorf; www.eppendorf.com; cat# 
5415 R)
Agarose gel electrophoresis unit (e.g. BioRad Sub-Cell Systems; www.bio-rad.com) and Dark 
Reader transilluminator (ClareChemical; www.clarechemical.com; cat# DR46)
or
E-Gel® iBase™ Power System (Invitrogen; www.invitrogen.com; cat# G6500) and E-Gel® 
SizeSelect 2% gels (Invitrogen; www.invitrogen.com; cat# G6610-02)
Qubit™ fluorometer (Invitrogen; www.invitrogen.com; cat# Q32857)
Incubator (e.g. Thermomixer comfort (Eppendorf; www.eppendorf.com; 5355 000.011 and 
5360 000.011))
Quantitative PCR machine (e.g. MyiQ2 Two-Color Real-Time PCR Detection System; BioRad; 
www.bio-rad.com)
Thermal cycler (e.g. PTC-200 PCR machine; MJ Research)
Reagent setup
Preparing adapters: 
Synthesize sequencing adapters as single-stranded oligos described in Table 1. CRiTiCAl: 
oligos should be minimally PAGE purified but for optimal efficiency double purification (e.g. 
double PAGE or HPLC-PAGE) is recommended.
Dissolve oligos in annealing buffer (10mM Tris pH8.0, 50mM NaCl, 1mM EDTA) at 100uM 
concentration. Mix complementary oligos (e.g. Adapter-A-For and Adapter-A-Rev) in 
equimolar concentration, heat them to 96°C for 2min followed by cooling to room 
temperature (~22°C) at a rate of 2°C/min in a PTC-200 PCR machine (MJ Research). Mix A- 
and B-type double stranded oligos in equimolar ratio, purify with QIAquick PCR Purification 
Kit, quantify using Quant-iT HS Assay Kit for double stranded DNA, dilute to 50 ng/ml and 
store them in single use aliquots at -20°C CRiTiCAl: multiple freeze-thaw cycles might result 
in the loss of the overhanging “T” base. 
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Preparing loading Dye:
Prepare a solution of 0.25% Orange G (0.25 gram per 100ml), 30% ultrapure glycerol and 
12% 50x TAE buffer in nuclease-free water. Vortex until the Orange G is completely dissolved 
and store at room temperature. Alternatively, ready-to-use Loading Dye can be purchased 
from New England Biolabs (www.neb.com; cat# B7022S).
PRoCeDuRe
Purification and quantification of starting material TiMing 1h
1|  Purify your sample with Qiagen PCR purification kit according to the 
manufacturer’s instructions. Elute in 40 µl EB buffer. CRiTiCAl sTeP: Samples 
must be free from contaminants (e.g. salt, enzyme, phenol) that could interfere 
with downstream reactions. 
2|  Measure dsDNA concentration with a Quant-iT HS Assay Kits for double 
stranded DNA. CRiTiCAl sTeP: Make sure that the measurement method of 
your choice is accurate for low quantities of DNA and can differentiate between 
dsDNA and ssDNA/RNA. Each sample should contain a minimum of 3 ng of 
double stranded DNA in a maximum volume of 40 µl. However, more than 40 
ng starting material might result in inefficient reactions. The majority of the 
DNA fragments should be in the range of 150-300bp (e.g. 100-600bp). 
 PAuse PoinT: Can be stored at -20°C for few months. 
end repair TiMing 1.5-2h
3|  Set up 50 µl reaction for each DNA sample as follows:
Component Volume Final
dsDNA 0.5 - 40 µl 3 - 40 ng^
ddH2O 0 - 40 µl (dsDNA and ddH2O 
together should add up to 40 µl)
-
T4 DNA ligase buffer (10x) with 10 mM ATP 5 µl 1x
dNTP mix (10mM each) 2 µl 0.4 mM each
T4 DNA polymerase (3 U/µl) 1 µl 3 U
DNA Polymerase I, Klenow Fragment (1 U/µl) 1 µl* 1 U
T4 polynucleotide kinase (10 U/µl) 1 µl 10 U
^ For samples with a large fragment size-range (sonicated DNA/chromatin, ds cDNA) starting <10ng is 
not recommended.
* DNA Polymerase I, Klenow Fragment (5 U/µl) first needs to be diluted 1:5 with ddH2O in order to obtain 
a 1 U/µl solution. This dilution should be prepared fresh and cannot be stored. 
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4|  Incubate in a thermomixer/incubator for 45 minutes at 20ºC.
5|  Follow the instructions in the Qiaquick PCR Purification Kit to purify and elute 
in 34 µl of EB buffer. Typical yield after column purification is 60-70% of starting 
material.
‘A’-tailing TiMing 1.5-2h
6|  Set up 50 µl reaction for each DNA sample as follows:
Component Volume Final
Blunt-ended, phosphorylated DNA sample 34 µl From Step 5
NEBuffer 2 (10x) 5 µl 1x
dATP (1 mM) 10 µl 0.2 mM
Klenow Fragment (3´→ 5´ exo–; 5 U/µl) 1 µl 5 U
7|  Incubate in a thermomixer/incubator for 45 minutes at 37ºC.
8|  Follow the instructions in the MinElute Reaction Cleanup Kit to purify and elute 
in 10 µl of EB buffer. Typical yield after column purification is 75-90% of input.
Adapter ligation TiMing 1.5-2h
9|  Set up 30 µl reaction for each DNA sample as follows:
Component Volume Final
‘A’-tailed DNA sample 10 µl From Step 8
Rapid ligation buffer (2x) 15 µl 1x
Adapter oligo mix (50 ng/µl) 1 µl 1.67 ng/µl
T4 DNA ligase (3 U/µl) 4 µl 12 U
 CRiTiCAl sTeP: The use of alternative ligases might result in undesired 
concatenation of the adapter sequences. 
10|  Incubate for 45 minutes at room temperature.
11|  Follow the instructions in the MinElute Reaction Cleanup Kit to purify and elute 
in 10 µl of EB buffer. Typical yield after column purification is 75-90% of input.
 PAuse PoinT: Can be stored at -20°C for few months. 
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size selection
12|  Due to better reproducibility and user friendliness we prefer to use the E-gel 
system (option A), but traditional agarose gel electrophoresis (option B) can 
work equally well. When working with low amount of sample (starting material 
<10 ng) the use of E-gel system (option A) is recommended to improve the 
yield from size selection. Yields vary greatly, depending on size distribution of 
fragments in the starting material.
(A) size selection on e-gel system TiMing 1-3h
(i)  Insert the E-Gel SizeSelect 2% gel into the E-Gel iBase Power System. 
(ii)  Add 10 µl ddH2O to 10 µl adapter ligated DNA sample from Step 11. 
(iii)  Load the gel as follows:
  20 µl sample into each well of the top row.
  5 µl 100bp DNA ladder (50 ng/µl) into middle well (lane M).
  20 µl ddH2O into all empty wells (top row).
  25 µl ddH2O into all collection wells and 10 µl for lane M of the bottom row.
(iv)  Place the amber filter over the E-Gel iBase.
(v)  Select Run SizeSelect 2% (program 8) and set time to 16 minutes.
(vi)  Stop the run after ~13min and collect all liquid (10-15 µl) from the collection 
wells CRiTiCAl sTeP: check if ladder is at ~220bp as running time might vary 
with the lot of E-Gel SizeSelect 2% gel.
(vii)  Fill the collection wells with 20 µl ddH2O and run for another 10-15 sec. 
Repeat this step >5 times until you collected DNA fragments in the size range 
of 220 – 320bp CRiTiCAl sTeP: For samples with <10 ng of starting material, 
more collections and use of the reverse run option (program 5) are highly 
recommended to increase yield. When samples do not appear in the 200-
300bp range (e.g. fragment range is slightly higher), a different range should 
be collected.
(viii) Purify the size selected DNA over MinElute column and elute it with 16 µl EB 
buffer. CRiTiCAl sTeP: Use RNase free tubes for collection of the eluate.
(b) size selection via gel electrophoresis TiMing >2h depending on number 
of samples and number of gel electrophoresis units
(i)  Prepare a 2 % agarose gel with TAE buffer (1x) containing GelStar (1:100000). 
CAuTion: GelStar is potentially carcinogenic and mutagenic. Always wear 
appropriate gloves and avoided inhaling the fumes of the gel.
(ii)  Mix each 10 µl adapter ligated DNA sample from Step 11 with 10 µl loading 
dye. CRiTiCAl sTeP: Lower concentration of the loading dye might result in 
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samples floating out of the well.
(iii)  Load 100 ng of 100bp DNA ladder to one lane of the gel. Load the entire 
sample in another lane of the gel, leaving at least one empty lane between 
ladder and sample. CRiTiCAl sTeP: To avoid cross-contamination between 
samples load only one sample per gel.
(iv)   Run the gel at 8V/cm for about 60 minutes. 
(v)   Excise a region of the gel with a clean scalpel on a Dark Reader transilluminator. 
The gel slice should contain fragments in the 300 ±25bp range (If the starting 
material is limited a broader range might be selected to obtain better yield. 
However you should not include fragments bellow 200bp). CRiTiCAl sTeP: 
Do not use traditional UV transilluminator as longer exposure to UV light can 
damage your DNA sample.
(vi)   Use a QIAGEN Gel Extraction Kit to purify the DNA on a MinElute Column from 
the agarose slices and elute DNA in 16 µl. CRiTiCAl sTeP: To avoid selective 
denaturation of highly AT-rich fragments do not heat your gel slice to 50°C, 
but rather perform the extraction at room temperature15. This can be achieved 
by gentle agitation and prolonged incubation of the gel slice in chaotropic as 
described by Quail and colleagues15. Use RNase free tube for collection of the 
eluate.
TRoublesHooTing
PAuse PoinT: Can be stored at -20°C for few months. 
in vitro transcription TiMing 12-16h
13|  Set up 39 µl reaction for each sample as follows (using reagents from 
MEGAscript T7 Kit):
 CRiTiCAl sTeP: Use of the MEGAshortscript T7 kit, which is designed for 
efficient transcription of short DNA fragments, in our hands results in multiple 
undesired truncated RNAs. 
Component Volume Final
Adapter-ligated and size-selected DNA 16 µl From Step 12
T7 Reaction buffer (10x) 4 µl 1x
NTP mix (18.75mM each) 16 µl 7.5mM each
Enzyme mix (10x) 3 µl 0.75x
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CRiTiCAl sTeP: Dissolve any precipitates in the reaction buffer before using it.
14| Incubate the reaction in an incubator at 37°C overnight.
15|  Add 1µl Enzyme Mix in the morning and incubate it for additional 2h.
16|  Follow the instructions in the RNeasy MinElute cleanup kit to purify and elute 
in 10 µl RNase-free H2O. Use RLT buffer with 1% β-mercaptoethanol. CAuTion: 
β-mercaptoethanol is toxic by inhalation, ingestion and through skin contact. 
Always wear appropriate gloves and eye protection and handle in a fume hood 
to prevent inhalation.
17|  Measure the concentration of the RNA using 1 µl sample and the Quant-iT 
Assay Kits for RNA. The expected concentration should be in the range of 5-100 
ng/µl.
 TRoublesHooTing
 PAuse PoinT: Before or after purification amplified RNA can be stored at -80°C 
for few months. 
 cDnA synthesis TiMing: 3-4h 
18|  Mix 8 µl T7 amplified RNA from Step 16 with 1 µl P5 primer (100 µM) and 
incubate at 70°C for 10 min, and then put it on ice for 2 min.
19|  Set up 20 µl reaction for each sample as follows:
Component Volume Final
Amplified RNA with P5 primer 9 µl 50-1000 ng (from Step 18)
First strand buffer (5x) 4 µl 1x
DTT (100 mM) 2 µl 10 mM
dNTP mix (10 mM each) 2 µl 1 mM each
RNasin RNase Inhibitor (40 U/µl) 1 µl 40 U
Superscript III  (200 U/µl) 2 µl 400 U
 CRiTiCAl sTeP: Add the reverse transcriptase (Superscript III) only after the 
reaction is warmed to 42 °C.
20|  Incubate for 1 hour at 42 °C.
21|  Add 0.5 µl RNase H (10 U/µl) and 0.5 µl RNase A (1 µg/µl) to each sample and 
incubate at 37°C for 15 min.
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22|  Set up 149 µl reaction for each sample as follows:
Component Volume Final
First strand synthesis reaction 21 µl From Step 21
ddH2O 109 µl -
NEBuffer 2 (10x) 15 µl 1x
P7 primer (100 µM) 1 µl 667 nM
dNTP mix (10 mM each) 3 µl ~0.3 mM each
23|  Denature at 96°C for 3 min and let it cool to 37°C (annealing) for ~5 min. 
24|  Add 1 µl Klenow Fragment (3´→5´ exo–) (5 U/µl) and incubate at 37°C for 1 
hour. CRiTiCAl sTeP: Use of DNA polymerase I instead of the Klenow fragment 
will result in truncation of the adapter sequence and consequently insufficient 
capturing on the flowcell.
25|  Follow the instructions in the Qiaquick PCR Purification Kit to purify and elute 
in 20 µl of EB buffer.
26|  Measure dsDNA concentration with a Quant-iT HS Assay Kits for double stranded 
DNA. The expected concentration should be in the range of 1-25ng/µl.
 TRoublesHooTing
27|  Test the presence of both adapters on each fragment by a P5-P7 qPCR. Make 
a serial dilution of each sample (100 fg/µl, 10 fg/µl, 1 fg/µl and 0.1 fg/µl) and 
assemble qPCR reaction as follows:
Component Volume Final
Sample (from Step 25) 5 µl *
H2O 6.5 µl -
SYBR green mix (2x) 12.5 µl 1x
P5-P7 primermix (10 µM each) 1 µl 0.4 mM each
* 500fg, 50fg, 5fg or 0.5fg depending on the dilution used
28|  Run the qPCR reaction on a qPCR machine according to manufacturer’s 
instructions. For threshold 100 on the MyIQ real time PCR machine (BioRad) 
our 50fg sample typically gives Ct values in the 16-17.5 range for  P. falciparum 
and ~18 Ct for M. tuberculosis. CRiTiCAl sTeP: different systems will give a 
different optimal Ct range, which needs to be tested and established in each 
lab. Different types of samples might give different optimal Ct-ranges (e.g. 
depending on fragment length and/or GC-content).
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 PAuse PoinT:  Store the library at 4°C for a couple of days or at -20°C for long-
term storage (up to one year).
 
 sequencing TiMing: 2-6d
29|  Use the library for single read or paired-end sequencing on the Illumina 
Sequencing platforms (GAII or HiSeq2000) according to the manufacturer’s 
instructions.
 CRiTiCAl sTeP: For optimal cluster density, you might have to load slightly 
more (about 1.3-1.5 times) from these libraries than from libraries that have 
been prepared according to the manufacturer’s protocol.
TiMing
For up to 8 purified and quantified DNA samples (Step 3 onwards) this protocol can 
be performed in 2 days. 
Steps 1-2: Purification and quantitation of starting material  1h
Steps 3-5:  End repair      1.5-2h
Steps 6-8:  ‘A’-tailing      1.5-2h
Steps 9-11:  Adapter ligation      1.5-2h
Step 12:  Size selection     1-3 (A) or >2h (B)
Steps 13-17:  In vitro transcription    12-16h (overnight)
Steps 18-28:  cDNA synthesis      3-4h
Step 29:  Sequencing     2-6d
TRoublesHooTing
Trouble shooting advice can be found in Table 2.
AnTiCiPATeD ResulTs
 
The LADS protocol outlined here employs T7 in vitro transcription to amplify 
double stranded DNA template and prepares it for Next Generation sequencing on 
one of the Illumina Platforms (GAII, HiSeq2000). The resulting libraries can be used 
for sequencing from one (single-read) or from both ends of the DNA fragments 
(paired-end). So far we have prepared over 70 LADS libraries from three different 
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types of samples (i.e. sonicated genomic DNA, mononucleosomal DNA fragments 
(figure 2A and 3A in ref. 161) and ds cDNA) that were derived from three different 
Plasmodium species, M. tuberculosis and also from methylated mouse DNA. 
Sequencing of LADS libraries is expected to provide more even coverage and better 
quantitation of AT- or GC-rich regions, which are underrepresented or completely 
lost in libraries obtained by PCR amplification (figure 1, supplementary figure 
1 and figure 1 in ref. 161). Furthermore LADS is compatible with most applications 
of sequencing (see Introduction), including SNP calling, since error rate of enzymes 
used in LADS (~0.01-0.001%) are substantially lower than the error rate of Illumina 
sequencing (~0.5-1% 212). Once established, LADS is expected to produce 10-500 ng 
of library from 3-40 ng of starting material, which is sufficient for loading minimally 
one but in most cases numerous lanes on the Illumina platforms. 
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supplementary figure 1: schematic 
representation of standard and 
amplifi cation-free library preparation 
for illumina sequencing. (A) In the 
standard Illumina protocol (www.
illumina.com) end-polished and A-tailed 
DNA fragments are ligated with a 
“sparrow tail” adapter containing a 
short complementary region and two 
diff erent sequencing primers (S1, S2) 
on the forward and reverse strands. 
After size-selection, ligated fragments 
are subject to 12 (or even 18) cycles 
of PCR amplifi cation to increase copy 
number. The “extended” PCR primers are 
also used to incorporate the sequences 
that facilitate hybridization to the 
oligonucleotides (P5, P7) attached to 
the surface of the fl owcell; (b) In the 
amplifi cation-free protocol (ref. 191) the 
“sparrow tail” adapters already contain 
the sequence used for capturing on the 
surface of the fl owcell. Therefore, after 
ligation and size selection, they can be 
directly used for sequencing.
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Supplementary Figure 2: Chapter 3
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supplementary figure 2: lADs preserves gC-rich regions of the M. tuberculosis genome. (A-C) 
Screenshots of the shotgun sequencing data obtained by diff erent library preparation methods from . 
40 or 400 ng sonicated genomic DNA from SH1:NLA000700874 strain was used to prepare sequencing 
libraries by standard PCR-based method (40ng starting material with 12 cycles of amplifi cation), 
amplifi cation-free method (400ng starting material) or LADS (40ng starting material). After sequencing 
on the Illumina GAII platform, 36bp sequence reads were mapped against the reference genome 
(H37Rv). Coverage plots were generated from equal number (~21 million) of unique and randomly 
placed non-unique reads by counting the number of tags in every 10bp window of the genome. Ratio-
plots display the sequencing data obtained after amplifi cation (PCR or T7) over the amplifi cation-free 
control in log2 scale (150bp moving window smoothening has been applied). (A) genome-wide view, 
(b-C) “zoom-in” to regions with extreme GC-content.
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Supplementary Figure 3: chapter 3
supplementary figure 3: Decrosslinking introduces sequence bias in ngs libraries. Formaldehyde 
cross-linked, fragmented  chromatin was decrosslinked for 4 hours at 60°C or overnight at 45°C in the 
presence of 0.2 or 0.5M NaCl. After purification, DNA was used for Illumina library preparation using 
linear T7 amplification and analyzed by qPCR for amplicons with different AT-content.
supplementary Table 1: A set of ‘barcoded’ adapters for LADS
Name Sequence (5’-3’)
Adapter-A1-For & AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT-
gTA*T
Adapter-A1-Rev & PTACAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCG-
TATCATT
Adapter-A2-For & AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT-
CAT*T
Adapter-A2-Rev & PATgAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCG-
TATCATT
Adapter-A3-For & AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATC-
TACg*T
Adapter-A3-Rev & PCgTAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCG-
TATCATT
Adapter-A4-For & AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCC-
GATCTTgC*T
Adapter-A4-Rev & PgCAAGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTAGATCTCGGTGGTCGCCG-
TATCATT
& Adapter oligos should be minimally PAGE purified, but ideally prepared by double purification (e.g. 
double PAGE, HPLC-PAGE) (CRiTiCAl!)
P 5’ phosphate group (CRiTiCAl!)
* phosphorothioate linkage that can stabilize the overhanging thymidine (OPTIONAL)
The sequences of barcodes are bolded. (Note: each sequence read is expected to start with either of 
the underlined three letter barcodes followed by ‘T’)
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AbsTRACT 
Transcriptome analysis by next-generation sequencing (RNA-seq) allows 
investigation of a transcriptome at unsurpassed resolution. One major benefit 
is that RNA-seq is independent of a priori knowledge on the sequence under 
investigation, thereby also allowing analysis of poorly characterised Plasmodium 
species. Here we provide a detailed protocol for RNA isolation and fragmentation, 
ribosomal RNA depletion and cDNA synthesis that enables the preparation of a 
sequencing library from 1-2 micrograms of total RNA. Although we focus our 
discussion on the quantitative measurement of gene expression, this protocol is 
suited for many applications of RNA-seq and allows analysis of most RNA species. 
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inTRoDuCTion
Rationale
Ever since they hit the market in 2005 213, 214, next-generation sequencing (NGS) 
platforms steadily won terrain over microarrays in the fields of transcriptomics (the 
quantitative study of the complete set of transcripts present in a cell) 211, 215. RNA-
seq (transcriptome analysis by NGS) has multiple advantages over microarrays 102, 
216: 1) It provides superior, base-resolution data; 2) Due to its digital nature, the 
dynamic range of RNA-seq is in principle unlimited and solely depends on the 
sequencing depth; 3) Analysis of paralogous sequences, previously hampered by 
cross-hybridization issues on microarrays, can be much more reliably performed 
by RNA-seq; 4) Prior knowledge on the sequence to be analyzed is not essential 
(although it facilitates the analysis) and 5) Data obtained by RNA-seq can be 
easily reanalyzed in relation to any new genome-build or datasets that becomes 
available. At the early days of this technology, costs for transcriptome analysis by 
NGS were substantially higher than those of the more commonly used microarrays. 
Due to decline in per-base-costs and application of multiplexing strategies (see 
later), these costs are starting to equalize.
NGS technology enables sequencing of millions of small DNA or cDNA molecules 
in parallel in a single experiment, thereby revolutionizing the speed of cDNA 
library analysis which previously relied on the cloning and capillary sequencing 
of expression sequence tags (ESTs) 217 or SAGE libraries 218. A typical RNA-seq 
experiment consists of the following steps (figure 1): 1) Isolation of RNA and 
conversion to cDNA; 2) Ligation of platform-specific adapters to each cDNA 
fragment to capture the fragments on a solid support; 3) Parallel sequencing of 
millions of locally amplified cDNA fragments via sequencing-by-synthesis, either 
via reverse terminator sequencing (Illumina Genome Analyzer), pyrosequencing 
(Roche 454 technology) or ligation (Applied Biosystems SOLiD) 215. Such analysis 
yields millions of short sequence reads (up to 30 or 100 million 36-150bp reads for 
the Illumina Genome Analyzer (GA) and HiSeq2000 platforms respectively) from 
one or both ends of the cDNA fragments. 
Applications of RNA-seq data are numerous. Its most common and straightforward 
application is the quantitative measurement of gene expression 216, which is based 
on the principle that the number of sequence reads (tags) matching to a transcript 
is directly proportional with the abundance of this transcript in the original sample, 
corrected for the length of the transcript (RPKM, Read per kilobase of transcript per 
million mapped reads 211). This approach has been implemented for a very wide 
range of organisms including Plasmodium 161, 167, 219. However, NGS has also been 
used for more specialized functions, such as detection of alternative splicing events 
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or novel splice sites 220, alternative promoter usage 221, alternative polyadenylation 
222, identification of 5’ and 3’ untranslated regions (UTRs) 138, detection of antisense 
transcription 188, non-protein coding 223 and small RNAs 224. 
Removal of host cells / tissues
Step 3.1.2
Figure 1: chapter 4
total RNA isolation
Steps 3.1.1-23
gDNA removal
Steps 3.1.14 & 22
removal of rRNA (option A)
by PolyA-selection
Step 3.2A.1
RNA fragmentation
Step 3.2A.2 or  3.2B.1
cDNA synthesis
Steps 3.2A.3-11 or  3.2B.2-4
removal of rRNA (option B )
by DSN treatment
Steps 3.2B.5-17
Adapter ligation & preparation of 
the sequencing library
Steps 3.3.1-2 & ref   
Sequencing
Mapping of the reads
Calculation of normalized 
“transcript-level” tables
Ranking of transcripts based on 
their differential abundance 
between conditions
Further bioinformatic analysis of 
deregulated genes
Pre-sequencing
processing
Post-sequencing
processing
225
figure 1: Flowchart summarizing the main steps in the RNA-seq procedure and a simple pipeline for 
subsequent data analysis of differentially expressed genes. The upper part (pre-sequencing processing) 
includes references to the steps in the methods section of this chapter. For the adapter ligation and 
sequencing, a more detailed description can be found in figure 3 of 225. In-depth discussion on the 
post-sequencing processing steps can be found in the “library preparation, sequencing & data analysis” 
paragraph of the introduction.
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Here, we will outline a protocol for non-directional, quantitative sequencing of 
Plasmodium falciparum cDNA on the current Illumina NGS platforms. Our protocol 
ensures highly quantitative genome-wide transcriptome analysis by employing 
linear amplification of the sequencing library (LADS 225), and has been successfully 
applied to P. falciparum, P. berghei and P. knowlesi transcriptomes (161, unpublished 
data). 
experimental design
Several steps in the RNA-seq procedure are critical to obtain high-quality data. 
Furthermore, alternative approaches for certain steps (e.g. different strategies for 
rRNA removal) will greatly influence the usability of the data to resolve specific 
research questions (e.g. detection of non-coding/anti-sense transcripts). Therefore, 
it is vital to consider upfront what will be the primary use of the data and adjust the 
sample preparation, sequencing protocols or data analysis accordingly. Below we 
discuss key steps in the procedure, alternative approaches and their influence on 
the information obtained. 
RnA isolation & cDnA synthesis: There are countless protocols for the isolation 
of RNA from Plasmodium-infected erythrocytes 226, Plasmodium mosquito- 227 and 
liver-stages 228. Here we provide a detailed description for isolation of Plasmodium 
falciparum total RNA from asexual blood-stages using Qiagen’s RNeasy Mini 
Columns. Regardless of the exact protocol in use, there are three critical points 
which deserve special attention: 1) minimization of contamination with host RNAs; 
2) removal of genomic DNA and 3) prevention of RNA degradation. 
RNA co-purified from host cells (e.g. white blood cells) can be differentiated from 
the Plasmodium RNA after sequencing; however it can compose a substantial part of 
the sequencing data and as such drastically decrease the efficiency of the analysis. 
To avoid contamination from human leukocytes, we make use of Plasmodipure 
filters. However, for isolation of salivary gland sporozoites, liver stage infections 
or P. berghei infected mice, other preventive measures need to be taken to avoid 
contamination by host cells/tissues.
Genomic DNA (gDNA) contamination is a major problem for data analysis, as it 
is virtually impossible to distinguishing contaminating gDNA from 5’ and 3’ UTR 
signals, polymerase read-through and low level antisense, non-coding or immature/
unspliced transcripts. Inclusion of a DNase degradation step is therefore strongly 
encouraged in all cases. To control the efficiency of the gDNA degradation, we 
advise to perform a reverse transcriptase minus (RT-) cDNA reaction on a fraction 
of the RNA sample as negative control before cDNA synthesis.
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To ensure RNA integrity, it is vital to avoid contamination with RNases. RNase-free 
solutions, reagents and labware should be used during all steps prior to cDNA 
synthesis. Furthermore, samples must be processed quickly (on ice) and multiple 
freeze-thaw cycles of the RNA should be prevented as much as possible. 
As ~95-99% of the total RNA is made up of ribosomal RNA (rRNA), it is important 
to deplete these sequences in order to allow sufficient sequencing-depth for other 
RNAs. Several strategies can be employed to deplete rRNA: 1) enrichment for 
polyadenylated transcripts by OligodT columns (this protocol & 229); 2) enrichment 
for 5’ capped RNAs using Terminator enzyme (Epicentre Biotechnologies & 167); 
3) specific capturing of rRNAs with RiboMinus (Invitrogen & 230) or Ribo-Zero 
methods (Epicentre Biotechnologies); 4) selection against rRNA sequences during 
first strand synthesis with not-so-random priming 186, 219 or 5) depletion of highly 
abundant RNAs by degradation of fast-rehybridizing double-stranded cDNAs 
(duplex-specific nuclease (DSN), this protocol & 231). It is important to realize that 
each depletion-strategy will influence sample composition to various degrees. 
For example, PolyA- or cap-selection may not be optimal for the identification 
of anti-sense or non-coding transcripts as part of these might be uncapped or 
non-polyadenylated. RiboMinus and Ribo-Zero approaches require a species-
specific set of oligos and therefore demand adaptation to Plasmodium. Similarly, 
the not-so-random approach will require a Plasmodium-specific optimized set of 
primers 219. The only generally applicable method is the specific-depletion of highly 
abundant RNAs (DSN method), as it retains middle- and low-abundant RNA species. 
Protocols for both PolyA-selection (option 3.2A) and DSN treatment (option 3.2B) 
are integrated in this chapter, as DSN treatment is most generally applicable but 
also more expensive and time-consuming compared to PolyA-selection. Both 
strategies will reduce ribosomal cDNA abundance in the sequencing library to ~15-
20% of the sequenced reads.
After removal of rRNAs (either via PolyA-selection or DSN treatment), the 
remaining transcripts need to be converted to small cDNA fragments before library 
preparation. Small fragments can be obtained either by fragmentation of the RNA 
or by shearing of cDNA in a later step of the procedure. As fragmentation of cDNA 
leads to either 5’ or 3’ bias 210, fragmentation of RNA resulting in more homogenous 
coverage of the transcripts is performed in our protocol. 
Once double-stranded cDNAs ranging ~100bp – 1kb are generated, the preparation 
of sequencing libraries can be performed. Typically 10 – 40 ng of ds cDNA is used 
per reaction, although lower amounts might work as well. For the PolyA-selection 
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protocol typically 1µg of total RNA will yield ~40ng of ds cDNA, whereas for DSN 
~750ng total RNA will yield ~15ng. The number of parasites required to obtain 
these amounts will vary significantly depending on the species, life-cycle stage of 
the parasites and the protocols used for work-up. Table 1 indicates the approximate 
number of P. falciparum parasites of different asexual stages that are required to 
obtain sufficient amounts of total RNA for PolyA-selection and DSN procedures, 
respectively.
Table 1: The approximate number of parasites minimally required for preparation of RNA-seq libraries 
using PolyA-selection and DSN treatment, respectively. 
P. falciparum life-cycle stage PolyA-selection (1µg) DSN treatment (750ng)
Ring ~2.5 * 108 parasites ~1.9 * 108 parasites
Trophozoite ~2 * 107 parasites ~1.5 * 107 parasites
Schizont ~5 * 106 parasites ~3.8 * 106 parasites
library preparation, sequencing and data analysis: Preparation of standard 
Illumina sequencing libraries involves 12-18 cycles of PCR amplification, which is 
known to result in underrepresentation or even loss of DNA fragments with extreme 
base composition 161, 191, 195, 196. Given that the Plasmodium genomes are amongst 
the AT-richest of all genomes, we strongly suggest to either avoid amplification (if 
sufficiently high amount of starting material (~400ng ds cDNA) is available, 191) or 
use linear amplification (LADS, 225) during library preparation. Although positive 
effects of optimised PCR conditions have been reported 232, 233, in our hands they 
resulted in rather limited improvement.
Before loading the sequencing library to one of the Illumina platforms, two 
important issues need to be considered: 1) how many reads are required? and 
2) what is the optimal read-length for the intended analyses? In our experience, 
~10 million reads mapped to the P. falciparum transcriptome provides sufficient 
coverage (average ~1800 reads/transcript) and enables reliable quantitation even 
of low abundant transcripts (with the exception of extreme low abundant and 
highly repetitive genes such as antigenic variation gene families). Given that the 
throughput in one lane of the HiSeq2000 sequencing platform exceeds this number 
currently by 10-fold, labelling of the individual libraries with specific sequence tags 
(“barcoding”) and sequencing 2 or more samples together (“multiplexing”, 234) will 
substantially reduce the cost of the sequencing. A list of barcoded adapters that are 
compatible with LADS is provided in supplementary Table 1 of 225. 
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Table 2: Percentage of uniquely “mapable” reads of different lengths for Plasmodium 
falciparum and berghei transcriptomes (single-end reads).
Read length (bp) P. falciparum P. berghei
36bp 93.7% 97.8%
54bp 95.2% 98.1%
76bp 96.0% 98.3%
108bp 96.6% 98.6%
 
The length of the sequence reads defines which percentage of the reads can be 
uniquely assigned (mapped) to the transcriptome (see Table 2) and whether 
individual transcripts can be uniquely identified. For example, in P. falciparum the 
standard 36bp reads of the GAII platform can be assigned to a unique transcript 
with 93.7% probability enabling analysis of most transcripts (see Table 2 for other 
read lengths and P. berghei transcriptome). However analysis of gene families 
(e.g. var), splice variants or assembly of transcriptomes from poorly annotated 
Plasmodium species benefit from longer reads and/or paired-end sequencing.   
The raw RNA-seq output consists of millions of sequence reads with associated 
quality scores. The processing and interpretation of this data is complex and will 
vary depending on the specific research question and experimental setup. For a 
comprehensive overview and up-to-date information on RNA-seq data analysis, 
we refer the reader to two excellent reviews 216, 235 and a web-based resource (rna-
seqblog.com). Since the primary objective of most RNA-seq studies is to identify 
transcripts with significantly altered abundance across experimental conditions 
(e.g. mutant vs wild-type, treated vs untreated) we here describe a rather simple 
pipeline for the analysis of differential gene expression analysis (lower part of 
figure 1). As a first step, high quality sequence reads need to be mapped to the 
genome or transcriptome of the species under investigation. For quantification 
of the relative abundance of different transcript we advise to map reads against 
the transcriptome (sequence of all annotated and “spliced” coding sequences 
available at www.genedb.org). Mapping reads against the genomic sequence, on 
the other hand, can provide additional information on isoforms, unannotated/
novel transcripts or non-coding transcripts, but requires special software/settings 
to deal with gap-mappings over exon-exon boundaries.  (Currently we use BWA 
236 to assign reads to their transcripts, but other mappers (e.g. SSAHA2 237) might 
work equally well.) Next, the data mapped against the genome sequence may be 
visualized in genomic context. (For Plasmodium spp. the freely available Artemis 
genome browser (238 or www.sanger.ac.uk/resources/software) can be used.) 
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As a second step, the number of reads matching to each transcript (isoform) is 
counted, substantially reducing the complexity of the data. To enable comparison 
of transcript levels between samples, the data are normalised and subjected to 
statistical analysis, resulting in a ranked list of transcripts with fold-changes and 
probability values. If the sequencing-depth of the different samples is comparable, 
calculation of RPKM-values provides a simple way for data normalisation. Finally, 
further bioinformatic analysis of the list of differentially expressed genes (e.g. 
clustering, GO annotation, principle component analysis) or its integration with 
other biological data (e.g. gene expression, proteomic, epigenomic or interactome 
datasets) can help to gain deeper biological insight.
MATeRiAls
Store reagents as indicated by the manufacturer. Order all reagents and materials that come 
into contact with RNA as RNase-free.
2.1 General reagents
Nuclease-free water
ß-mercaptoethanol
Analytical-grade absolute ethanol. Dilute absolute ethanol with nuclease-free water to 
obtain 70% and 80% ethanol solutions.
Quant-iT assay kits for RNA and double-stranded DNA (HS) (Invitrogen) or equivalent.
Isopropanol
5M Ammonium Acetate (Ambion)
Linear Acrylamide (Ambion) or equivalent
2.2 RNA isolation
Plasmodipure filter (EuroProxima)
RNeasy Mini Kit (Qiagen), containing buffers RLT, RW1 and RPE, RNeasy Mini columns and 
clean 2ml collection tubes.
RNase-free DNase Set (Qiagen), containing DNase I and RDD buffer.
2.3A PolyA-selection
Oligotex mRNA Mini Kit (Qiagen), containing oligotex mix, columns, collection tubes and 
buffers OBB, OW2 and OEB.
2.3B DSN treatment
T4 DNA Polymerase (Promega, 10 U/µl).
4x Hybridization Buffer: mix 200µl RNase-free 1M HEPES buffer pH7.2-7.5 (Invitrogen) and 
RNase-free 400µl 5M NaCl (Ambion) with 400µl nuclease-free water 239 and store as aliqouts 
at -20°C.
Duplex-specific nuclease (DSN, Evrogen), containing lyopilized DSN enzyme, DSN storage 
buffer, 10x DSN Master Buffer and 2x DSN Stop Solution.
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Agencourt AMPure XP (Beckman Coulter Genomics).
2.4 rRNA fragmentation and cDNA synthesis
5x Fragmentation Buffer: 200mM Tris-Acetate pH8.2, 500mM Potassium-Acetate, 150 mM 
Magnesium-Acetate 211. Either prepare all buffer components RNase-free or purchase ready-
made stock solutions. Buffer can be stored at room temperature (RT).
AT-corrected random nonamer primers (Biolegio). For P. falciparum we use 76% AT-primers, 
dissolved in nuclease-free water or TE at 11µg/µl, aliquoted and stored at -20°C.
Superscript III reverse transcriptase (Invitrogen, 200 U/µl), including 5x First Strand Buffer 
and 0.1M DTT.
dNTP mix (Invitrogen, 10mM each): mix equal volumes of 100mM dTTP, dATP, dGTP, dCTP 
with 6 volumes nuclease-free water.
RNasin Plus RNase inhibitor (Promega, 40 U/µl).
5x Second Strand Buffer (Invitrogen).
E. Coli Ribonuclease H (RNase H, Ambion, 10 U/µl)
DNA Polymerase I (Invitrogen, 10 U/µl).
E. Coli DNA Ligase (New England Biolabs, 10 U/µl).
QIAquick PCR Purification Kit (Qiagen), including QIAquick Spin columns, buffers PB & PE 
and elution buffer (EB).
2.5 Library preparation
For reagents and equipments used during library preparation, we refer to the list provided 
in 225.
2.6 Equipment
Temperature-controlled centrifuge
Temperature-controlled benchtop centrifuge
Qubit fluorimeter (Invitrogen), or equivalent
Thermal cycler with heated lid
Magnetic Particle Concentrator for Microtubes of Eppendorf Type (Magnetic rack, Dynal AS, 
only necessary in case the DSN protocol is used or optional AMPure purification is employed 
after size selection).
DNase/RNase-free Reaction tubes (Eppendorf )
DNase/RNase-free filter tips
MeTHoDs
Carry out all procedures on ice, unless stated otherwise (see note 1).
3.1 RnA isolation (see note 2, note 3 & note 4)
1|  Take the parasite culture from 37ºC and quickly bring it to ice. For P. falciparum 
asexual stages, minimally use the number of parasites specified in Table 1.
2|  Mount the Plasmodipur filter on a syringe and pass the parasite culture though 
this filter (see note 5 & note 6).
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3|  Spin the Pf-infected erythrocytes at 600g for 5min at 4ºC.
4|  Remove supernatant as much as possible.
5|  Add 12 pellet volumes of RLT buffer supplemented with 1% ß-mercaptoethanol 
and resuspend well. Allow this mixture to warm to room temperature (RT) 
before proceeding (see note 7).
6|  Add 12 pellet volumes of RNase-free 70% ethanol to the parasite/RLT/ß-
mercaptoethanol-solution and mix well at RT.
7|  Load 700µl of ethanol/parasite/RLT/ß-mercaptoethanol-mixture onto an 
RNeasy Mini column at RT (see note 8 & note 9). 
8|  Spin the column for 25sec at 9,600g at RT and discard the flow-through (see 
note 10).
9| Reload the column with another 700µl of ethanol/parasite/RLT/ß-
mercaptoethanol-mixture, spin for 25sec at 9,600g at RT and discard the flow-
through (see note 10).
10|  Reload the column with the rest of the ethanol/parasite/RLT/ß-
mercaptoethanol-mixture (600µl), spin for 30sec at 9,600g at RT and discard 
the flow-through and collection tube (see note 10).
11|  Transfer the column to a clean 2ml collection tube.
12|  Apply 700µl RW1 buffer to the column and spin for 25sec at 9,600g at RT. 
Discard the flow-through.
13|  Apply 350µl RW1 buffer to the column and spin for 25sec at 9,600g at RT. 
Discard the flow-through.
14|  Apply 80µl DNase/RDD mixture directly onto the membrane of the column 
and leave to incubate at RT for 18min.
15|  Apply 350µl RW1 buffer to the column and spin for 25sec at 9,600g at RT. 
Discard the flow-through.
16|  Apply 500µl buffer RPE to the column and spin for 25sec at 16,200g at RT, 
discard the flow-through.
17|  Apply another 500µl buffer RPE to the column and spin for 1min at 16,200g at 
RT. Discard the flow-through, spin again for 2 minutes and discard the flow-
through and collection tube.
18|  Place the column into an RNase-free 1.5ml Eppendorf tube and apply 100µl 
nuclease-free water directly on the membrane of the column.
19|  Spin for 1min at 16,200g at RT and transfer the water with RNA to a new 
Eppendorf tube. Place on ice.
20|  Add 350µl RLT buffer to the 100µl RNA in water and let it warm to RT (see note 
11).
21|  Add 250µl 70% ethanol to each RNA/RLT-mixture and pool all the aliquots 
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from a single RNA sample over one RNeasy column by loading 700µl RNA/
RLT/ethanol-solution, spinning for 25sec at 9,600g at RT, discarding the flow-
through and reloading. Repeat until the last aliquot has been loaded, spin for 
30sec at 9,600g at RT and discard the flow-through (see note 12 & note 13).
22|  Repeat steps 12 - 19.
23|  Measure your RNA concentration by Nanodrop, Quant-iT RNA kit or equivalent 
(see note 14, 15 & 16).
3.2 – option A: PolyA-selection & cDnA synthesis (see note 17 & note 18)
After 3.1 RNA isolation, continue with either 3.2 – option A for the PolyA-protocol 
OR with 3.2 – option B for the DSN-protocol, then continue with 3.3 Library 
preparation.
1|  Follow the instructions from the “Oligotex mRNA Spin-Column Protocol for 
isolation of Poly A+ mRNA from total RNA” in the Oligotex Handbook (provided 
with the Oligotex mRNA Mini Kit). Perform all steps at RT unless stated 
otherwise in the protocol. Elute 2 times with 100µl 70°C OEB buffer (see note 
19, note 20 & note 21). 
2|  Use 1-5µg total RNA equivalent per RNA hydrolysis reaction. For each reaction, 
fill up the volume with nuclease-free water until 120µl and then add 30µl 5x 
Fragmentation Buffer on ice. Mix and quickly place at 85°C for 1min and 45sec. 
Immediately transfer to ice after incubation (see note 22).
3|  Precipitate the RNA by adding 1 volume Isopropanol, 1/5th volume 5M 
Ammonium Acetate (NH4OAc) and 2,5µl linear acrylamide carrier. Store at 
-80°C overnight (O/N) (see note 23 & note 24).
4|  Reconstitute the precipitated RNA in nuclease-free water as follows. Spin 
for 30min at 16,200g at 4°C. Remove all supernatant, but leave the pellet 
untouched. Add 1ml icecold 70% ethanol and spin for 10min 16,200g at 4°C. 
Remove the ethanol, spin again for 1min at 16,200g at 4°C and remove all 
ethanol as much as possible. Then leave the pellet dry at RT with the lid open. 
Dissolve the pellet in 8.25µl nuclease-free water for at least 10min on ice.
5|  For the first strand synthesis reaction, add 0.75µl AT-corrected random nonamer 
primers (see note 25) to 8.25µl RNA (see note 26). Use no more than 5µg total 
RNA equivalent (see note 20) per cDNA synthesis reaction.
6|  Incubate the reaction for 10min at 70°C, directly transfer to ice and incubate on 
ice for at least 2min.
7|  Then add 4µl 5x First Strand Buffer, 2µl 0.1M DTT, 2µl dNTP mix and 1µl RNasin 
RNase inhibitor to the reaction mixture, mix and spin at 4°C.
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8|  Prewarm the reaction mixture for 2min at 37°C, add 2µl Superscript III enzyme, 
mix and incubate for another 10min at 37°C followed by 1hour incubation at 
42°C.
9|  For the second strand synthesis, add 91.8µl nuclease-free water, 30µl 5x Second 
Strand Buffer, 0.2µl RNase H, 3µl dNTPs, 4µl DNA Polymerase I and 1µl E. coli 
DNA Ligase (see note 27). Incubate the reaction mixture for 2hours at 16°C.
10| Purify your sample over a QIAquick spin column using the “QIAquick PCR 
Purification Kit Protocol” of the QIAquick Spin Handbook (provided with the 
QIAquick PCR purification kit) and elute in 35µl EB (see note 28).
11|  Measure the concentration of your sample by Quant-iT HS assay kit for double-
stranded DNA (see note 29, note 30 & note 31).
3.2 – option b: cDnA synthesis & Dsn treatment (see note 32 & note 33)
After 3.1 RNA isolation, continue with either 3.2 – option A for the PolyA-protocol 
OR with 3.2 – option B for the DSN-protocol, then continue with 3.3 Library 
preparation.
1|  Use 750ng-2µg total RNA per hydrolysis reaction. For each reaction, fill 
up the volume with nuclease-free water until 120µl and then add 30µl 5x 
Fragmentation Buffer on ice. Mix and quickly place at 85°C for 2min and 15sec. 
Immediately transfer to ice after incubation (see note 22).
2|  For cDNA synthesis follow steps 3-9 of 3.2 – option A. Do not use more than 
1µg total RNA per cDNA synthesis reaction (see note 26).
3|  Add 1µl T4 DNA Polymerase to the second strand cDNA reaction mixture and 
incubate for 10min at 16ºC.
4|  Follow step 10 from 3.2 – option A (see note 34).
5|  Prepare the DSN reactions on ice as follows: Add 13.5µl hydrolyzed RNA in 
nuclease-free water to 4.5µl 4x Hybridization buffer. Gently pipet up-and-
down 10x to mix the content and transfer to a 200µl PCR tube (see note 35 & 
note 36).
6|  Transfer the samples to a thermal cycler and incubate for 2min at 98ºC followed 
by incubation at 68ºC for 24hours (see note 37). Then keep at 68ºC until the 
end of the DSN treatment.
7|  Prepare the lyopilized DSN enzyme according to the manufacturers 
recommendations (“DSN dilution protocol” on the information sheet provided 
with the kit).
8|  Dilute the 10x DSN Master buffer to 2x with nuclease-free water and pre-heat 
to 68ºC for at least 10min.
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9|  Quickly add 20µl pre-heated 2x DSN Master buffer to the 68ºC DSN reaction 
and resuspend 10x (see note 38 & note 39). Incubate for 10min at 68ºC.
10|  Add 2µl DSN enzyme per reaction, resuspend 10x (see note 38 & note 39) and 
incubate at 68ºC for 45min.
11|  Add 40µl 2x DSN Stop Solution and place the samples on ice.
12|  Pool all the reactions from the same sample and purify over a QIAquick spin 
column using the “QIAquick PCR Purification Kit Protocol” in the QIAquick Spin 
Handbook (provided with the QIAquick PCR purification kit). Elute in 35µl EB 
(see note 28).
13|  Perform a second strand synthesis as follows (see note 40): add 0.5µl AT-
corrected random nonamer primers (see note 25) to the single-stranded cDNA 
in 35µl EB. Incubate for 10min at 70ºC followed by at least 2min incubation on 
ice.
14|  Add 4µl 5x First Strand Buffer, 2µl 0.1M DTT, 5µl dNTP mix, 30µl 5x Second 
Strand Buffer, 68.5µl nuclease-free water and 4µl DNA Polymerase I (see note 
27). Incubate the reaction mixture for 1hour at 37°C.
15|  Add 1µl E. coli DNA Ligase and 1µl T4 DNA Polymerase and incubate for 1hour 
at 16°C.
16|  Purify over AMPure beads at RT as follows:  add 150µl beads to the 150µl cDNA 
sample and resuspend 10 times. Incubate for 15min and place the Eppendorf 
tubes in a magnetic rack for 2min. Remove 295µl supernatant and add 200µl 
80% ethanol. Incubate for 30sec, remove the ethanol and repeat the wash with 
200µl 80% ethanol. Remove the ethanol after 30sec and let beads dry for 15min 
on the magnetic rack. Remove the tubes from the magnetic rack, resuspend 
beads well in 22.5µl EB, incubate for 2min and place back in magnetic rack for 
2min. Collect 20µl sample from magnetic rack and transfer to a clean Eppendorf 
tube (see note 41, note 42 & note 43).
17|  Measure the concentration of your sample by Quant-iT HS assay kit for double-
stranded DNA (see note 29, note 30 & note 31).
3.3 library preparation (see note 44 & note 45)
1|  Use 10 – 40ng double-stranded cDNA per library preparation reaction (see 
note 46).
2|  For library preparation follow the detailed LADS protocols provided in 
Hoeijmakers et al., 2011 225 (see note 47).
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noTes
1. CRiTiCAl: All reagents and labwares should be free of RNases. Bench and pipettes 
needs to be cleaned and RNase-free, gloves should be changed regularly and contact 
with sources of RNase contamination should be avoided.
2. Prepare all solutions for 3.1 RNA isolation upfront, so you can process your samples as 
quickly as possible. Add 1% ß-mercaptoethanol to RLT buffer (from the Qiagen RNeasy 
Mini Kit) in a fume hood. This solution can be stored for 1 month. Dissolve the lyophilized 
DNase I in nuclease-free water according to the manufacturers recommendations 
(RNeasy Mini Handbook “Appendix D: Optional On-Column DNase Digestion with the 
RNase-free DNase Set”, provided by RNeasy Mini Kit) and store aliquots at -20°C. Mix 1 
volume DNase I with 7 volumes RDD buffer (supplemented with the RNase-free DNase 
Set), resuspend using a pipette (do not vortex!) and keep on ice. This solution needs to 
be prepared fresh. 
3. TiMing: Timing depends on the number of samples and the number of columns to be 
processed per sample. For a 10ml 5% haematocrit culture generally 2-2.5 hours should 
be sufficient to perform 3.1 RNA isolation.
4. For species other than P. falciparum and/or life cycle stages other than asexual blood-
stages the specific steps described under RNA isolation might need to be adjusted. 
Alternatively, use of in-house protocols for total RNA isolation is advised. Keep in mind 
that removal of host contamination and genomic DNA is crucial and RNA needs to be 
intact before proceeding with rRNA depletion and cDNA synthesis (3.2).
5. ConTRol: Make a bloodsmear to allow determination of parasitemia and staging.
6. Do not use suspensions of more than 50% haematocrit and do not pass more than 25ml 
of 50% haematocrit solution (or equivalent red blood cell volumes) through one filter to 
ensure efficient removal of leukocytes.
7. CRiTiCAl: Store the parasite/RLT/ß-mercaptoethanol-solution (no 70% ethanol!) on ice. 
However, it is critical that the parasite/RLT/ß-mercaptoethanol-solution reaches room 
temperature (~22ºC) before ethanol is added as otherwise undesired precipitation of 
RNA might occur.
8. Use one RNeasy Mini column per 2ml of mixture to prevent clogging of the column with 
haemoglobin. For samples with bigger volumes multiple columns need to be used.
9. CRiTiCAl: If more than 6 columns will be used, there is a risk that columns will dry 
during handling resulting in poor RNA yields. Therefore, not more than 6 columns 
should be processed together. 
10. CAuTion: Discard the ethanol/parasite/RLT/ß-mercaptoethanol-mixture in a closable 
container or inside a fume hood as ß-mercaptoethanol fumes are toxic by inhalation.
11. Incorporation of this second column purification for RNA cleanup will greatly enhance 
the purity of the sample and remove contaminating proteins (e.g. haemoglobin). 
Furthermore, the 2nd DNase treatment included in this cleanup will ensure (complete) 
removal of gDNA contamination.
12. To decrease loss on the column, all 100µl aliquots from the same sample will be pooled 
over a single column for cleanup. However, keep in mind that the maximum binding 
capacity of an RNeasy Mini column is 100µg of RNA.
13. To prevent loss of RNA by precipitation in the tube, only add the ethanol directly before 
loading the sample to the column.
14. ConTRol: Take a 100-500ng total RNA aliquot and check its integrity on a 1.5% agarose 
gel. The aliquot can be stored at -80°C. Make sure that all reagents (e.g. loading dye, 
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ladder, agarose, electrophoretic-buffer) and gel-trays used for running the agarose gel 
are RNase-free as degradation can also occur during electrophoresis. 
15. If sufficient amounts of total RNA are obtained it is advisable to also store total RNA 
as backup. This can be used for validation later on, or for repeating PolyA-selection or 
DSN treatment in case any of the downstream steps fail. Total RNA can be stored at 
-80°C or precipitated for stable storage. For precipitation add 1 volume isopropanol, 
1/5th volume 5M Ammonium Acetate (NH4OAc) and 2µl linear acrylamide as carrier. Mix 
and store at -80ºC.
16. PAuse PoinT: Although continuous processing of the sample until after the PolyA-
selection is preferred to avoid any degradation or breakage of the RNA, it is possible to 
stop here are store the RNA at -80ºC.
17. TiMing: PolyA-selection and RNA hydrolysis together approximately take 1hour. After 
RNA hydrolysis an overnight precipitation is advised, but 3-4hours at -80ºC should also 
be sufficient. cDNA synthesis requires about 5-7hours, but if an RT- control is performed 
an extra day should be included for the reverse transcriptase minus cDNA synthesis 
reaction and qPCR control before cDNA synthesis can be started.
18. CRiTiCAl: Please be aware that in case a PolyA-selection is employed, it is crucial that all 
mRNA’s are intact as otherwise a selective loss of 3’end sequences will occur hindering 
accurate transcript quantification.
19. An Oligotex Mini column has the capacity for no more than 1mg total RNA. For higher 
amounts, the use of multiple columns is advised.
20. Due to the very low amounts of RNA left after PolyA-selection we do not attempt 
measurement of RNA concentrations from this point on. All downstream calculations 
are based on the amount of total RNA that was taken for PolyA-selection and is called 
“total RNA equivalent”.
21. PAuse PoinT: Poly A+ mRNA can be stored in OEB buffer at -80ºC.
22. Quick processing is critical for the RNA hydrolysis procedure. After adding the 5x 
Fragmentation Buffer, rapidly start the 85°C incubation as the RNA might precipitate 
if the solution is kept on ice prior to hydrolysis. Following the 85°C incubation, keep 
solution cold as prolonged exposure at higher temperatures (even RT!) will result in 
continuing hydrolysis and reduction of the RNA fragment size.
23. Although an overnight incubation is advised to guarantee efficient precipitation of the 
RNA, incubation for 3-4 hours at -80°C should also be sufficient.
24. PAuse PoinT: The precipitated RNA can be stored at -80ºC for longer periods of time.
25. More homogeneous coverage of transcripts will be obtained if the random primers 
are adjusted in AT-content to match the overall base composition of the transcriptome 
under investigation. For Plasmodium falciparum, random nonamer primers with an 
average AT-content of 76% are employed.
26. It is highly advisable to first perform a separate RT- cDNA reaction (including all reaction 
components except the enzymes) to ensure the absence of contaminating (genomic) 
DNA. 
27. A premix of the nuclease-free water, buffer and dNTPs can be made if more than one 
sample is converted to cDNA. Enzymes should be added last and individually.
28. To increase yield the column can be incubated at 37°C for 1min after adding the EB 
buffer, but before spinning.
29. ConTRol: To check for the presence of genomic DNA, a qPCR on a RT+ reaction, a RT- 
reaction and a water control for some transcripts can be employed. 
30. In case genomic DNA is detected in your sample (RT- control gives signal in the qPCR) 
Hoeijmakers.indd   90 20-04-12   14:42
Hoeijmakers_PROEF (all).ps Back - 45     T1 -    Black CyanMagentaYellow
Transcriptome analysis using RNA-seq
91
an extra gDNA degradation step should be included. This can be performed as follows: 
To every 8µl RNA/gDNA in water, add 1µl 10x NEBuffer 4 and 1µl RNase-free TURBO 
DNase. Incubate the sample at 37°C for 25min followed by 10min inactivation of the 
DNase at 70°C. Than precipitate the sample by adding 1 volume isopropanol, 1/5th 
volume 5M Ammonium Acetate (NH4OAc) and 2µl linear acrylamide as carrier, mix and 
store at -80ºC.
31. ConTRol: To check the quality of your double-stranded cDNA it is advised to perform 
a qPCR reaction for a couple of transcripts with known expression profiles.
32. TiMing: RNA hydrolysis takes app. 15min followed by overnight precipitation. 
However, 3-4hours precipitation at -80ºC should also be sufficient. cDNA synthesis, DSN 
treatment and the additional second strand synthesis add up to about 2.5-3days. If an 
RT- control is performed, an extra day should be included for the reverse transcriptase 
minus cDNA synthesis reaction and qPCR control before cDNA synthesis can be started.
33. The DSN protocol described here is modified from 239.
34. PAuse PoinT: Purified ds cDNA can be stored at 4°C for short or at -20°C for prolonged 
periods of time.
35. Use not more than 250ng per DSN reaction. Therefore, for every sample a minimum of 
3 separate DSN reactions will be required.
36. CRiTiCAl: To avoid extensive evaporation use the heated lid option on the thermal 
cycler. Make sure that there are no liquid drops on the sides of the tubes, as this will 
interfere with the efficiency of rehybridization and consequently the efficiency of the 
DSN treatment. 
37. Perform preparatory steps 7-8 of 3.2 – option B, before the 24hours incubation is over, 
so the pre-heated 2x DSN Master buffer can be added to the DSN reaction exactly after 
24hours incubation.
38. CRiTiCAl: To prevent cooling of the DSN reactions during the procedure, work fast, 
keep the thermal cycler closed in between steps and do not handle more than 6 tubes 
(maximally 2 samples) at a time. Keep the reaction in the thermal cycler at any time 
during the DSN treatment.
39. CRiTiCAl: Resuspend with the pipet set at 35µl and do not touch the sides of the tube. 
Make sure that all liquid remains at the bottom of the tube and no droplets stick to the 
sides.
40. This step will make the cDNA double-stranded, as double-stranded cDNA is the required 
input for the library preparation.
41. Since small (<100bp) ribosomal RNA fragments might still be present in the sample 
it is advised to perform a size-selection on AMPure beads before library preparation. 
Since this selection maintains fragments above 200bp in length, care must be taken 
that during the size-selection-on-gel step of the library preparation only ranges above 
350bp should be selected.
42. Put the beads to RT at least 30min and vortex well before use.
43. Make the 80% ethanol solution fresh before every AMPure purification.
44. TiMing: Library preparation can be performed in 2days. Sequencing takes 2-5days 
depending on the read length and whether single-end or paired-end sequencing is 
employed.
45. To avoid unnecessary platform-dependent variation in the data, we recommend that 
samples are sequenced on the same platform with the use of the same sequencing 
reagents (e.g. same version of the kits) as significant changes in base composition bias 
has been observed with changing sequencing kit versions. 
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46. Due to the generally large fragment range, use of less than 10ng input is not 
recommended. However, lower inputs might works if extra care is taken to extract as 
much material as possible during the gel size-selection (see troubleshooting guide in 
225).
47. If, after library preparation and LADS amplification, small fragments (~100-150bp) 
are observed on the Experion/Bioanalyzer, an extra AMPure purification step is 
recommended to remove all fragments below 200bp. These small fragments might 
occur due to self-ligation of the adapters and will lead to inaccurate quantification of 
the library and a substantial number of reads with adapter sequence.
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AbsTRACT 
Epigenetic regulatory mechanisms and their enzymes are promising targets for 
malaria therapeutic intervention; however, the epigenetic component of gene 
expression in P. falciparum is poorly understood. Dynamic or stable association 
of epigenetic marks with genomic features provides important clues about their 
function and helps to understand how histone variants/modifications are used for 
indexing the Plasmodium epigenome. We describe a novel, linear amplification 
method for next-generation sequencing (NGS) that allows unbiased analysis of the 
extremely AT-rich Plasmodium genome. We used this method for high resolution, 
genome-wide analysis of a histone H2A variant, H2A.Z and two histone H3 marks 
throughout parasite intraerythrocytic development. Unlike in other organisms, 
H2A.Z is a constant, ubiquitous feature of euchromatic intergenic regions 
throughout the intraerythrocytic cycle. The almost perfect colocalisation of H2A.Z 
with H3K9ac and H3K4me3 suggests that these marks are preferentially deposited 
on H2A.Z-containing nucleosomes. By performing RNA-seq on 8 time-points, we 
show that acetylation of H3K9 at promoter regions correlates very well with the 
transcriptional status whereas H3K4me3 appears to have stage-specific regulation, 
being low at early stages, peaking at trophozoite stage, but does not closely follow 
changes in gene expression. Our improved NGS library preparation procedure 
provides a foundation to exploit the malaria epigenome in detail. Furthermore, our 
findings place H2A.Z at the cradle of P. falciparum epigenetic regulation by stably 
defining intergenic regions and providing a platform for dynamic assembly of 
epigenetic and other transcription related complexes. 
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AuTHoRs suMMARY
Plasmodium falciparum is a unicellular pathogen that is responsible for the 
most severe form of malaria. Similar to other eukaryotic organisms, its genome 
is organized into chromosomes by proteins called histones. Modification or 
replacement of these histones has marked effects on the packaging grade of DNA 
and instructs the recruitment of protein complexes, thereby regulating essential 
cellular processes such as gene expression and replication. Here we unveil the 
genome-wide localization of two histone H3 modifications (K9ac/K4me3) and 
a histone variant, H2A.Z, during development of the parasite in the human red 
blood cells. We find that all three epigenetic features are predominantly present 
in intergenic regions of the P. falciparum genome suggesting an interconnecting 
role in regulation of gene expression. H2A.Z levels appear to be largely 
invariable throughout intraerythrocytic development while placement/removal 
of the histone marks is dynamic with H3K9ac and H3K4me3 being transcription-
coupled and stage-specific, respectively. These observations support a model 
in which H2A.Z-containing nucleosomes serve to demarcate regulatory regions 
in the parasite’s genome and promote transcription initiation by guiding 
chromatin modifying and transcription initiating complexes. The findings and 
methodological developments presented in this paper provide a cornerstone 
for future epigenome research in eukaryotic pathogens and vital information to 
understand and to interfere with parasite development and survival. 
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inTRoDuCTion
Plasmodium falciparum, the deadly protozoan parasite, causes malaria via the 
invasion of erythrocytes. During its ~48h asexual reproductive cycle within human 
red blood cells (RBC), the parasite exploits and remodels the host cell, multiplies 
and finally ruptures the RBC to invade fresh erythrocytes. This process demands 
the timely expression of distinct sets of proteins 241. Accordingly, analysis of 
steady-state RNA levels revealed a precise, well-timed program for expression of 
functionally similar groups of genes 139, 167, 227, while nuclear run-on experiments 
demonstrated that the bulk of the transcriptional activity occurs at metabolically 
active and replicative stages of development 169. Although post-transcriptional 
mechanisms like mRNA decay 141 and translational repression 142, 242 are involved 
in the regulation of certain groups of genes, regulatory mechanisms are likely to 
predominantly act on transcription initiation 143. Due to the enormous evolutionary 
diversification of DNA binding proteins, a handful of putative trans-acting factors 
have only recently been identified 147. Putative functions of AP2-type DNA binding 
proteins in a simple cascade of gene activation/repression have been postulated 243 
and recently two AP2 proteins were shown to act as essential transcription factors 
in P. berghei ookinete 244 and sporozoite 245 development. However, the hypothesis 
that a cascade of AP2 factors would regulate the waves of gene expression typical 
to intraerythrocytic development of P. falciparum 243 still needs experimental 
verification.
In addition to direct regulation of gene expression by DNA binding proteins, 
posttranslational modification of histones and associated changes in the chromatin 
structure play a key role in long-term maintenance of the gene expression status. 
Epigenetic states are established and amended by several distinct mechanisms 
such as DNA methylation, non-coding RNAs, histone tail modifications, nucleosome 
remodelling or exchange of histone variants 246. Intriguingly, the Plasmodium 
genome is devoid of DNA methylation 148 and lacks the RNA interference machinery 
160, although non-coding RNAs 247, 248 and antisense transcripts 249 have been 
detected. Analysis of Plasmodium histones identified 44 different posttranslationally 
modified residues and four different histone variants (H2A.Z, H2Bv, H3.3 and CenH3 
153, 155). Accordingly, histone modifying enzymes and chromatin remodellers appear 
to be well represented in apicomplexan parasites 250, 251. With the genome-wide 
analysis of a few histone modifications/chromatin-associated proteins we have just 
begun to unveil the unique features of the malaria epigenome 156, 252. For example, 
deacetylation and subsequent tri-methylation of lysine 9 on histone H3 as well as 
recruitment of heterochromatin protein 1 (PfHP1), demarcate heterochromatic 
islands and are likely mandatory for general silencing of resident antigenic variation 
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genes 156, 157, 166, 176. About 90% of the P. falciparum genes, however, fall outside 
these H3K9me3/HP1-marked heterochromatic domains. Therefore the malaria 
epigenome, unlike its human counterpart, is dominated by histone modifications 
generally associated with transcriptionally active states of genes (i.e. H3K4me3, 
H3K9ac, H3K14ac and H4ac 155). Our exploratory survey revealed a rather unusual 
pattern of enrichment of two of these marks (H3K4me3 and H3K9ac) in almost all 
intergenic regions 156 and provided evidence that epigenetic marking is subject to 
changes during intraerythrocytic development. The exact timing of these changes 
and the mechanism by which they are targeted to intergenic regions remained 
enigmatic.
Here we report the genome-wide ChIP-seq profiling of three epigenetic features 
(H3K4me3, H3K9ac and H2A.Z) as well as RNA-seq analysis of the transcriptome 
throughout Plasmodium falciparum intraerythrocytic development. Importantly, 
development of a linear amplification method for next generation sequencing was 
vital for true genome-wide ChIP-seq analysis and enabled, for the first time, highly 
quantitative analysis of the extremely AT-rich intergenic regions. High-resolution 
analysis both in space and time was essential to reveal the different dynamics of 
H3K4me3 and H3K9ac marking. Collectively our findings support the hypothesis 
that H2A.Z-containing nucleosomes stably demarcate intergenic/regulatory 
regions of the P. falciparum genome and serve as a scaffold for stage-specific as 
well as transcription-coupled recruitment of histone modifying enzymes that 
dynamically place, read or erase histone modifications. 
 
ResulTs
novel deep-sequencing approach for analysis of malaria epigenome and 
transcriptome
In this study we applied state-of-the-art deep-sequencing technology to explore 
the epigenome (ChIP-seq) and transcriptome (RNA-seq) of P. falciparum at multiple 
stages of intraerythrocytic development (iRBC cycle). Given that analysis of highly 
AT-rich sequences provided a major challenge and hindered quantitative analysis 
of the malaria genome and recently published amplification-free method 191 is not 
applicable for sequencing when small quantities of input material are available, 
we developed a T7 polymerase-based method for library preparation resulting 
in unbiased amplification of samples. We tested the new method on sonicated 
genomic DNA and compared it to the standard PCR-based and amplification-free 
sample preparation protocol 191. 
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figure 1: T7 amplification results in perfectly representative libraries for illumina sequencing. 
(A-b) Screenshots of sequencing data of P. falciparum genomic DNA prepared by different amplification 
methods on (A) a part of chr9 (log2-ratio plots of the sequencing data obtained after amplification over 
amplification-free control) and (b) the centromeric regions of chr5 (76bp sequence reads plotted per 
10bp window) (C) distribution of sequence reads in relation to AT-content (“n” refers to the number of 
150bp windows with given AT-content, y-axis displays average number of tags per 150bp window) (D) 
Scatterplot analysis of amplified sequencing data against amplification-free gold standard in 150bp 
windows across GC-richer coding and AT-rich intergenic regions of the P. falciparum genome. 
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Visual inspection of the sequencing data revealed marked differences in coverage 
between the amplification-free and PCR-amplified genomic DNA (figure 1A). 
Relative depletion or complete loss at AT-rich intergenic regions was apparent even 
with just 6 cycles of amplification. On the contrary, mapping of sequences from the 
T7-amplified library resulted in nearly homogenous coverage indistinguishable 
from that of the amplification-free control (figure 1A) even at 100% AT-rich 
centromeric regions (figure 1b). To quantify the bias in relation to the DNA 
sequence composition, we counted the number of sequenced reads mapped to 
each 150bp window of the Plasmodium genome and plotted these against their 
AT-content (figure 1C). As previously reported 191, PCR amplification biases in 
favour of average GC sequence composition and causes substantial depletion 
or even complete loss of signal for AT-rich fragments. However, T7-amplified and 
control libraries display identical sequence coverage. Notably, extremely AT-rich 
sequences are slightly underrepresented in unamplified as well as in T7-amplified 
genomic DNA (figure 1C) probably due to a slight bias in amplification during 
cluster formation. Biased PCR- and unbiased T7-amplification was confirmed by 
qPCR (data not shown).
Finally, we determined the correlation of the different amplification methods 
by plotting the tag counts in 150bp windows against the unamplified control. 
As expected, both 12- and 6-cycle PCR-amplified genomic sequences deviate 
substantially from the amplification-free sequences both in coding and intergenic 
regions, whereas the correlation between T7 and no amplification is linear (figure 
1D). In conclusion, our method enables preparation of highly representative NGS 
libraries from few nanograms of starting material, providing an invaluable tool for 
highly quantitative analysis of extreme genomes/transcriptomes, like that of P. 
falciparum. 
Using this optimized protocol in combination with immunoprecipitation of mono-
nucleosomal DNA (native ChIP), we generated genome-wide profiles of histone H3 
lysine 4 tri-methylation (H3K4me3), histone H3 lysine 9 acetylation (H3K9ac) and 
histone H2A variant (H2A.Z) at 4 stages (early ring, late ring, trophozoite, schizont) 
during the iRBC cycle (supplementary figure 1). A minimum of 5.5M uniquely 
mapped, 76bp sequence reads for each sample provides app. 20x overall coverage 
and over 95% mapability for the P. falciparum genome (supplementary figure 
2). To correct for nucleosome occupancy, mono-nucleosomal input DNA was also 
sequenced from the corresponding samples. As an illustration of the effectiveness 
of the optimized sequencing protocol, highly AT-rich intergenic nucleosomal DNA 
was readily detected in these input tracks, demonstrating comparable nucleosome 
occupancy in coding vs intergenic regions (supplementary figure 3A) and 
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coverage of nucleosomes over the entire P. falciparum genome. This is in contrast 
to other reports 170, 171, which showed a lack of nucleosomes in intergenic regions 
(supplementary figure 3b). 
Our extensive ChIP-seq dataset provides detailed insight into the dynamics of 
the epigenome during intraerythrocytic development (discussed below), which 
confirms and very significantly extends our earlier findings on H3K4me3 and H3K9ac 
obtained by the use of microarray technology 156. We verified that both histone H3 
modifications are predominantly present at intergenic regions. Furthermore, we 
detect dynamic marking of intergenic regions during 4 stages of intraerythrocytic 
development, which significantly expands the analysis performed on the 5’ ends of 
coding regions from rings and schizonts we reported previously 156. Additionally, 
the increased temporal and special resolution unveiled an uncoupling of H3K9ac 
and H3K4me3 marks in early stages of intraerythrocytic development (see below). 
RnA-seq analysis of the  transcriptome during intraerythrocytic development
To correlate epigenetic features with steady state level of mRNAs, RNA-seq was 
performed at 8 time-points during the iRBC cycle on polyA+ RNA (supplementary 
figure 1). The obtained sequence data provides deep coverage of the blood-
stage transcriptome and evidently contributes to the ongoing refinement of the 
P. falciparum genome annotation. Given the high sensitivity of the method we 
obtained sequence reads from most coding regions of the Plasmodium genome 
indicating that over 90% of all genes are expressed to some extent (0.1-50000 
tags/1000bp) during intraerythrocytic development. As expected, the transcription 
profile of our parasite culture exhibits good general correlation with the recently 
published P. falciparum transcriptome 167 in cycle progression (supplementary 
figure 4A, R2=0.73-0.78 for comparable stages). However, correlations between 
2 subsequent stages within either of the datasets (representing a 5 or 8 hour 
stage advance) are higher than those of similar time-points between the datasets. 
These differences likely result from differences in parasite strain/clone, culturing 
conditions and synchronicity/staging, stressing that for precise correlation of 
histone marks to RNA levels it is necessary to generate transcriptome data from the 
same parasite population used for epigenome analysis.
Normalisation methods presume equal transcriptional activity across stages 
(i.e. normalise to total signal intensity of arrays or to total RNA-seq tag number). 
However, transcriptional activity has been shown to significantly vary, being low 
after invasion of a red blood cell and reaching the highest level at trophozoite 
stage 169. We observed this variation in overall transcriptional activity in the RNA 
yield from these stages (supplementary figure 4b). Therefore, correction of 
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the normalised RNA-seq tag numbers at each stage for the total transcriptional 
activity per nuclei (see M&M section for details) provides a better approximation 
of the transcriptional output per gene at each stage. Accordingly we used this 
correction method when comparing RNA levels with epigenetic features through 
the intraerythrocytic cycle. 
H2A.Z marks euchromatic intergenic regions
The P. falciparum genome encodes for multiple histone variants (H2A.Z, H2Bv, H3.3, 
CenH3), but their localization and function has remained elusive. To explore the 
function of the histone variants we set out to analyze the genomic localization 
of H2A.Z. Since the N-terminus amino acid sequence of PfH2A.Z is distinct from 
that of other eukaryotes, an antibody against its N-terminal peptide was raised 
and proved to recognize both acetylated and non-acetylated forms of the protein 
(supplementary figure 5). For the analysis of its canonical counterpart, H2A, a 
parasite line ectopically expressing a Ty1-epitope tagged version of H2A was 
generated (supplementary figure 6). Using these tools we profiled the genome-
wide distribution of H2A.Z- and H2A-containing nucleosomes in schizont stage 
parasites. This analysis revealed clear enrichment of H2A.Z in intergenic regions 
of the Plasmodium genome and a largely complementary Ty1-H2A pattern with 
enrichment in the coding body of genes (figure 2A). Similar complementary 
patterns were also apparent when the ChIP-over-input ratio was calculated and 
plotted for each intergenic and coding region of the genome (figure 2b). Notably, 
H2A.Z occupancy differs considerably between intergenic regions (figure 2b,C). 
To understand the nature of this variation, we plotted H2A.Z-over-input ratios of 
intergenic regions in a histogram, divided this into three categories based on their 
level of H2A.Z occupancy (figure 2C) and correlated them with different genomic 
features (figure 2C,D). Most strikingly, intergenic regions low in H2A.Z were 
predominantly located at subtelomeric and chromosome internal heterochromatic 
islands (74%; figure 2C,D) as defined by the presence of H3K9me3 and HP1 
156, 157. General depletion of H2A.Z from the heterochromatin domains is also 
apparent on the chromosome-wide view of its ChIP-seq profile (figure 2D) and is 
complemented by an increase of H2A occupancy (data not shown). 
In summary, H2A.Z localises preferentially to euchromatic intergenic regions in the 
P. falciparum genome and likely makes these regions more accessible for binding of 
other proteins. However, contrary to other organisms where H2A.Z occupies a single 
or a few nucleosomes adjacent to the transcription start site 253, in Plasmodium the 
average width of the H2A.Z marked regions is 1248bp (6-8 nucleosomes, data not 
shown) nearing the average size of the euchromatic intergenic regions (~1500bp). 
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figure 2: H2A.Z localizes to euchromatic intergenic regions. (A) Screenshots of the H2A.Z and H2A-
Ty1 ChIP-seq coverage plots obtained from schizont stage parasites (b) Box-plot displaying the ratios 
of ChIP’ed vs mono-nucleosomal input DNA tag counts in every coding and intergenic regions of the 
P. falciparum genome. (C) Distribution of H2A.Z over mono-nucleosomal input tag counts in intergenic 
regions displayed as a histogram and their separation to three categories (low, medium, high). Table lists 
the percent of basepairs for each category located in heterochromatic vs. euchromatic domains of the 
P. falciparum epigenome. (D) Localization of intergenic regions with diff erent H2A.Z occupancy (from C) 
across entire chromosome 7. H2A.Z coverage plot is included at the bottom. 
H3K9ac and H3K4me3 dynamically co-occur with stably H2A.Z marked 
regions
To compare the localisation of H2A.Z to H3K9ac and H3K4me3 markings we 
computed the average gene profi les of these features in schizont stage parasite 
(supplementary figure 7). These profi les showed a very clear colocalisation of 
the modifi cations and H2A.Z over the intergenic regions, suggesting that H3K9ac 
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and H3K4me3 are preferentially placed/retained on or next to H2A.Z-containing 
nucleosomes. 
Performing ChIP-seq analysis on multiple stages throughout the iRBC, we observed 
that H2A.Z occupancy largely remains constant across stages, while H3K9ac and 
H3K4me3 levels show clear variation (figure 3A, supplementary figure 8). This 
stable H2A.Z level and dynamic H3 marking (peaking at the trophozoite stage) is 
also apparent when ChIP-over-input ratios are plotted for each intergenic region of 
the genome (figure 3b). 
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figure 3: H2A.Z occupancy is invariable, while H3K9ac and H3K4me3 marking is dynamic through 
the intraerythrocytic cycle. (A) Screenshots of the H2A.Z, H3K9ac and H3K4me3 ChIP-seq and mono-
nucleosomal input coverage plots at four stages of intraerythrocytic development (ER: early ring; LR: 
late ring; T: trophozoite; S: schizont) (b) Box-plot displaying the ratios of ChIP’ed vs mono-nucleosomal 
input DNA tag counts in every coding and intergenic region of the P. falciparum genome at four stages 
of intraerythrocytic development. 
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Together these observations support a hypothesis that in P. falciparum H2A.Z 
demarcates intergenic regions and by itself or in combination with other proteins 
likely serves as a scaffold for recruitment of histone modifying complexes that 
acetylate H3K9 and/or trimethylate H3K4. 
Visual inspection of the ChIP-seq profiles revealed two exceptions where dynamic 
H3 marking occurred independent of stable H2A.Z marking. In the coding body 
of over 100 genes, local increase in H3K9ac was observed specifically at the 
trophozoite stage (see supplementary figure 9 for a representative example). 
Markedly, these changes occurred in regions with low H2A.Z levels and were not 
accompanied by H3K4me3. Given the occurrence of these acetylated islands 
specifically at the replicative stage and their rather regular spacing (on average 
150-200kb), they might correspond to the origins of replication, which have been 
shown to be regularly spaced 254 and regulated by H3 and H4 acetylation in other 
organisms 255-258 but have not yet been identified in Plasmodium. The mechanism of 
acetylation of those regions is currently unknown, but a histone acetyltransferase 
(HAT) has been reported to associate with the origin recognition complex (ORC) in 
other organisms 259-261. Therefore recruitment of acetylases in a replication-coupled 
manner directly by ORC components might be responsible for the observed 
acetylation independent of H2A.Z deposition.
Another intriguing example of H2A.Z-independent H3K9ac (and H3K4me3) marking 
during early stages of the iRBC cycle (supplementary figure 10) can be observed 
about 2kb upstream of antigenic variation genes located at the very end of the 
chromosomes (upsB type var genes). Var genes have been shown to be expressed 
in a mutually exclusive manner during ring stage 165. Since multiple var genes 
are active in our parasite population and the ring-stage acetylation is observed 
at almost all upsB type promoters, it seems that this modification has no direct 
causal relation with the expression of these genes. It is intriguing however that this 
marking is specific to 1-2 nucleosomes located directly adjacent to/overlapping 
with SPE2 repeats (supplementary figure 10), which have been shown to be 
bound by an AP2-type DNA binding protein, PfSIP2, at least during late stages of 
development 175. Therefore, binding of this or other factor(s) associated with the 
SPE2 motif likely contributes to the dynamic (de)acetylation of these regions.
H3K9 acetylation follows dynamic changes in transcriptional activity while 
H3K4 trimethylation is stage-specific
To assess the role of these epigenomic features in relation to gene expression, 
we first computed the average gene profiles of euchromatic genes with different 
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mRNA levels (low, medium-low, medium-high, high) within each stage and 
compared them among stages (supplementary figure 11). These profiles 
indicated general correlation between mRNA expression and H2A.Z deposition 
as well as H3K9 acetylation at the 5’end and upstream of genes at all stages. 
Intriguingly, unlike H2A.Z and H3K9ac, H3K4me3 did not exhibit general correlation 
with transcriptional activity at early stages. Although a higher H3K4me3 marking 
can be observed on the promoter and 5’ coding sequence of active genes at the 
latest stages of development (as previously shown by 156), this increase is largely 
independent of the level of transcription. 
Next we investigated whether the increased level of these marks at the promoter 
of genes follows the changes in gene expression through intraerythrocytic 
development. We performed k-means clustering of euchromatic genes based 
on the relative abundance of their transcript across 8 stages (figure 4). Then, we 
compared these gene expression profiles with the relative level of H2A.Z, H3K9ac 
or H3K4me3 occupancy immediately upstream of each gene across 4 stages 
(figure 4A). H2A.Z showed relative constant occupancies across these stages, 
largely independent of changes in gene expression (figure 4A), supporting our 
hypothesis that it functions as a ‘stable mark’. On the other hand H3K9ac patterns 
clearly followed the patterns of expression for most genes (figure 4A) including 
genes with highest mRNA level at ring stages. Strikingly, H3K4me3 showed only 
minor enrichment at early stages but clear marking at later stages at all promoter 
regions. Dynamic association of H3K9ac with transcriptional activity and invariable 
increase in H3K4me3 at later stages independent of transcription, is also evident on 
the average pattern of these features for 3 clusters of early, mid and late expressed 
genes (figure 4b). 
In summary, our data supports a hypothetical model in which H2A.Z-containing 
nucleosomes serve as a constant mark of intergenic regions in the P. falciparum 
genome. As such they likely provide a platform for histone modifying enzymes to 
place and/or remove H3K9ac in a transcription-coupled manner, while H3K4me3 
appears to be deposited in a stage-specific manner.
DisCussion
In this study we present detailed genome-wide localization maps and 
comprehensive analysis of three epigenetic features accompanied by in-depth 
transcriptome sequencing during the intraerythrocytic development of the 
protozoan parasite, Plasmodium falciparum. Our findings reveal important insights 
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into the dynamic as well as static components of the malaria epigenome and how 
they contribute to the control of gene expression. 
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figure 4: H3K9 acetylation dynamically associates with transcriptional activity during 
intraerythrocytic development. (A) Heatmap representation of the relative transcriptional activity 
of ~ 3800 euchromatic genes and relative H2A.Z occupancy or H3K9ac/H3K4me3 marking upstream 
of genes throughout intraerythrocytic development (1 equals to the sum of occupancy values at all 
stages). 12 groups of genes were identified based on their transcriptional profile using k-means 
clustering. Note that this clustering has been performed after correcting for total transcriptional activity 
per nucleus (supplementary figure 4). The percent of genes belonging to each cluster are displayed 
next to the cluster. (b) H2A.Z, H3K9ac and H3K4me3 profiles were plotted through development for 3 
clusters of genes (from figure 4A, indicated by arrows) with maximum transcriptional activity at the 
beginning (top), in the middle (middle) or at the end (bottom) of the intraerythrocytic cycle. Y-axis was 
scaled to maximal occupancy. Solid lines represent average H2A.Z, H3K9ac or H3K4me3 profiles for each 
cluster, grey lines represent individual genes.
Thus far, genome-wide studies on the Plasmodium epigenome 156, 157, 166, 171, 175, 262 
have been performed on microarrays. There are, however, several limitations to 
this technology; the most serious drawback for its use in malaria epigenomics is 
the lower and highly variable signal obtained from intergenic probes. To perform 
highly quantitative epigenome and transcriptome analysis at high resolution, 
we utilised the technological advances provided by next generation sequencing 
(NGS) technology. Deep sequencing has many advantages over microarray 
hybridization 263 but the method is still under intense development and suffers 
Hoeijmakers.indd   108 20-04-12   14:42
Hoeijmakers_PROEF (all).ps Back - 54     T1 -    Black CyanMagentaYellow
Dynamic & Stable Marks of the Plasmodium Epigenome
109
from ‘childhood sicknesses’ 193. For example PCR amplification, typically used 
to obtain sufficient amount of DNA results in under-representation or even 
complete loss of sequences with high AT-content (characteristic of P. falciparum), 
severely hampering the quality and quantitation of the sequence data. Omitting 
PCR amplification altogether has been reported to circumvent this problem 
efficiently 191, but it is not feasible for many applications when limited amounts of 
material is available (ChIP-seq, RNA-seq, GRO-seq, 5C, Ribo-seq, etc). Therefore we 
developed a linear T7-based method for NGS library amplification that effectively 
circumvents this bias and yields representative libraries for sequencing. We have 
unambiguously shown that our method results in unbiased sequencing coverage 
of the P. falciparum genome, and for the first time enables highly quantitative 
analysis of extremely AT-rich intergenic regions (even up to 100%). Importantly, by 
using the unbiased protocol to sequence mono-nucleosomal DNA fragments we 
clearly demonstrate that nucleosome occupancy is comparable between coding 
and intergenic regions of the P. falciparum genome (supplementary figure 3A). 
Therefore we assume that the recently reported low intergenic signal in histone 
H4 ChIP-on-chip 171 or MAINE-seq 170 experiments is likely due to a general loss of 
AT-rich sequences during sample preparation, rather than to lower nucleosome 
occupancy, because their “nucleosomal occupancy” closely follows the genomic 
GC-content (supplementary figure 3b). Furthermore, we detect nucleosomes 
throughout the entire P. falciparum genome, but we cannot exclude the existence 
of local and temporal nucleosome free regions.
Our ChIP-seq analysis shows that euchromatic intergenic regions of the P. falciparum 
genome are occupied by a specific nucleosome subtype that contains the histone 
variant H2A.Z. This variant in other organisms has been reported to have diverse 
functions, including heterochromatin formation and boundary maintenance, 
but is most commonly associated with the transcription start site of a subset of 
genes and involved in transcription initiation 27. As H2A.Z has been found at the 
5’ end of both active and inactive genes in yeast 264 it is argued that it provides an 
open or poised chromatin environment that is amendable both for transcriptional 
activation or repression. In P. falciparum we find that H2A.Z is stably present at 
both 5’ and 3’ ends of euchromatic genes, thus it serves as a constant feature of 
intergenic regions. Although H2A.Z occupancy appears to be invariable across the 
four developmental stages its level is highest in the promoter region of genes with 
the highest mRNA level (supplementary figure 11). Therefore it might define the 
general strength of promoters but not their temporal activity. Such transcription 
promoting/permissive function may be exerted by the physicochemical properties 
of this nucleosome subtype. H2A.Z, in combination with other variants (H3.3 
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44 or H2Bv 47, 48) has been reported to form less stable nucleosomes and likely 
facilitates the access of transcription factors to the underlying DNA sequence 
thereby promoting transcription. Notably, acetylation of H2A.Z specifically 
occurs at promoters of active genes in yeast 265 and probably further facilitates an 
“open” chromatin state. Since our antibody recognizes both acetylated and non-
acetylated H2A.Z with similar affinity, further experiments with acetylation specific 
antibody will be required to characterise the distribution of acetylated H2A.Z in 
the malaria epigenome. Previous mass-spectrometric analyses however provided 
a strong indication that unlike its metazoan counterpart 266, 267 the chromatin-
associated H2A.Z pool in P. falciparum 155 is dominated by the acetylated form, 
suggesting a general transcriptionally permissive function. Orthologs of the 
histone acetyltransferases (Gcn5 and Esa1) that acetylate the N-terminus of H2A.Z 
in higher eukaryotes 265 have been found in Plasmodium 147. Intriguingly, the amino 
acid sequence of this histone tail differs substantially between the parasite and its 
human host (supplementary figure 5). Therefore it is tempting to speculate that 
besides or instead of Gcn5 and Esa1 orthologs, any of the seven less conserved 
HATs encoded in Plasmodium genome might be involved in acetylation of the 
unique N terminal extension of PfH2A.Z. 
In yeast, deletion of H2A.Z leads to decreased expression of genes close to the 
subtelomeric heterochromatic domain suggesting a function of H2A.Z in boundary 
maintenance 268. This could also be the case in Plasmodium. Selective deposition of 
H2A.Z to euchromatin, or its eviction from heterochromatin could be guided by 
marks of other core histones characteristic to these regions (reviewed in 269, 270). For 
example in yeast, several acetylation marks (e.g. H3K14ac 271, 272; or H4K16ac 273) and a 
bromodomain containing component of the SWR1 complex have been implicated 
in targeted H2A.Z deposition271, 272. Such mechanism could also be responsible 
for the higher H2A.Z occupancy of active genes in Plasmodium but an additional 
sequence based mechanism might exist to fully confine H2A.Z to intergenic 
regions of the malaria genome. One such mechanism has been described in yeast, 
where a 22bp long sequence motif commonly found in promoters is necessary 
and sufficient for H2A.Z deposition and formation of an adjacent nucleosome-free 
region 264.
Finally, H2A.Z could promote transcription by recruitment of histone modifying/
remodelling complexes. The almost perfect colocalisation of H2A.Z with H3K4me3 
and H3K9ac in intergenic regions of the Plasmodium genome (supplementary 
figure 7) raises the intriguing hypothesis that these nucleosomes indeed serve 
as a preferred substrate for H3 modifying enzymes and that the H2A.Z-marked 
intergenic regions provide a scaffold for the dynamic placement/removal of specific 
Hoeijmakers.indd   110 20-04-12   14:42
Hoeijmakers_PROEF (all).ps Back - 55     T1 -    Black CyanMagentaYellow
Dynamic & Stable Marks of the Plasmodium Epigenome
111
histone marks. The exact composition of this H2A.Z-containing nucleosome 
subtype is at the moment unknown and any other histone (variant) or histone 
modification contained within this nucleosome subtype might be responsible 
(alone or in combination) for the recruitment of histone modifiers/chromatin 
remodellers. However, similar enrichment of H3K4me2-3 and H3K9ac on H2A.Z-
containing nucleosomes was observed in other eukaryotes 34, 274 suggesting that 
the underlying mechanism is evolutionary conserved. Notwithstanding these 
observations and the fact that similar crosstalk between other core histones has 
been described (e.g. H2A and H4 275 or H2B and H3 276), the proteins involved in H2A.Z-
containing nucleosome dependent recruitment of histone methyltransferases or 
acetylases remain to be identified.
Similar to H2A.Z, H3K9ac is also a common feature of euchromatic intergenic 
regions in the Plasmodium genome as most promoters and even the 3’ end of 
genes are acetylated to some extent as compared to coding bodies of genes (as 
reported previously by us 156 and others 171). However, in contrast to the stable H2A.Z 
occupancy throughout the developmental stages, the level of H3K9ac at promoter 
regions dynamically follows the pattern (figure 4) and level (supplementary 
figure 11) of transcription throughout intraerythrocytic development. Similar 
association of this mark with transcriptional activity has been observed in yeast 
and higher eukaryotes 40, 277. The temporal resolution of our dataset does not allow 
firm conclusions whether H3K9 acetylation occurs before or after transcriptional 
activation and thus is required for transcription or simply is a consequence of it. 
Notably, the changes in H3K9ac levels between different stages are moderate 
(2.1 fold on average) and may not solely instruct stage-specific transcription. 
Interestingly, Chaal and colleagues (2009 262) observed dramatic changes in gene 
expression upon treating malaria parasites with an HDAC inhibitor (apicidin), but 
found no direct link between changes in acetylation levels and transcription. 
Similarly, we find that treatment of parasites with another HDAC inhibitor (SAHA) 
affects the acetylation level of a large number of genes in the parasite’s genome, 
but leads to the activation of only a small group of genes (Salcedo-Amaya 
and Stunnenberg, unpublished observations). Collectively these observations 
suggest that although H3K9 acetylation is intimately coupled to transcription 
in P. falciparum it is not or not the only instructive mark. Further studies of the 
enzymes (complexes) responsible for placement/removal of these marks and their 
mechanisms of recruitment are indispensable to elucidate the order of events and 
the underlying mechanism.
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Unlike H3K9ac, the dynamic H3K4me3 marking does not follow the temporal pattern 
of gene expression. Instead H3K4 methylation at nearly all intergenic regions occurs 
in a stage-specific manner, being low at early stages and increasing at later stages 
of development (figure 4). Since we readily detected H3K4 trimethylation over the 
SPE2 sites (supplementary figure 10) at early stages, we are confident that the 
lower level of H3K4me3 at ring stages is not due to the lower efficiency of the ChIP. 
We can, however, not formally exclude the possibility that other modifications on 
the H3 histone tail (e.g. phosphorylation of T3) interfere with H3K4me3 antibody 
binding at early stages. Nevertheless, reduced global level of H3K4me3 at early 
stages has also been observed on Western-blot 278. The observed stage-specific 
methylation patterns can be the result of placement of the mark at the trophozoite 
stage and/or by its removal at the end of the intraerythrocytic development. Histone 
methylation marks can be placed by SET domain containing enzymes 279. Of the 9 
SET-domain proteins encoded in the Plasmodium genome, PfSET1 (PFF1440w) and 
PfSET4 (PFI0485c) were predicted to have H3K4 methylation activity based on their 
homology to yeast and human enzymes 278. The most likely candidate to remove 
methylation from H3K4 is the homologue (PFL0575w) of the human demethylases 
LSD1. Because at the mRNA level none of these enzymes exert distinctive stage 
specificity (278, our RNA-seq data), it seems likely that their potentially stage-specific 
expression/activity is regulated at the translational or posttranslational levels.
Intriguingly, we find H3K4me3 to be enriched at the promoter of active genes at later 
stages of development independent of their expression levels (supplementary 
figure 11). As the average gene profile of H2A.Z in schizont stage is identical to 
that of H3K4me3 (supplementary figure 11), and H3K4me3 marks are found 
preferentially on regions occupied by H2A.Z (supplementary figure 7), this 
binary H3K4me3 pattern could simply be the consequence of H2A.Z occupancy.
Although the exact function of H3K4me3 is poorly characterized, this mark has 
been linked to transcription initiation, elongation and RNA processing in other 
eukaryotes 280 and was found to associate with several active transcription-related 
factors including TFIID 75. Accordingly, H3K4me3 not only colocalizes with H3K9ac 
but also exhibits a similar function. Since in P. falciparum H3K4me3 is present at 
the intergenic regions at the transcriptional most active trophozoite and schizont 
stages, it is not unthinkable that it functions in combination with H3K9ac to 
enhance the expression of those genes that are activated by transcription factors. 
Indeed, the presence of both H3K4me3 and H3K9ac marks strongly enhanced TFIID 
binding to histone H3 in mammals 75, indicating that the presence of both marks has 
a cumulative effect on the recruitment of the transcription machinery. Nonetheless, 
the disconnect between H3K4me3 and H3K9ac observed in Plasmodium, opens up 
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the appealing possibility that an evolutionary diversification of their functions has 
occurred in the Plasmodium lineage providing a potential weak spot to specifically 
target malaria parasites.
In summary our data identifies H2A.Z as a rather static component of the P. 
falciparum epigenome, which demarcates intergenic regions and is part of a 
scaffold of H2A.Z-containing nucleosomes for subsequent dynamic modification 
of H3K4 and H3K9 residues in either a stage-specific or transcription-coupled 
manner. These results set the gateway towards uncovering the role of histone 
code in indexing the malaria epigenome, in transcriptional regulation and other 
essential processes in Plasmodium falciparum, which might disclose a whole new 
repertoire of targets for therapeutic intervention. 
MATeRiAls & MeTHoDs
Parasite Culture:
Parasites were cultured in standard RPMI medium supplemented with 10% human serum 
and 0.2% NaHCO3 in 250ml tissue culture flasks and candle jars. The culture was synchronised 
with multiple rounds of sorbitol treatments and Percoll gradient centrifugation. After 
the last Percoll gradient centrifugation, 5% red blood cells were added with a couple of 
hours delay ensuring better synchronicity and lack of invasion of fresh RBC before time-
point zero (0hpi). Medium was changed at every 10 hours, but not less than 10h before 
collection. After 20h post-invasion (hpi), double volume of medium was added to ensure 
optimal development of the parasites. The culture was divided to separate culture flasks 
(20ml each) but these were mixed with every change of medium. Samples for RNA and 
chromatin isolation were collected at every 5 or 10hpi, respectively (supplementary figure 
1). Parasites were immediately placed and processed on ice. At each time point parasitemia, 
stages and average number of nuclei were defined by visual inspection of Giemsa stained 
blood smears (supplementary figure 1). 
All experiments were carried out on 3D7 P. falciparum parasites. For profiling of canonical 
H2A, parasites were transfected with a pARL-1a- plasmid 281 encoding Ty1-tagged version 
of PfH2A (PFF0860c) under the control of the chloroquine resistance transporter promoter 
(supplementary figure 6A). Expression of the transgene in the presence of 40nM 
WR99210 was confirmed using the monoclonal anti-TY1 antibody (BB2) that exclusively 
recognises the tagged H2A protein on Western blot and immune fluorescence microscopy 
(supplementary figure 6b,C; IFA on methanol fixed parasites were performed according 
to 282) 
generation of polyclonal H2A.Z antibody: 
The H2A.Z antibody (PFC0920w) was created by immunizing rabbits with the peptide 
ATA-KVIGGKVGGKVGG conjugated to keyhole limpet cyanin (KLH). Antibody was purified 
by affinity chromatography using the same peptide. The specificity of the antibody was 
tested in dotblot with the same as well as an acetylated version (K6 and K10) of this peptide 
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and in Western blot against total nuclear extract from P. falciparum mixed stage parasites 
(supplementary figure 5).
ethical statement:
The immunization of the rabbit for H2A.Z antibody production used in this study was 
carried out in strict accordance with the regulations and recommendations of the Dutch 
Law for Animal Experimentation (WOD). The immunization experiment was carried out 
at the Central Animal Laboratory of the Radboud University Medical Center and was 
approved by the Committee for Animal Experiments of the Radboud University (Permit 
Number: KUNDEC2001-83). All efforts were made to minimize suffering of the rabbit during 
immunization and the final bleeding was carried out under hypnorm anesthesia
genomic DnA extraction and fragmentation:
Genomic DNA was extracted from in vitro cultured ring stage malaria parasites (P. falciparum, 
3D7 strain). Nuclei were isolated after saponin lysis of the red blood cells (0.05% saponin 
in PBS) and lysis of the parasites (10mM Tris pH8.0, 3mM MgCl2, 0.2% NP40) on a 0.25M 
sucrose cushion. Following Proteinase K digestions at 37°C for 4h (50ug/ml PK in 10mM Tris 
pH8.0, 20mM EDTA, 0.5% SDS) remaining proteins were removed by phenol-chlorophorm 
extraction and genomic DNA was precipitated in the presence of EtOH (2.5 volume) and 
sodium-acetate (0.1 volume of 3M). DNA pellets were dissolved in TE (50ng/ul) and sonicated 
to fragments of 100-700bp in 100ul aliquots using the Bioruptor UCD200 (Diagenode).
Chromatin immunoprecipitation:
Native ChIP was carried out as described earlier 156, 157. In short: After saponin lysis of the red 
blood cells and lysis of the parasites, nuclei were separated using a 0.25 M sucrose buffer 
cushion. Native chromatin was prepared by MNase digestion and subsequent extraction 
with salt-free buffers (10 mM Tris pH 7.4, 1 mM EDTA; 1 mM Tris pH 7.4, 0.2 mM EDTA). 
Chromatin was diluted in 2×ChIP incubation buffer (100 mM NaCl, 20 mM Tris pH 7.4, 6 
mM EDTA, 1% Triton X-100, 0.1% SDS). ~400 ng DNA-containing chromatin was incubated 
with 1 µg antibody (H3K9ac (Diagenode pAb-004-050, lot#DA-0010); H3K4me3 (AbCam 
ab8580, lot# 617802)) overnight at 4°C followed by the addition of 10 µl A/G beads and 
further incubation for 2 h. After washing with buffers containing 100, 150 and 250 mM NaCl, 
immunoprecipitated DNA was eluted and purified using PCR purification columns (Qiagen). 
For each antibody 3 ChIP reactions were performed in parallel to obtain sufficient amount 
of DNA for ChIP-seq.
 
RnA isolation and cDnA synthesis:
RNA was isolated from 20 ml synchronous culture (see Parasite Culture) at 8 time-points 
covering all stages of the intraerythrocytic development. RNeasy Mini Kit (Qiagen) was used 
according to manufacturer’s instructions (12 columns were used for RNA isolation of each 
sample and the resulting RNA was further cleaned on two columns). DNase treatment was 
performed on the columns (Qiagen, RNase-Free DNase set) at both rounds of purification. 
Total RNA was directly subjected to a single round of polyA-selection (Qiagen, Oligotex mRNA 
Mini Kit) to enrich for mRNAs. Subsequently, 3-5 mg total RNA-equivalent polyA+ mRNA was 
fragmented by hydrolysis in 40 mM Tris-Acetate pH8.2, 100 mM potassium acetate, 30 mM 
magnesium acetate for 1min 45sec at 85°C followed by purification via precipitation.
cDNA was synthesized from 3-5 mg total RNA-equivalent fragmented polyA+ mRNA. 
First strand synthesis was performed by Superscript III Reverse Transcriptase (400 units, 
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Invitrogen) in the presence of 1x first strand buffer (Invitrogen), 11 mg AT-corrected nonamer 
primers (76%AT), 10 mM DTT, 1 mM each of dNTPs and 40 units RNasin Plus RNase inhibitor 
(Promega) in 20 ml total volume. The reaction was incubated at 37°C for 10 minutes and 
subsequently at 42°C for 1 hour. A similar reaction lacking reverse transcriptase (RT- control) 
was assembled to check for any genomic DNA contamination by qPCR and was negative for 
all samples.
Single-stranded cDNA was converted to double-stranded cDNA by E. coli DNA Polymerase I 
(40 units, Invitrogen) and E. coli DNA ligase (10 units, New England Biolabs) in the presence 
of RNase H (2 units, Ambion). The 150 ml reaction mixture in 1x second strand buffer 
(Invitrogen) supplemented with 0.2 mM each of dNTPs was incubated at 16°C for 2 hours. 
Afterwards, ds cDNA was purified using MinElute Reaction Clean-up Kit (Qiagen). ~ 40 ng of 
each sample ranging in size from 100bp–1kb was used for sequencing sample preparation 
as described below.
High throughput sequencing:
To avoid any changes in the composition of the samples due to PCR amplification we 
developed an unbiased linear T7 amplification method that produces highly representative 
sequencing libraries (detailed protocol has been submitted to Nature Protocols and available 
upon request). In short: End repaired and A-tailed DNA fragments are ligated with custom 
adapters (A and B) corresponding to the two strand of the Illumina adapters, one of which 
(B) is extended by the T7 promoter sequence. Ligated and size selected DNA fragments are 
then in vitro transcribed using T7 polymerase. cDNA synthesis from the resulted RNAs is 
initiated from a primer complementary to the adapter A ensuring that the library will only 
contain full-length fragments with two distinct adapters. After removal of excess primers via 
gel extraction, DNA fragments are directly used for cluster formation and sequencing.
To test the newly developed linear amplification protocol, 40 ng of the sonicated 
genomic DNA was used for library preparation by standard PCR-based (Illumina) or our T7 
amplification protocols, and 400 ng DNA was processed by the amplification-free method 
191. Amplification-free samples were processed as 10 reactions of 40 ng.
For ChIP-seq or RNA-seq analysis 6-40 ng immunoprecipitated and mono-nucleosomal input 
DNA or ds cDNA was used for preparation of sequencing libraries by the T7 amplification 
method. 
Sequencing libraries (32.5 pmol each) were loaded on the Illumina Genome Analyzer IIx and 
sequenced for 76 cycles from one side of the fragments (Standard Cluster Generation Kit 
v2 and 2x 36-cycle sequencing kit v3). Quality filtered 76 bp sequence reads were mapped 
against the Plasmodium falciparum genome assembly (PlasmoDB v6.1) for ChIP and input 
samples or against the Plasmodium falciparum annotated transcripts (PlasmoDB v6.1) for 
mRNA samples using BWA 236. 
Data analysis:
For comparative analysis a common number of uniquely mapped reads were picked for 
each dataset, respectively: 10M for genomic DNA; 5.5M for ChIPed; 11M for input, 8.2M for 
mRNA samples. (Since for the later ring H3K4me3 ChIP only 3.9M tags were obtained, for this 
particular dataset the number of tags was adjusted to 5.5M by 1.6M tags randomly selected 
from the same dataset.) 
Coverage plots were generated by counting the number of overlapping, uniquely mapped 
76bp tags in 10bp windows and visualized in SignalMap (NimbleGen). Ratio tracks were 
obtained by dividing the tag counts with the corresponding tag counts of the amplification-
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free method, smoothened by moving average method (in a 150bp window) and displayed 
on a log2 scale. GC-track was generated by plotting the GC-content (%) per 150bp window 
of the Plasmodium falciparum genome (PlasmoDB v6.1).
For scatter plots the number of uniquely mapped tags were counted in 150bp windows 
(based on the location of the first base) and plotted against the corresponding value of the 
amplification-free sample. These 150bp windows were assigned to coding and intergenic 
regions (genome annotation PlasmoDB v6.1) if more than half of their sequence falls into 
either of these categories. To correlate the coverage with AT-content, these 150bp windows 
have been grouped on the bases of their AT-content and the average number of unique and 
non-unique randomly placed tags mapping to these groups was displayed.
To calculate theoretical mapability, all possible sequence tags of a given length that can be 
obtained from the P. falciparum genome (PlasmoDB v6.1) were determined and mapped 
against this reference genome. Sequence tags at the size of 10-40, 42, 44, 46, 48, 50, 52, 60, 
70, 76, 80, 90, 100, 125 and 150 bases were generated using a python script that uses all 
positions in the genome sequences as a start and takes the given number of bases (length) 
including and upstream of the starting base. Mapability at each position of the genome was 
calculated by counting the number of overlapping, uniquely mapped tags in a 10bp window 
and plotted as a percent of maximum. For general mapability the percentage of uniquely 
mapable tags in the whole genome were defined and plotted according to their read length. 
To determine mapability in subsections of the genome (heterochromatin, euchromatic, 
euchromatic coding, euchromatic intergenic) tags were assigned to the specified regions if 
at least 50% of the tag falls within these regions (intersections were done using a Perl script). 
Boxplots were generated in R from the ratios of the tag counts in the ChIPed vs input or 
input vs genomic DNA datasets using standard settings. Tags were assigned to the coding 
or intergenic regions (genome annotation PlasmoDB v6.1) if more than 50% of the tag 
falls within these regions. Heterochromatic regions were defined based on genome-wide 
localization of Plasmodium falciparum heterochromatin protein 1 (PfHP1) published by 
Flueck et al. 157. Intergenic regions were defined as the non-coding sequences between two 
adjacent genes.
For comparison of different datasets on nucleosome occupancy raw MAINE-seq data for 
three stages 170 was downloaded from the GEO database and analysed as described above, 
while processed datafiles for H4 ChIP-on-chip experiments 171 were obtained from PlasmoDB. 
To determine correlations between RNA-seq data from Otto and colleagues 167 and our 
dataset, 36bp single-end reads (resulting from truncating longer reads to the first 36bp) 
were mapped against the P. falciparum transcriptome (annotated transcripts PlasmoDB v6.1) 
and 1.9M uniquely mapped tags were randomly selected from each. The sum of all tags 
mapping to one gene was determined for each dataset and correlations were obtained in R 
on log-transformed values using default settings.
Average gene profiles were computed for ~2600 genes within the euchromatic domain 
(given the general lack of signal in the heterochromatic domain) with coding body of 1-10kb 
(excluding extremely small or large genes) and a minimum of 800bp intergenic regions on 
both sides (to minimize overlap with flanking region of nearby genes). The coding body 
of these genes was divided into twenty equal size windows and four 150bp windows 
immediately up- or downstream represented flanking sequences. The ratio of the tag 
counts in the ChIPed vs input datasets has been computed in each individual windows and 
averaged in the corresponding window of all genes with similar expression levels (genes has 
been divided to four equal sized group with different expression levels based on the number 
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of RNA-seq tags mapping to every 1000bp of their transcript in a given stage). 
For expression profiling of genes, RNA-seq sequence reads from 8 stages of the RBC cycle 
were mapped against the transcriptome (annotated transcripts; PlasmoDB v6.1) and 8.2M 
uniquely mapped tags were randomly selected from each. To provide better approximation 
of the true transcriptional activity, tag density (per 1000bp) values at each stage were 
adjusted by a scaling factor derived from total RNA yield and the average number of nuclei, 
respectively (see supplementary figure 4, scaling factor calculated by dividing total RNA 
yield by the average number of nuclei per parasite). Relative transcriptional activity of each 
euchromatic gene (with min 100tags/1000bp at least in one of the stages on non-scaled tag 
counts, including ~3800 genes in total) was calculated by dividing the scaled tag density at 
the particular stage by the sum of the scaled tag densities across all 8 stages. Twelve groups 
of genes with similar expression pattern through the intraerythrocytic cycle were identified 
by k-means clustering of genes and visualised on a heatmap (MultiExperimentViewer). The 
expression profile of each gene was then matched with the profile of H2A.Z occupancy/
H3K9ac or H3K4me3 marking in the H2A.Z occupied region (peak) immediately upstream 
of the gene. (H2A.Z peaks were called on the combined H2A.Z ChIP-seq dataset if the 
ratio over input was higher than 1 on a minimum length of 150bp). Relative marking/
occupancy through the intraerythrocytic cycle was calculated similarly to that of the relative 
transcriptional activity (scaled to the sum of ChIP-over-input ratios across stages).
Data deposition:
Raw sequencing data and processed data files described in this publication are deposited in 
NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number 
GSE23787 for mono-nucleosomal inputs, H2A, H2A.Z, H3K9ac and H3K4me3 ChIP-seq and 
RNA-seq expression data (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE23787). 
All data is also available at PlasmoDB (www.plasmodb.org).
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suPPleMenTARY
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~1.83 nuclei/parasite
10hpi
R 100%, T 0%, S 0%
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5% hematocrit
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with >95% within a 7 hour window
Cycle length ~ 43 hours
Collections:
9.5% parasitemia
0 - 20hpi: 5% hematocrit
25 - 40hpi: 2.5% hematocrit
Suppl m tary Figure 1 - chapter 5
supplementary figure 1: sample collection scheme. (A) Collection scheme for total RNA (every 
5h) and nuclei (every 10h) from highly synchronous P. falciparum culture (3D7 strain). hpi: hours post-
invasion (b) Representative image of Giemsa stained blood smear at each time point. Percentage of 
ring (R), trophozoite (T) or schizont (S) stage parasites and the number of nuclei per parasite have been 
defined be visual inspection of 1000 infected red blood cells.
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Supplementary Figure 2 - chapter 5
supplementary figure 2: Mapability of sequences reads with different length on the highly AT-
rich  genome. (A-C) Plasmodium falciparum genomic sequence (PlasmoDB v6.1) was used to generate 
all possible reads of fixed length. Reads were mapped back onto the genome and the percentage of the 
uniquely mapable fragments (mapping to a unique position in the genome) were plotted according 
to the length of the sequence tags in the (A) whole genome (b) euchromatic or repeat-rich and multi 
gene family containing heterochromatic domains (C) euchromatic coding and AT-rich intergenic 
regions, respectively. (D-e) Representative screenshot displaying the percentage of uniquely mapable 
fragments of 36bp, 52bp, 76bp and 100bp in the heterochromatic (D) and euchromatic (e) domains.
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Supplementary Figure 3 - chapter 5
supplementary figure 3. nucleosome occupancy is similar between coding and intergenic regions. 
(A) Box-plot displaying the ratios of mononucleosomal vs genomic DNA tag counts in every coding 
(C) and intergenic (IG) regions of the P. falciparum genome at four diff erent stages of intraerythrocytic 
development  (ER: early ring; LR: late ring; T: trophozoite; S: schizont). (b) Representative screenshot 
showing direct comparison of H4_ChIP-on-chip (log2-ratio ChIP-over-genomic DNA) 171, MAINE-seq 
170 and our mononucleosomal Illumina sequencing coverage plots at three stages of intraerythrocytic 
development (ER/R: early ring/ring; T: trophozoite; S: schizont). Bottom track displays GC-content (%) 
per 150bp window.
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Supplementary Figure 4 - chapter 5
supplementary figure 4: RnA-seq interdataset comparison and scaling method. (A) R2-correlation 
values from pair-wise comparison of our 8 stages RNA-seq and 7 stages of published RNA-seq data 
167 of 3D7 Plasmodium falciparum parasites. Colour code indicates the level of correlation (black = 
highest, white = lowest). (b) Graph showing the scaling factor used for scaling of RNA-seq data to better 
approximate transcriptional activity per nuclei. Scaling factor is calculated based on the amount of total 
RNA collected from each stage divided by the average number of nuclei per parasite in that stage. 
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A
500ng
B
250ng
125ng
62.5ng
31.3ng
15.6ng
7.8ng
NonAc.       Ac.  peptide 
  αH2A.Z 1:500
C
6kDa
15kDa
19kDa
26kDa
37kDa
3D7 nuclear isolate (10ug) 
 αH2A.Z 1:5000
PfH2A.Z -------------------------MEVPGKVIGGKVGGKVGGKVLGLGKGGKGKTGSGKT-K 38
TgH2A.Z -------------------------MDGAGKV-GGKVGGKVGGKVGGMGKGGKGKSGSGKG-K 37
HsH2A.Z ------------------------------------------------MAGGKAGKDSGKA-K 15
TbH2A.Z MSLTGDDAVPQAPLVGGVAMSPEQASALTGGKLGGKAVGPAHGKGKGKGKGKRGGKTGGKAGR 63
PfH2A -------------------------------------------------MSAKGKTGRKKASK 14
TgH2A -------------------------------------------------MSAKGAGGRKKTSS 14
HsH2A -------------------------------------------------MSGRGKQGGKARAK 14
TbH2A --------------------------------------------------MATPKQAVKKASK 13
PfH2A.Z KAPLSRASRAGLQFPVGRVHRMLKSRISSDGRVGSTAAVYAAAILEYLTAEVLELAGNATKDL 100
TgH2A.Z KAPLSRAARAGLQFPVGRVHRMLKSRISSEGRVGSTAAVYASAILEYLTAEVLELAGNASKDL 99
HsH2A.Z TKAVSRSQRAGLQFPVGRIHRHLKSRTTSHGRVGATAAVYSAAILEYLTAEVLELAGNASKDL 77
TbH2A.Z RDKMTRAARADLNFPVGRIHSRLKDGLNRKQRCGASAAIYCAALLEYLTSEVIELAGAAAKAQ 126
PfH2A G--TSNSAKAGLQFPVGRIGRYLKKGKYAK-RVGAGAPVYLAAVLEYLCAEILELAGNAARDN 74
TgH2A GKKVSRSAKAGLQFPVSRIGRYLKKGRYAK-RVGVGAPVYLAAVLEYLCAEILELAGNAARDH 76
HsH2A A--KTRSSRAGLQFPVGRVHRLLRKGNYAE-RVGAGAPVYLAAVLEYLTAEILELAGNAARDN 74
TbH2A GG-SSRSVKAGLIFPVGRVGTLLRRGQYAR-RIGASGAVYMAAVLEYLTAELLELSVKAAAQQ 74
:.: :*.* ***.*: *: * * ..:* :*:**** :*::**:*:
PfH2A.Z --KVKRITPRHLQLAIRGDEELDTLIK-ATIAGGGVIPHIHKALMNKVPLPPTAQKKPKKN 158
TgH2A.Z --KVKRITPRHLQLAIRGDEELDTLIK-ATIAGGGVIPHIHKSLMTKGPSTQPMKKAKK-- 155
HsH2A.Z --KVKRITPRHLQLAIRGDEELDSLIK-ATIAGGGVIPHIHKSLIGKKGQQKTV------- 128
TbH2A.Z --KTERIKPRHLLLAIRGDEELNQIVN-ATIARGGVVPFVHKSLEKKIIKKSKRGS----- 179
PfH2A --KKSRITPRHIQLAVRNDEELNKFLAGVTFASGGVLPNIHNVLLPKKSQLKAGT-ANQDY 132
TgH2A --KKTRIIPRHIQLAVRNDEELSKFLGGVTIANGGVMPHVHAVLLPKHSKSKGKHGVSQEF 135
HsH2A --KKTRIIPRHLQLAIRNDEELNKLLGKVTIAQGGVLPNIQAVLLPKKTESHHKAKGK--- 130
TbH2A TKKTKRLTPRTVTLAVRHDDDLGALLRNVTMSRGGVMPSLNKALAKKQKSGKHAKATPSV- 134
* *: ** : **:* *::*. :: .*:: ***:* :: * *
Supplementary Figure 5 - chapter 5
supplementary figure 5: generation and characterisation of polyclonal H2A.Z antibody. (A) 
Alignment of the protein sequence of histone H2A and H2A.Z proteins from H. sapiens, P. falciparum, T. 
brucei, T. gondii. Highly conserved core domain is surrounded by dashed line. Acetylated lysines at the 
N-terminus of H2A.Z are bolded and underlined. Peptide used for immunisation is highlighted yellow. 
(b) Dot blot experiment demonstrating similar affinity of the H2A.Z antibody to the acetylated and 
non-acetylated peptide. (C) The H2A.Z antibody specifically recognises its target protein in total nuclear 
isolate from asynchronous parasite culture. 
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A
B C
hHDFRCam 5’ hrp2 3’crt 5’ Pb 3’PfH2ATy
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Supplementary Figure 6 - chapter 5
supplementary figure 6: generation and characterisation of H2A-Ty1 strain. (A) Map of the 
pARL-1a-Ty1-H2A plasmid transfected into 3D7 parasites. (b) Western blot demonstrating specific 
recognition of the Ty1-tagged H2A protein by the BB2 antibody in the transgenic parasite line. (C) 
Immunofluorescent assay showing nuclear localisation of the ectopically expressed Ty1-H2A protein at 
all stages of the intraerythrocytic cycle.
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Supplementary Figure 7 - chapter 5
supplementary figure 7: H3K9ac and H3K4me3 shows very similar localisation to H2A.Z. Average 
profile of H2A.Z occupancy, H3K9ac and H3K4me3 marking over euchromatic genes in schizont stage 
parasites. The coding region is indicated by the arrow (divided into 20 bins), 5’ and 3’ intergenic regions 
are displayed as 4 blocks of 150bp bins.
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Supplementary Figure 8 - chapter 5
supplementary figure 8: H2A.Z occupancy is invariable, while H3K9ac and H3K4me3 marking is 
dynamic through the intraerythrocytic cycle. Screenshot of same chr2 region as shown in figure 3. 
Instead of coverage plots, H2A.Z-, H3K9ac- and H3K4me3-over-mononucleosomal input log2-ratios are 
displayed at four stages of intraerythrocytic development (ER: early ring; LR: late ring; T: trophozoite; S: 
schizont).
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Supplementary Figure 9 - chapter 5
supplementary figure 9: Regions specifi cally acetylated on H3K9 during trophozoite stage 
independent of H2A.Z, might corresponds to origins of replication. Screenshots of the H2A.Z, 
H3K9ac and H3K4me3 ChIP-seq coverage plots at four stages of intraerythrocytic development (ER: 
early ring; LR: late ring; T: trophozoite; S: schizont) from a subsection of chromosome 10. Region with 
increased H3K9ac only in trophozoite stage is surrounded by dashed line.
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Supplementary Figure 10 - chapter 5
supplementary figure 10: sPe2 repeats upstream of upsB type var genes carry H3K9ac and 
H3K4me3 independent of H2A.Z. Screenshots of the H2A.Z, H3K9ac and H3K4me3 ChIP-seq coverage 
plots at four stages of intraerythrocytic development (ER: early ring; LR: late ring; T: trophozoite; S: 
schizont) from the distal end of chromosome 2. SPE2 repeat containing region carrying H3K9ac and 
H3K4me3 during ring stage is surrounded by dashed line.
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supplementary figure 
11: H2A.Z occupancy 
and H3K9ac marking 
upstream of genes 
correlates with steady 
state mRnA levels. 
Average profile of H2A.Z 
occupancy, H3K9ac 
and H3K4me3 marking 
over groups of genes 
with different mRNA 
levels at four stages 
of intraerythrocytic 
development. To avoid 
signal coming from the 
neighbouring genes 
only euchromatic genes 
(~2600) with a minimum 
of 800bp intergenic 
region on both sides 
were included in this 
analysis. Coding body is 
indicated by the arrow 
(divided into 20 bins), 5’ 
and 3’ intergenic regions 
are displayed as 4 blocks 
of 150bp bins.
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AbsTRACT
Plasmodium spp. are amongst the most devastating infectious agents responsible 
for about 225 million clinical malaria cases and nearly 1 million deaths annually. 
Components of the P. falciparum epigenome are largely conserved compared 
to commonly studied model organisms, but also display some unique features. 
Histone variant H2Bv is such a unique epigenome component, as it solely occurs in 
apicomplexan and trypanosomatid parasite species. In this study we explored the 
genome-wide localization of PfH2Bv. We demonstrate that H2Bv co-localizes with 
histone variant H2A.Z to euchromatic intergenic regions throughout P. falciparum 
intraerytrocytic development. Interestingly, these variants form a double-variant 
nucleosome subtype, similar to those identified in the protozoan parasites 
Trypanosoma brucei and Toxoplasma gondii. The PfH2A.Z- and PfH2Bv-containing 
nucleosomes are enriched in promoters over 3’ intergenic regions and histone 
variant occupancy increases with increasing length of the intergenic domain. 
Remarkably, both histone variants exhibit a clear positive correlation towards AT-
content, indicating that the sequence composition might be instructive for histone 
variant deposition. In summary, our data suggest that the H2A.Z/H2Bv double-
variant nucleosome demarcates presumed regulatory regions of the P. falciparum 
epigenome, where it might provide a scaffold for dynamic regulation of gene 
expression in this deadly human pathogen. 
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inTRoDuCTion
Plasmodium falciparum is the protozoan parasite responsible for almost 1 million 
malaria deaths annually 105. It has a complex life cycle involving a mosquito vector 
and a human host 131. During host infection, P. falciparum invades multiple different 
cell types and adopts various morphological states 131, which necessitates a 
tight control of gene expression to allow the timely presence of key proteins 143. 
Accordingly, a cascade of gene expression has been observed during parasite 
intraerythrocytic development 139. Nevertheless, gene regulation in Plasmodium is 
still poorly understood 144. Although a family of 27 plant-like AP2-type transcription 
factors was identified in 2005 145, only one of these factors has been profiled for 
its genome-wide localization 175. Besides direct regulation of gene expression by 
transcription factors, protein abundance can be controlled at various other levels. 
Epigenetic processes are believed to play an essential role in the regulation of 
transcription initiation 144. Intriguingly, histone H3 lysine 9 acetylation (H3K9ac) 
positively correlates to gene expression during the intraerytrocytic development 
161. Furthermore, accumulating evidence indicates that epigenetic features 
index the P. falciparum epigenome into functionally distinct domains, including 
heterochromatic, euchromatic and centromeric regions 156, 157, 161, 166, 252, 283.
Epigenetic mechanisms act at the level of chromatin and influence all DNA-
associated processes in a cell 2. The nucleosome that forms the building block of 
chromatin is composed of an octameric protein core containing two copies each 
of the core histones (H2A, H2B, H3 and H4) surrounded by ~147bp of DNA 5. The 
N-terminal histone tails that protrude from this core can be posttranslationally 
modified at various residues, thereby influencing nucleosome function 2. In 
addition, core histones can be exchanged by histone variants, which have a 
somewhat different amino acid sequence and can bear distinct post-translational 
modifications. Histone variants play various functions in numerous organisms and 
are often essential 284, 285.
The Plasmodium falciparum genome encodes 4 histone variants (H2A.Z, H2Bv, 
H3.3 and CenH3) 153, for two of which we recently revealed their genome-wide 
localization. Similar to its conserved function in other organisms 286, PfCENH3 
was found to demarcate P. falciparum centromeres 283. In contrast, histone variant 
H2A.Z has been reported to be involved both in gene activation and silencing in 
different organisms and localizes to various distinct genomic features, including 
gene promoters and heterochromatin boundaries 27. In P. falciparum, this histone 
variant occupies euchromatic intergenic regions of the genome, where it probably 
functions in transcriptional control 161, 287. However, genome-wide localization of 
Hoeijmakers.indd   133 20-04-12   14:43
Hoeijmakers_PROEF (all).ps Front - 67     T1 -    Black CyanMagentaYellow
Chapter 6
134
histone variant PfH2Bv has not been explored. 
H2Bv is a protozoan specific histone variant and has so far been identified in the 
apicomplexan and trypanosomatid lineages of this subkingdom 288. Despite the 
fact that apicomplexan and trypanosomatid H2Bv are claimed to have independent 
evolutionary origins 288, H2B variant in the apicomplexan parasite Toxoplasma 
gondii 289, 290 and the trypanosomid T. brucei 47 dimerize with histone variant H2A.Z, 
associate with active histone marks 48, 290, 291 and are enriched on active genes in 
targeted ChIP 290 or transcription start sites of polycistronic transcripts genome-
wide 48 in T. gondii and T. brucei respectively, suggesting that they might have 
similar functions in these parasite lineages. H2Bv in the apicomplexan parasite 
Plasmodium falciparum has not been studied in detail, but multiple acetylation 
sites have been identified on its N-terminal tail 153, 155. Interestingly, all P. falciparum 
H2Bv acetylated lysine residues are conserved in T. gondii 288 and acetylation of 
lysine 7 and 19 has been detected on TbH2BV 291.
As a first step towards identification of H2Bv function in Plasmodium, we set out 
to unravel the genome-wide localization of P. falciparum H2Bv. We show that 
histone variants H2A.Z and H2Bv co-localized to euchromatic intergenic regions 
and reside in a double-variant nucleosome subtype. Collectively, our data indicate 
that the H2A.Z/H2Bv double-variant nucleosome demarcates regulatory regions 
of the P. falciparum genome and might play a role in transcriptional control of this 
important human pathogen.
ResulTs
PfH2bv localizes to euchromatic intergenic regions of the P. falciparum 
genome
Plasmodium falciparum histone variant H2Bv (PF07_0054) encodes for a 123 
amino-acid protein that differs from canonical H2B (PF11_0062) mostly in its 
N-terminal domain 153. H2Bv is a protozoan-specific H2B variant that has so far only 
been identified in Apicomplexa and Trypanosomatida 288. Sequence comparison 
(figure 1A) reveals that PfH2Bv is similar to apicomplexan histone H2B variants 
(89%, 86% and 79% identity or 99%, 96% and 98% similarity to Toxoplasma gondii, 
Babesia bovis and Crytosporidium parvum, respectively), but differs substantially 
from Trypanosoma brucei H2BV (only 37% identity and 81% similarity). Thus far, 
the genome-wide localization of trypanosomid H2BV has been explored 48, but 
extensive surveys into the genomic localization of apicomplexan H2B variant are 
lacking. Therefore, we generated a Plasmodium falciparum 3D7 line expressing 
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an episomal Ty1-tagged copy of PfH2Bv (figure 1b,C) in order to determine its 
genome-wide localization. Figure 1: chapter 6
A
B
Toxoplasma gondii        MSGK------GPAQKSQAAKKTAGKS--LGPRYR-----RRKRTESFALYIYKVLKQVHPETGVSKKSMSIMNS 61
Babesia bovis            MSGK------VPSSKSQAAKKTAGKS--LGIRYR-----RKKRIESFSLYIYKVLKQVHPETGVSKKSMSIMNS 61
Plasmodium falciparum    MSGK------GPAQKSQAAKKTAGKT--LGPRHK-----RKRRTESFSLYIFKVLKQVHPETGVTKKSMNIMNS 61
Cryptosporidium parvum   MSGKSGKSIKGPAQKQQAAKKTAGKSPADGGKRK-----RRKRTESFALYIYKVLKQVHPETGISKKSMSIMNS 69
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figure 1: generation of H2bv-Ty1 3D7 parasite line. (A) Alignment of the amino acid sequence of 
H2Bv in various protozoan parasites. Plasmodium falciparum H2Bv (PF07_0054), Toxoplasma gondii H2Bv 
(TGME49_009910), Babesia bovis H2B.1 (BBOV_IV006840), Cryptosporidium parvum H2B (cdg7_1700) 
and Trypanosoma brucei H2BV (Tb11.02.5250) are included in this analysis. Amino acid identity is 
indicated by asterix (*) and similarity by dots (. or :) and colour code. (b) Map of the pARL-1a-H2Bv-
Ty1 plasmid transfected into 3D7 P. falciparum parasites. (C) Western blot of acid-extracted histones 
demonstrating specifi c recognition of H2Bv-Ty1 by the BB2 antibody in the transgenic parasite line.
Native chromatin immunoprecipitation (nChIP) of mono-nucleosomal fragments, 
followed by linear amplifi cation for deep sequencing (LADS) 225 and next-generation 
sequencing was performed as in 161 to obtain a minimum of 10.6M 76bp sequence 
reads for both H2Bv-Ty1 ChIP and corresponding mono-nucleosomal input from 
three stages (ring, trophozoite, schizont) of intraerythrocytic development. Visual 
inspection of H2Bv-Ty1 coverage plots of schizont stage parasites reveals a clear 
enrichment of signal in euchromatic regions of the genome (figure 2A). Zooming 
into these regions, a specifi c localization to intergenic regions can be observed 
(figure 2b). Counting the number of sequence reads localizing to euchromatic 
coding, euchromatic intergenic, heterochromatic coding or heterochromatic 
intergenic regions in ChIP and input libraries, respectively, corroborated the 
preferential localization of histone variant H2Bv to euchromatic intergenic regions 
(figure 2C). 
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Figure 2: chapter 6
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figure 2: P. falciparum H2bv localizes to euchromatic intergenic regions. (A-b) Screenshot of the 
coverage plot of H2Bv-Ty1 distribution over the entire chromosome 4 (A) and part of a euchromatic 
region at chromosome 11 (b) obtained from schizont stage parasites. Heterochromatin is indicated in 
dark red and genes are depicted as blue boxes. (C) Piecharts plotting the proportion of sequence reads 
mapped on euchromatic intergenic or coding and heterochromatic intergenic or coding regions of 
H2Bv-Ty1 ChIP-Seq and input from schizont stage parasites.
PfH2bv and PfH2A.Z display similar localization and form a double-variant 
nucleosome subtype
Genome-wide localization of schizont stage H2Bv-Ty1 reveals a preferential 
localization to euchromatic intergenic regions almost indistinguishable from what 
we previously observed for histone variant PfH2A.Z 161. PfH2A.Z was found to stably 
demarcate euchromatic intergenic regions at multiple asexual stages of red blood 
cell infection 161. 
To verify whether the co-occupancy of both histone variants observed in schizont 
stages, is stable throughout intraerythrocytic development, H2Bv-Ty1 occupancy 
was also determined in ring and trophozoite stages. Indeed, both histone variants 
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clearly occupy euchromatic intergenic regions at all three stages of development 
(figure 3A) and average gene profiles of euchromatic genes in ring, trophozoite and 
schizont stage parasites substantiate this finding (figure 3b). Furthermore, when 
plotting H2A.Z and H2Bv-Ty1 tag counts in intergenic or coding regions (figure 
3C, top and bottom panels, respectively) of ring, trophozoite and schizont 
stage libraries, a clear positive correlation can be observed, confirming the co-
localization of both histone variants on the Plasmodium genome. Especially when 
considering that these datasets were produced from independent experiments 
and result from distinct 3D7 mother-lines (the H2Bv-Ty1 originated from a different 
lab and contains multiple deletions on different chromosomes and a duplication at 
chr13), the datasets correlate remarkably well.
A closer examination of the scatterplots of intergenic regions reveals a few 
regions that display higher signals in the H2Bv-Ty1 experiment compared to the 
H2A.Z profiles (indicated in red in figure 3C). Most of these signals were found 
to originate from heterochromatic domains (data not shown), which might 
indicate that heterochromatic intergenic regions contain some levels of histone 
variant H2Bv especially at trophozoite stages. Notably, the trophozoite H2Bv-Ty1 
dataset also displays generally slightly lower enrichment at intergenic regions 
and infrequently provide signal in coding bodies of genes. This can be observed 
in the coverage plot (figure 3A), the slightly lower enrichment at promoters in 
the average gene profiles (figure 3b) and the reduced correlation between H2Bv 
and H2A.Z intergenic signals in trophozoite stage parasites (figure 3C). Although 
this slightly different pattern at the trophozoite stage is highly reproducible in 
an biological replicate (targeted ChIP, data not shown), at the moment it remains 
ambiguous whether these two observations are true biological phenomena or due 
to the slight miss-expression of the H2Bv protein.
The co-localization of both variants in P. falciparum described above, suggests that 
H2A.Z and H2Bv variants reside in the same nucleosome particle, similar to what 
has been observed in T. gondii 290 and T. brucei 47. For that reason, we performed an 
immunoprecipitation experiment on mono-nucleosomes derived from the H2Bv-
Ty1 line (figure 3D). Immunoprecipitation of H2Bv-Ty1 results in co-IP of H2A.Z but 
not canonical H2A. Similarly, immunoprecipitation using aH2A.Z antibody results 
in a robust pull-down of H2Bv-Ty1, whereas a control IP using control rabbit IgG 
co-immunoprecipitates neither of the histones.
In summary, our analysis reveals that Plasmodium falciparum H2Bv and H2A.Z 
histone variants reside in the same nucleosome particle and localize to euchromatin 
intergenic regions of the genome.
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Figure 3: chapter 6
A
B
gene
H2Bv-Ty1
Ring
72
00
0
73
00
0
74
00
0
75
00
0
76
00
0
77
00
0
78
00
0
79
00
0
80
00
0
81
00
0
82
00
0
83
00
0
84
00
0
85
00
0
86
00
0
87
00
0
88
00
0
89
00
0
90
00
0
91
00
0
92
00
0
93
00
0
94
00
0
95
00
0
96
00
0
97
00
0
98
00
0
99
00
0
10
00
00
10
10
00
chr2
1
-1
0
275
1
275
1
275
1
275
1
275
1
275
1
H2Bv-Ty1
Trophozoite
H2Bv-Ty1
Schizont
H2A.Z
Ring
H2A.Z
Trophozoite
H2A.Z
Schizont
H2A.Z
H2Bv
C
αTy1
αH2A
αH2A.Z
αT
y1
 IP
αH
2A
.Z
 IP
co
nt
ro
l I
P
17
%
 in
pu
t
D
H
2B
v 
R
in
g 
(s
qr
t p
er
 r
eg
io
n)
H2Az Ring (sqrt per region)
0      20     40     60     80    100
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
Coding
R2 = 0.88
H
2B
v 
T
ro
ph
oz
oi
te
(s
qr
t p
er
 r
eg
io
n)
H2A.Z Trophozoite (sqrt per region)
0      20     40     60     80    100
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
Coding
R2 = 0.89 
H
2B
v 
S
ch
iz
on
t
(s
qr
t p
er
 r
eg
io
n)
H2A.Z Schizont (sqrt per region)
0      20     40     60     80    100
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
Coding
R2 = 0.85
Intergenic
R2 = 0.91
H
2B
v 
R
in
g 
(s
qr
t p
er
 r
eg
io
n)
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
Intergenic
R2 = 0.83
H
2B
v 
T
ro
ph
oz
oi
te
(s
qr
t p
er
 r
eg
io
n)
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
Intergenic
R2 = 0.90
H
2B
v 
S
ch
iz
on
t
(s
qr
t p
er
 r
eg
io
n)
0 
   
 2
0 
   
40
   
 6
0 
   
80
   
10
0
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Ring
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Trophozoite
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Schizont
C
hI
P
-o
ve
r-
in
pu
t r
at
io
 
figure 3: PfH2A.Z and PfH2bv have similar genome-wide localization profiles throughout 
intraerythrocytic development and reside in the same nucleosome particle. (A) Screenshot of 
the H2Bv-Ty1 and H2A.Z ChIP-Seq coverage plots over a part of a euchromatic region of P. falciparum 
chromosome 2 at ring, trophozoite and schizont stage parasites. Genes are depicted as blue boxes. (b) 
Average profile of ChIP-over-input ratio’s of H2A.Z and H2Bv-Ty1 occupancy at ring, trophozoite and 
schizont stages showing the distribution of both variants over 1855 euchromatic genes and their 5’ 
and 3’ flanking regions. Coding body is indicated by an arrow (divided into 20 bins), 5’ and 3’ intergenic 
regions are displayed as four blocks of 150bp. (C) Scatterplot analysis of H2A.Z and H2Bv-Ty1 ChIP-
Seq sequence reads mapped on intergenic or coding regions of the entire genome, obtained from 
ring, trophozoite and schizont parasites. R-square values are included in each graph. (D) Western blot 
analysis of histone proteins (H2A, H2A.Z and H2Bv-Ty1) immunoprecipitated by the anti-H2A.Z, anti-Ty1 
and a control antibody from mono-nucleosomes of the H2Bv-Ty1 parasites.
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PfH2A.Z/PfH2bv occupancy rises with increasing length and AT-content of 
promoter regions
Although both H2A.Z and H2Bv are enriched in almost every euchromatic intergenic 
region, variant histone occupancy still differs considerably between individual 
regions. Previously, we established that most intergenic regions low in H2A.Z 
occupancy reside in heterochromatic domains 161. Nonetheless, low occupancy 
regions infrequently occur within the euchromatin. Additionally, regions displaying 
medium as well as high variant-occupancy inhabit this domain (figure 2D of 161 
and supplementary figure 1). To explore the variable levels of H2A.Z and H2Bv 
in different euchromatic intergenic regions, we investigated whether and which 
genomic features correlate with variant histone occupancy.
The average gene profiles presented in figure 3b suggest that 5’UTR regions of 
genes maintain higher variant histone levels compared to the 3’UTRs. Indeed, 
when subdividing euchromatic intergenic regions based on their adjacent 
gene orientation either as convergent (neighboring to two 3’ends), divergent 
(neighboring to two 5’ends) and tandem (neighboring to one 3’ and one 5’end) 
high occupancy is most prevalent in divergent regions (two promoters), whereas 
low occupancy is almost exclusively observed at convergent regions (two 3’ ends) 
(figure 4A). This finding indicates that although H2A.Z and H2Bv-containing 
nucleosomes are generally enriched in euchromatic intergenic regions, occupancy 
is highest at promoter regions of genes. Additionally, the domains most enriched 
for H2A.Z and H2Bv display an increased median length when compared to the 
lowly occupied domains which have a median size of only ~600bp (figure 4b), 
possibly indicating that a minimal length of the AT-rich intergenic region per se 
might be required to trigger efficient deposition of H2A.Z/H2Bv-type nucleosomes. 
Examination of the coverage plots by visual inspection suggested that H2A.Z 
and H2Bv occupancy might be correlated to AT-content (data not shown). To 
explore the possibility that genomic AT-content was correlative to histone variant 
occupancy, we calculated the ChIP-over-input ratio for every 150bp window of the 
euchromatic domain for H2A.Z, H2Bv-Ty1 and plotted this against their AT-content. 
As shown in the boxplots in figure 4C, intergenic regions with increasing AT-
content indeed display markedly increased median H2A.Z and H2Bv occupancies. 
Importantly, a similar correlation to AT-content exists for genic regions (both exons 
and introns) (figure 4D), although absolute histone variant enrichments are lower 
at comparable AT-content. Therefore, H2A.Z and H2Bv histone variants seem to 
preferentially localize to AT-rich regions of the P. falciparum genome.
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figure 4: PfH2A.Z and PfH2bv occupancy increases with genomic AT-content and is enriched 
in long promoter regions. (A) Histogram displaying the percentage of euchromatic intergenic 
regions with low, medium or high H2A.Z- and H2Bv-occupancy with respect to the orientation of their 
neighboring genes (convergent (3’-3’), tandem (3’-5’) or divergent (5’-5’)). (b-D) Box-plots displaying 
the distribution of H2A.Z and H2Bv-Ty1 ChIP-over-input ratio’s (b) in low, medium and highly H2A.Z- or 
H2Bv-occupied regions plotted against the length of the euchromatic intergenic region, (C) in 150bp 
windows of euchromatic intergenic regions and (D) in 150bp windows of coding, exonic and intronic 
euchromatic regions plotted against their genomic AT-content. All analyses were performed on data 
obtained from schizont stage parasites, unless indicated otherwise. 
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In conclusion, we have shown that histone variants H2A.Z and H2Bv form a double-
variant nucleosome subtype and locate to euchromatic intergenic regions of the 
Plasmodium falciparum genome, where they display highest occupancies in long 
promoter regions. Furthermore, both variants display a clear positive correlation 
towards genomic AT-content. Although the molecular principle behind this 
correlation is at the moment unclear, an intriguing possibility is that genomic AT-
content is instructive in histone variant deposition. 
DisCussion
In this study we show that histone variants H2A.Z and H2Bv reside in a double-
variant nucleosome subtype in the human malaria parasite P. falciparum, similar 
to T. gondii 290 and T. brucei 47. We reveal that both variants localize to euchromatic 
intergenic regions throughout intraerythrocytic development and are enriched 
on promoters over 3’ intergenic domains. Furthermore, PfH2A.Z and PfH2Bv levels 
increase on longer intergenic regions and show a remarkable positive correlation 
to genomic AT-content.
We demonstrated that PfH2Bv and PfH2A.Z occupy regulatory regions of the 
Plasmodium genome in a rather ubiquitous fashion and form a double-variant 
nucleosome subtype. Although we observed some difference between H2A.Z 
and H2Bv levels especially in the heterochromatic domain and in particular at the 
trophozoite stage, we cannot exclude that this discrepancy is at least partially due 
to the slight over- and/or misexpression of the H2Bv-Ty1 protein. Notably, our H2Bv 
profiles were generated from an episomal 3D7 line where H2Bv-Ty1 expression is 
under control of chloroquine resistance transporter promoter, which exhibits peak 
activity at the trophozoite stage (RNA-seq from 161). However, the endogenous 
H2Bv mRNA is most highly expressed during schizont stages, but is constitutively 
present during intraerythrocytic development and displays a pattern very 
comparable to the mRNA profile of H2A.Z (153, RNA-seq from 161). As PfH2Bv and 
PfH2A.Z ChIP-seq localization profiles display occupancy of euchromatic intergenic 
regions at three different stages and given that the endogenous variant mRNAs 
follow comparable expression profiles, it seems likely that the double-variant 
H2A.Z/H2Bv nucleosomes demarcate euchromatic intergenic regions throughout 
intraerythrocytic development. Given the continuous presence, but dynamic 
marking by H3K4me3 and H3K9ac 161, of these double-variant nucleosomes in the 
vast majority of intergenic regions, it seems plausible that H2A.Z and/or H2Bv is 
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specifically recognized by writer, reader and/or eraser complexes. Further studies 
to unravel which components of this ‘scaffolding’ nucleosome might be specifically 
recognized by different epigenetic complexes, will be necessary to identify the 
molecular mechanisms underlying the dynamic histone modifications found 
associated with euchromatic intergenic domains.
Interestingly, deletion of the first 23 amino acids of the H2BV N-terminal tail in 
T. brucei did not affect parasite viability, contrary to deletion of full-length H2BV 
which is essential 47, suggesting that this part of the tail of the H2BV protein as 
well as the acetylations found on K7 and K19 291 are dispensable for recognition 
of this nucleosome subtype for essential functions. However, it remains to be 
tested whether H2Bv, H2A.Z or their N-terminal tails are dispensable for survival 
of P. falciparum. Interestingly, the N-terminal tail of P. falciparum H2A.Z as well as 
PfH2Bv can be highly acetylated at several positions 153, 155. The functional relevance 
of the observed modifications is, however, completely unexplored. Furthermore it 
is also unclear whether H2Bv and/or H2A.Z acetylation in Plasmodium is dynamic, 
whereby it might contribute to dynamic recruitment of epigenetic enzymes to 
the nucleosome ‘scaffold’. Alternatively, H2A.Z and/or H2Bv acetylation could 
influence nucleosome properties. Experimental data in T. brucei 48 and in P. 
falciparum (unpublished observation, R. Bártfai, W. Hoeijmakers & H. Stunnenberg) 
indicate that variant nucleosomes in both species are less stable compared to their 
canonical counterparts. As a consequence, double-variant nucleosomes residing 
on regulatory DNA sequences might be more readily displaced by chromatin 
remodelling or transcription machinery. Alternatively, these nucleosomes might 
display a reduced residence time (e.g. a higher ‘off’ rate) on the DNA, thereby 
temporally exposing regulatory sequences for transcription factor binding. In 
either of these models, H2A.Z/H2Bv double-variant nucleosome subtype likely 
play a positive transcription regulatory role in line with their increased levels 
on promoter regions (figure 4A) and the higher H2A.Z occupancy on strong 
promoters identified previously (figure s11 of 161). An intriguing possibility is that 
dynamic acetylation of (either or both) histone variants influences nucleosome 
stability and results in an even less stable nucleosome subtype, thereby enhancing 
transcriptional activity in a temporally regulated fashion. Indeed, acetylation 
of N-terminal histone tails has been reported to result in a reduced interaction 
between nucleosomes and DNA, thereby destabilizing the nucleosome 267, 292. 
However, it remains to be explored whether histone variant modifications in 
Plasmodium are dynamic and how they might influence nucleosome properties 
and/or recruitment of chromatin-associated proteins. 
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In this study we observe a remarkable correlation between H2A.Z/H2Bv occupancy 
and genomic AT-content, not only in intergenic, but also in coding regions of the 
genome (both in exons and in introns). At the moment the molecular underpinning 
of this correlation is unclear, but as none of the other organisms studied thus far 
have reported an increased preference of H2A.Z nucleosomes for AT-rich sequences, 
nor do they posses such an extreme genomic AT-content 133, 136, there is a significant 
possibility that this process is Plasmodium-specific. One possible explanation 
for the observed correlation would be that only the H2A.Z/H2Bv nucleosomes 
are able to wrap these highly AT-rich regions. Nucleosome occupancy is indeed 
reported to be elevated in GC-rich regions in various in vitro and in vivo studies 
293 and the presence of poly-dAdT or long homopolymeric A or T stretches have 
been reported to be unfavorable for nucleosome formation 294, 295. It is tempting to 
speculate that H2A.Z/H2Bv nucleosomes might posses an intrinsic preference for 
highly AT-biased genomic DNA. Indeed, an altered DNA sequence specificity for 
certain histone variants has been suggested recently 295. However, the sequence 
preference of H2A.Z-containing nucleosomes was shown to be very similar, if not 
identical, to that of canonical nucleosomes in budding yeast 296. Alternatively, the 
higher occupancy of double-variant nucleosomes at AT-rich regions might be 
driven by a histone chaperone with a preference for AT-rich sequences depositing 
H2A.Z/H2Bv dimers preferentially at these sites. All of the above models support 
the intriguing possibility that genomic AT-content might be instructive for histone 
variant localization. Functional experiments testing the above hypothesis will be 
pertinent to reveal the mechanisms underlying this extraordinary correlation. 
In light of the increasing drug resistance against current anti-malarial medication, 
there is an urgent need to identify new targets for therapeutic intervention. Processes 
that are specific to the parasite, when compared to its human host provide targets 
for drug development. As H2Bv is a protozoan-specific epigenome component, 
processes targeting this variant could provide a promising target for development 
of anti-malarial drugs. Our study suggests that P. falciparum H2Bv may play a role 
in epigenome organization and gene expression regulation by demarcation of 
regulatory elements in the Plasmodium genome. Consequently, enzymes targeting 
H2Bv-containing nucleosomes might be candidates for drug development. Insight 
in the preferential deposition or recognition of H2Bv-nucleosomes by effector-
protein complexes is currently lacking. Therefore, additional studies to unravel the 
properties of H2A.Z/H2Bv double-variant nucleosomes, identify the chaperone 
involved in H2Bv deposition and uncover effector-proteins that specifically 
recognize this nucleosome subtype will be imperative to explore the potential use 
of epidrugs targeting H2Bv-associated pathways in the battle against malaria.  
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MATeRiAls & MeTHoDs
Parasite Culture:
Parasites were cultured in standard RPMI medium supplemented with 10% human serum 
and 0.2% NaHCO3 and 2.5% human O+ red blood cells in 250ml tissue culture flasks and 
candle jars. The culture was synchronised with multiple rounds of sorbitol treatments and 
Percoll gradient centrifugation. A last Percoll gradient centrifugation was applied in the 
cycle prior to collection as in 161. Medium was changed at every 10 hours, but not less than 
10h before collection. After 20h post-invasion (hpi), double volume of medium was added 
to ensure optimal development of the parasites. The culture was divided to separate culture 
flasks (20ml each) but these were mixed with every change of medium. 
For profiling of H2Bv, 3D7 P. falciparum parasites were transfected with a pARL-1a- plasmid 
281 encoding C-terminally Ty1-tagged version of PfH2Bv (PF07_0054) under the control of 
the chloroquine resistance transporter promoter (figure 1b). Expression of the transgene 
in the presence of 20nM WR99210 was confirmed using the monoclonal anti-Ty1 antibody 
(BB2) that exclusively recognises the tagged H2Bv protein on Western blot (figure 1C).
Chromatin immunoprecipitation:
Native ChIP was carried out essentially as described in 161. In short: Red blood cells and 
parasites were lysed using saponin and a hypotonic buffer, after which nuclei were separated 
using a 0.25M sucrose buffer cushion. Native chromatin was prepared by MNase digestion 
and subsequent extraction with salt-free buffers (10 mM Tris pH 7.4, 1 mM EDTA; and 1 mM 
Tris pH 7.4, 0.2 mM EDTA). Chromatin was diluted in 2×ChIP incubation buffer (100 mM 
NaCl, 20 mM Tris pH 7.4, 6 mM EDTA, 1% Triton X-100, 0.1% SDS). ~400 ng DNA-containing 
chromatin was incubated with 2 µg BB2 antibody overnight at 4°C followed by the addition 
of 10 µl A/G beads (SantaCruz Biotechnology) and further incubated for 2 h. After washing 
with buffers containing 100, 150 and 250 mM NaCl, immunoprecipitated DNA was eluted 
and purified using PCR purification columns (Qiagen). Five ChIP reactions were performed 
in parallel and pooled to obtain sufficient amount of DNA for ChIP-seq.
High throughput sequencing:
Sequencing libraries were prepared from 6.1 - 40 ng of H2Bv-Ty1 ChIP or corresponding 
mono-nucleosomal input DNA as described in 225. Sequencing libraries (14-15 pmol each) 
were loaded on the Illumina Genome Analyzer IIx and sequenced for 76 cycles from one 
side of the fragments (Standard Cluster Generation Kit v4 and 2x 36-cycle sequencing kit v4). 
76 bp sequence reads were mapped against the Plasmodium falciparum genome assembly 
(PlasmoDB v6.1) using BWA 236. 
Data analysis:
PfH2A.Z genome-wide localization profiles were used from 161. For comparative analysis 
10.6M uniquely mapped reads were randomly selected for each dataset. As the H2Bv-
Ty1 parasite line carried multiple deletions in its subtelomeres at chromosomes 1, 4 and 
7 (positions 558360-643292, 6800-33800 and 1437250-1501717 respectively) and a 
single duplication at chr. 13 (position 150901-380691), these regions were excluded in all 
subsequent analysis.
Coverage plots were generated by counting the number of overlapping, uniquely mapped 
76bp tags in 10bp windows and visualized in SignalMap (NimbleGen). For all subsequent 
analysis tags were assigned to a particular region if the center position of the 147bp 
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mono-nucleosomal fragment falls into this region. Heterochromatin was defined as by the 
presence of H3K9me3 156 and HP1 157. Regions localized on the hetero-euchromatic border 
were excluded from the analysis. 
Average gene profiles were computed for 1855 genes within the euchromatic domain 
(given the general lack of signal in the heterochromatic domain) with coding body of 1-10kb 
(excluding extremely small or large genes) and a minimum of 800bp intergenic regions on 
both sides (to minimize overlap with flanking region of nearby genes) as in 161. In short, ChIP-
over input ratio’s were determined for H2A.Z and H2Bv for each of the 20 bins within the 
coding body of genes and each of the four 150bp windows immediately flanking the coding 
sequence. The average for each window was plotted in figure 3b.
For scatterplots the number of uniquely mapped tags were counted in each intergenic or 
coding region of the H2Bv-Ty1 genome. H2A.Z and H2Bv square-rooted signals were plotted 
in R for ring, trophozoite and schizont stages. R2 of square-rooted values were determined 
in R using the “lm” function. 
Regions of low-, medium- or high-histone variant occupancy were defined as in 161 by 
calculation of ChIP-over-input ratio for each intergenic region of the H2Bv-Ty1 genome and 
subsequent plotting as histogram in R (supplementary figure 1A). H2Bv low = -4.5 – -1 
(log2), H2Bv medium = -1 – 0.75 (log2) and H2Bv high = 0.75 – 3 (log2). Cut-offs for low/
medium/high categories in the H2A.Z dataset were updated from 161 (corrected for the 
differing H2A.Z and input tags applied in the analysis) as follows: H2A.Z low = -5 – -1 (log2), 
H2A.Z medium = -1 – 1 (log2), H2A.Z high = 1 – 3 (log2).
Euchromatic intergenic regions were classified as convergent (containing two 3’UTRs), 
tandem (containing one 3’ and one 5’UTR) or divergent (containing two 5’UTRs) and the 
number of H2A.Z and H2Bv low, medium- or high-occupancy regions were counted for 
each class. Subsequently, the percentage of total low-, medium- or high-occupancy regions 
allocated to each intergenic class were plotted in figure 4A. 
Box-plots were generated in R using standard settings (outlier values were not shown). For 
figure 4b, the length of each euchromatic intergenic region assigned as low, medium or 
high (see above, figure 2C from 161 and supplementary figure 1 for category definition) 
was plotted for H2A.Z and H2Bv respectively. To determine a correlation between H2A.Z- 
or H2Bv-occupancy and genomic AT-content (figure 4C,D), ChIP-over-input ratio’s were 
determined for every 150bp window in euchromatic intergenic, euchromatic coding, 
euchromatic exonic or euchromatic intronic regions (regions below 100bp in length or with 
a zero input value for any of the stages were excluded from the analysis). AT-content for 
each 150bp window was determined and ChIP-over-input ratio’s were plotted as box-plot 
for each AT-category (50-60% AT, 60-70%AT, 70-80%AT, 80-90%AT and 90-100% AT) in R. AT-
categories containing less that forty 150bp windows were not included in the plots.
Western blotting:
Acid-extracted histones from 3D7 mother- and H2Bv-Ty1 transgenic-line were separated 
on 18% SDS-PAGE and transferred to Protean nitrocellulose membrane (Whatman, 0.45 
µm).  The membrane was probed with mouse aTy1 (1:1000, BB2 antibody) and rabbit aH2A 
(1:1000, Millipore 07-146) and secondary aMouse IRDye 680 (1:15000, LI-COR Biosciences 
926-32220) and aRabbit IRDye 800CW (1:15000, LI-COR 926-32211) and measured on the 
Odyssey system (LI-COR Biosciences). Co-immunoprecipitations were performed on mono-
nucleosomes harvested from H2Bv-Ty1 schizont stages as for native ChIP using 2mg BB2, 
1ml aPfH2A.Z (from 161) or 1mg control rabbit IgG (Upstate (Millipore) 12-370). Three ChIP 
reactions were performed for each antibody, proteins were precipitated by acetone and 
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pooled for western analysis (as above) together with half an input reaction. The membrane 
was probed with mouse aTy1 (1:1000, BB2 antibody), rabbit aPfH2A.Z (1:2500, 161) or rabbit 
aH2A (1:1000, Millipore 07-146) and secondary aMouse-HRP (1:3000, Dako 2016-09) or 
aRabbit-HRP (1:3000, Dako 2017-04) was detected with ECL western blotting detection 
reagents (GE Healthcare RPN2106) on blue sensitive film (CEA). 
Data deposition:
All datafiles have been submitted and are available at PlasmoDB (www.plasmodb.org).
ACKnoWleDgeMenTs
The research described in this manuscript has received funding from the Netherlands 
Organization for Scientific Research (NWO TopTalent 021.001.011) and the European 
Community (EVIMalaR EU-FP7_242095). We are grateful to Marga van de Vegte-Bolmer, 
Rianne Siebelink-Stoter and Wouter Graumans of the Plasmodium Culturing Facility for help 
and expertise on parasite culturing. Furthermore, we would like to thank Anita Kaan for 
cloning, Eva Janssen-Megens and Yan Tan for operation of the Genome Analyzer and Dr. 
Colin Logie and all our other colleagues at the Molecular Biology Department for valuable 
discussions and ideas. This project greatly benefited from the excellent resource provided by 
PlasmoDB 134 and GeneDB 133, 240.
Hoeijmakers.indd   146 20-04-12   14:43
Hoeijmakers_PROEF (all).ps Back - 73     T1 -    Black CyanMagentaYellow
Double-variant nucleosomes in P. falciparum
147
suPPleMenTARY
Supplementary Figure 1: chapter 6
A
B
heterochromatin
H2Bv-Ty1
0 40
00
0
80
00
0
12
00
00
16
00
00
20
00
00
24
00
00
28
00
00
32
00
00
36
00
00
40
00
00
44
00
00
48
00
00
52
00
00
56
00
00
60
00
00
64
00
00
68
00
00
72
00
00
76
00
00
80
00
00
84
00
00
88
00
00
92
00
00
96
00
00
10
00
00
0
10
40
00
0
chr3
1
-1
0
1
-1
0
1
-1
0
1
-1
0
300
1
H2Bv-high
H2Bv-medium
H2Bv-low
0
500
1000
1500
F
re
qu
en
cy
Intergenic H2Bv-Ty1 tags / Intergenic input tags (log2)
-5          -4          -3          -2          -1          0            1           2           3
low
medium
high
supplementary figure 1: P. falciparum intergenic regions occupied by H2bv can be divided 
based on their low, medium of high occupancy levels and localize to distinct genomic locations. 
(A) Distribution of H2Bv-Ty1 ChIP-seq-over-input log2-ratio’s of each intergenic region of the H2Bv-
Ty1 genome, displayed as histogram and divided into three categories (low, medium, high) based on 
H2Bv occupancy. Note that both euchromatic and heterochromatic intergenic regions are included in 
this analysis. (b) Localization of H2Bv-Ty-low, -medium and -highly occupied regions (from A) over P. 
falciparum chromosome 3. Heterochromatic regions and the H2Bv-Ty1 coverage plot are included at 
the bottom.
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AbsTRACT
Centromeres are essential for the faithful transmission of chromosomes to the next 
generation, therefore being essential in all eukaryotic organisms. The centromeres 
of Plasmodium falciparum, the causative agent of the most severe form of 
malaria have been broadly mapped on most chromosomes, but their epigenetic 
composition remained undefined. Here, we reveal that the centromeric histone 
variant PfCENH3 occupies a 4-4.5kb region on each P. falciparum chromosome, 
which is devoid of pericentric heterochromatin but harbors another histone 
variant, PfH2A.Z. These CENH3 covered regions pinpoint the exact position of the 
centromere on all chromosomes and revealed that all centromeric regions have 
similar size and sequence composition. Immunofluorescence assay of PfCENH3 
strongly suggests that P. falciparum centromeres cluster to a single nuclear location 
prior to and during mitosis and cytokinesis but dissociate soon after invasion. In 
summary, we reveal a dynamic association of Plasmodium centromeres, which bear 
a unique epigenetic signature and conform to a strict structure. These findings 
suggest that DNA-associated and epigenetic elements play an important role in 
centromere establishment in this important human pathogen.
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inTRoDuCTion
Faithful segregation of chromosomes during mitosis and meiosis is of paramount 
importance for the development and reproduction of all eukaryotic organisms. 
The centromere, a specialized chromatin structure that is restricted to a single 
region on each chromosome 51, governs the assembly of the kinetochore, mediates 
attachment of sister chromatids to the microtubule spindles and coordinates their 
movement to the daughter cells 297. Given this conserved and essential function, 
surprisingly little similarities in DNA sequence composition can be found between 
centromeric regions of different organisms 298. Centromeric DNA represent one 
of the fastest evolving parts of the genome 299 and the size of centromeres is 
highly variable, ranging from the single nucleosome covered “point centromere” 
of budding yeast (Saccharomyces cerevisiae) to the megabase sized  “regional 
centromeres” in plants and vertebrates 300. Although repetitive elements are 
characteristic features of most centromeres, conservation between species 301 or 
even between different chromosomes is absent, indicating that DNA sequence 
is not the major determinant of centromere specification. Accordingly, although 
DNA sequence-driven specification of centromere positions has been identified in 
budding yeast 302, in most eukaryotes epigenetic mechanisms play the dominant 
role in the establishment and maintenance of centromeres 303. In these organisms, 
centromere assembly can potentially occur at any permissible point in the genome 
that allows for the incorporation of the histone H3 variant CENH3 (also known as 
CENP-A) 51. Various features have been reported to facilitate centromere formation, 
including sequence composition (e.g. AT-rich) and structure (repeats, transposable 
elements), low gene density, transcription of non-coding RNA (ncRNA) as well as 
vicinity to heterochromatic domains 300. Once centromeric chromatin is established 
the formation of additional centromeres within the same chromosome is prevented 
and the position of this centromere is faithfully propagated through numerous 
generations 300.
Plasmodium falciparum is an obligate protozoan parasite responsible for the most 
severe form of malaria in humans, which puts social and economic burden on 
developing countries where this disease is endemic. During its complex lifecycle 
the parasites undergo numerous cell divisions, the most characteristic of which 
is schizogony, whereby the parasite progresses through several rounds of DNA 
replication and mitosis followed by a mass cytokinesis event, resulting in numerous 
daughter parasites 131, 304, 305. While mitosis in Plasmodium differs from mitosis in 
other eukaryotes in various aspects (reviewed by 306), centromeres and associated 
proteins also play a central role in segregation of P. falciparum chromosomes 
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307. Centromeres on all chromosomes have been mapped at ten to hundreds of 
kilo-base (kb) resolution by etoposide-mediated topoisomerase II cleavage 308 
and generally coincide with single ~2kb long, extremely AT- and repeat-rich 
sequence. These sequences have been designated as potential centromeres 309, 
310 and could be pinpointed for 13 of the 14 P. falciparum chromosomes 308-310. 
However, since no such AT-rich sequence could be identified on chromosome 10 
the centromere on this chromosome remains poorly defined at ~1.1Mb from the 
left arm 308. Interestingly, in a related rodent malaria parasite (P. berghei), similar 
AT-rich sequences were found to be sufficient for centromere establishment and 
faithful segregation of artificial chromosomes 311. Moreover, small non-coding 
RNAs expressed from sequences surrounding these AT-rich sequences have been 
detected and implicated in centromere formation in P. falciparum 312. Although 
a homologue of CENH3 has been identified in Plasmodium 153, 155 and has been 
shown to localize to the nucleus 313, its association with centromeres has not been 
investigated. Here, we describe the high-resolution analysis of chromosomal and 
nuclear localization of PfCENH3, which reveals a distinct marking of a 4-4.5kb region 
on each P. falciparum chromosome. Our data show a strictly conserved size and 
structure to which all 14 P. falciparum centromeres concur suggesting an essential 
role of these structural and epigenetic elements in centromere specification and/or 
assembly. Furthermore, we show that PfCENH3 occupies centromeres throughout 
intraerythrocytic development, and that it localizes to a single nuclear location prior 
to and during mitosis and cytokinesis. Interestingly, after merozoite invasion of red 
blood cells multiple PfCENH3 foci are observed per ring stage nucleus suggesting 
that the centromeric cluster is subject to cell cycle-associated rearrangements.
ResulTs & DisCussion 
PfCenH3 localizes to a single region on each chromosome
A universal characteristic of centromeres is the replacement of canonical histone H3 
for the variant histone CENH3 on centromeric DNA sequences 54, 314. Previous analysis 
of the P. falciparum genome sequence led to the identification of three histone H3 
encoding genes, which were assigned as canonical histone H3 (PFF0510w, also 
named H3.1) 151, variant histone H3.3 (PFF0865w) 154 and the centromeric histone 
H3 variant CenH3 (PF13_0185) 153. However, besides confirmation of its mRNA 
139, 153, protein expression 155 and nuclear localization 313, PfCENH3 has not been 
investigated in depth.
To gain insight into PfCENH3 function we set out to profile its genome-wide 
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localization at single-base resolution using a rabbit polyclonal anti-PfCENH3 
antibody 313, native chromatin-immunoprecipitation of PfCENH3-associated 
DNA and deep sequencing (nChIP-seq) in schizont stage parasites. This analysis 
evidenced a single PfCENH3-covered region on each P. falciparum chromosome 
(figure 1A). Closer examination (figure 1b, supplementary figure 1A) 
revealed that PfCENH3-covered domains reside in gene-free regions and span 
4-4.5kb in size on all chromosomes, except for chromosome 10 where PfCENH3 
occupies 2.2kb only (figure 1C). These PfCENH3-covered regions coincide with 
the previously predicted 133 and experimentally verifi ed centromere locations 308. 
However, PfCENH3 occupancy extends beyond the ~2.5kb long and extremely 
AT-rich sequences that have been predicted as centromeric DNA 133, but is more 
confi ned than the P. falciparum centromeres mapped by etoposide-mediated 
topoisomerase-II cleavage (which spread over ~10kb) 308. Whether this results from 
topoisomerase-II occupancy outside the PfCENH3-covered regions, or whether 
it is the consequence of the relatively low resolution of etoposide-mediated 
topoisomerase cleavage compared to the single-base resolution of nChIP remains 
to be investigated. In conclusion, we demonstrate that PfCENH3 is also a hallmark 
feature of centromeres in P. falciparum demarcating a 4-4.5kb centromeric region 
on all but one chromosomes.Figure 1: c apter 7 
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Chromosome 6 477751 482011 4260
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figure 1: PfCenH3 localization is confi ned to a single region on each of the 14 chromosomes. 
(A) Chromosome-wide coverage plot of PfCENH3 (purple) on P. falciparum chromosome 12 in schizont 
stage parasites. (b) Close-up view of the enrichment of PfCENH3-over-input (purple) at the centromere 
of chromosome 9. GC-content in every 100bp is shown in grey and coding regions are depicted as 
blue boxes. (C) Table with chromosomal position and length of the PfCENH3-covered regions (manually 
defi ned as > 4-fold over input) on all 14 chromosomes. * Note that the actual length of the newly 
assembled PfCENH3-covered region on chromosome 10 is larger by 2267bp (see figure 2).
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experimental validation reveals incorrect genome assembly of the 
chromosome 10 centromeric region 
Our genome-wide localization of PfCENH3 reveals the exact location of the P. 
falciparum centromere on chromosome 10, which has so far not been identifi ed. 
It pinpoints a specifi c region devoid of open reading frames in the vicinity of the 
position broadly defi ned previously 308. This earlier estimated location 308 deviates 
~160kb from the PfCENH3-covered region identifi ed here and is consistent with 
the low-resolution obtained by gel separation of mega-base sized fragments. 
Intriguingly, our PfCENH3 mapping suggested a reduced size for the putative 
centromere on chromosome 10 when compared to the PfCENH3-covered regions 
on all other chromosomes (figure 1C, supplementary figure 1A). Furthermore, 
the fact that this region only contained a short stretch of AT-rich sequence explains 
why it had not been identifi ed previously 133. The reduced size and the absence 
of an extensive AT-rich domain could be either the result of a functional variant 
to the Plasmodium centromere or simply represent a mistake in the genome 
annotation 308. To explore the second possibility we designed two primer pairs 
complementary to the sequence surrounding the small AT-richer region within the 
PfCENH3-covered domain of chromosome 10 (figure 2A, supplementary figure 
1A). Based on the current P. falciparum genome annotation (PlasmoDB version 8.0), 
these primers should amplify a ~600bp fragment. 
B
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figure 2: sequence-assembly reveals a ~2.5kb long AT-rich centromeric core domain on P. 
falciparum chromosome 10 similar to all other chromosomes. (A) PCR amplifi cation of the 
chromosome 10 PfCENH3-covered region by primers F1-R1 and F2-R2 from genomic DNA of 3D7 and 
NF54 parasites strains as well as an unrelated fi eld isolate (NF135) results in an ~2.8kb fragment (black 
arrow) instead of the ~0.6kb fragment (red arrow) expected from the current genome assembly. M, DNA 
ladder. Sketch depicts the position of the primers and the approximate position of the ~2.2kb insert. (b) 
Screenshot of P. falciparum chromosome 10 centromeric region after inclusion of the newly assembled 
2267bp sequence (grey box), revealing clear PfCENH3 enrichment (purple), low GC-content (grey) and 
the presence of multiple repeats of varying size and copy number (arrows). The genes neighboring the 
centromere are indicated as blue boxes.
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However, PCR on genomic DNA of 3D7 and NF54 as well as an unrelated field isolate 
(NF135) resulted in a ~2.8kb product (figure 2A) indicating that indeed a ~2.2kb 
sequence is missing from the genome assembly of P. falciparum chromosome 10. 
To assemble the missing part of chromosome 10 we made use of the sequence 
reads from the PfCENH3 nChIP-seq that did not map to the current P. falciparum 
genome sequence. Based on these 76 bp reads and guided by the sequence of the 
PfCENH3-covered sequence on chromosome 10 we assembled a 2267 bp sequence 
(supplementary figure 2), which was validated by standard capillary sequencing. 
Similar to the AT-rich core of the other centromeres 308 this sequence is highly 
enriched for PfCENH3, extremely AT-rich (98 %) and contains multiple repeats of 
varying size and copy number (figure 2b). However, these repeats did not show 
significant similarity when compared to repeats in the AT-rich centromere domains 
on the other chromosomes. In conclusion, CenH3 localization aided the definition 
of the exact location of the centromere on chromosome 10 (supplementary 
figure 1b), and also revealed and closed a gap in the current genome assembly. 
All P. falciparum centromeres conform to the same size and structure
Correcting the annotation of chromosome 10 was critical to reveal the highly 
unified size and structure of centromeric regions for all P. falciparum chromosomes. 
The length of the PfCENH3-covered regions uniformly ranges between 4-4.5kb, 
encompassing a 2-2.5kb extremely AT- and repeat-rich core (figure 3A). 
The presence of a conserved centromere structure and strict size might indicate 
that Plasmodium centromere identity is sequence-mediated, contrary to models 
of epigenetic inheritance for most other eukaryotes 303, 312, 314. The hypothesis, 
that centromere identification in P. falciparum is sequence mediated, is further 
supported by an elegant study 311 confirming the important role of an AT-rich 
domain (but not it’s flanking sequence) in centromere function in the rodent malaria 
parasite P. berghei. These authors describe the generation of a Plasmodium artificial 
chromosome (PAC), which is faithfully segregated through many generations 
by inclusion of an AT-rich centromeric core. Additionally, both P. yoelli and, with 
slightly lower efficiency, P. falciparum AT-rich centromeric DNA could complement 
for the P. berghei centromere sequence in PAC segregation assays 311, indicating 
that the AT-rich core is sufficient for centromere establishment and that this feature 
is likely conserved throughout the Plasmodium lineage. Interestingly, no conserved 
motif that could mediate centromere formation has been identified within these 
AT-rich sequences 133, 308, 310 although we observed an apparent over-representation 
of “AATTAA”-type motifs and under-representation of polyA and polyT tracks.
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figure 3: Composition and 
epigenetic makeup of P. 
falciparum centromeres. (A) 
Bar-graph depicting the size of 
the PfCENH3-covered (>4 fold 
ChIP-over-input, purple) and AT-
rich centromeric core (>97%, 
white) centromeric domains for 
all 14 P. falciparum chromosomes. 
(b) Screenshot of chromosome 
2 centromeric region showing 
ChIP-over-input log2 ratio plots 
for PfCENH3 (purple), H3K9me2 
(light purple), H3K9me3 (dark 
purple), Ty1-H2A (light green) 
and PfH2A.Z (dark green). Genes 
are depicted as blue boxes and a 
100bp GC-content track is included 
in grey. (C) Bargraph depicting 
the size distribution of the 
mononucleosomal DNA fragments 
in the entire P. falciparum 
genome (black) and in the AT-rich 
centromeric core domains (white). 
(D) The conserved centromeric 
structure is in support of a 
model that PfCENH3-containing 
nucleosomes are specifi cally 
deposited to the AT-rich core 
(grey). These nucleosomes might 
contain histone variant PfH2A.Z, 
which is enriched in this region. 
Furthermore, these nucleosomes 
can occupy up to 1kb on both sides 
of the AT-rich core (purple). Due to 
the apparent lack of pericentric 
heterochromatin (H3K9me2/3 and 
PfHP1) or conserved DNA motifs 
fl anking the PfCENH3-covered 
region, we hypothesize that the 
spreading of the centromeric 
chromatin is limited to a few 
nucleosomes only. 75nt and 175nt 
non-coding RNAs (blue wavy lines) 
transcribed from bidirectional 
promoters fl anking the AT-rich 
cores were reported by Li and 
co-workers 312 and potentially 
contribute to centromere 
formation. Topoisomerase II 
activity might extend beyond the 
PfCENH3-covered domain 308. 
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Expanding the analysis to the PfCENH3-covered 1kb regions flanking the core 
did not reveal any additional sequence motifs that could potentially function in 
targeted recruitment of PfCENH3-containing nucleosomes. Interestingly, the P. 
falciparum centromeric sequence used to complement the P. berghei centromere 
by Iwanaga and co-workers displayed no sequence identity to the P. berghei and P. 
yoeilli sequences 311, indicating that AT-richness of the core, but not the sequence 
per se, is required for centromere specification.
The fact, that such extreme AT content is unfavorable for the deposition of 
canonical nucleosomes 315, suggests a model in which extremely AT-rich 
centromeric cores within the Plasmodium genome are selectively occupied 
by PfCENH3-type nucleosomes. A similar model has been proposed for other 
eukaryotes where silent centromeric repeat regions were speculated to form 
chromatin ‘gaps’ devoid of nucleosomes after replication, which then later are 
filled preferentially by deposition of CENH3-nucleosomes 51, 286. Features that may 
contribute to the ability of PfCENH3-nucleosomes to occupy extremely AT-rich 
sequences are unknown, however, in other organisms histone variant H2A.Z 316 and 
an atypical hemisomal nucleosome structure 317 were both shown to contribute 
to centromere organization. We therefore explored the possible contribution of 
these factors to centromere formation in P. falciparum. Indeed, we observed the 
presence of histone H2A variant, PfH2A.Z 161 at centromeric regions (figure 3b). In 
addition, the smaller size of DNA fragments obtained after MNase digestion from 
the centromeric core regions (~130bp instead of the canonical 147bp, figure 3C) 
indicates a reduced level of DNA protection by centromeric PfCENH3 nucleosomes, 
as was previously reported to be a special feature of CENH3-containing hemisomes 
in other eukaryotes 317, 318. Nonetheless, the specific properties of P. falciparum 
centromeric nucleosomes and the mechanism by which they are targeted to 
Plasmodium centromeres have to be further explored.
Importantly, our results show that PfCENH3 occupancy extends beyond the AT-
rich core up to 1kb on either side (supplementary figure 1A). Such spreading 
of centromeric proteins has previously been described during the formation of 
neocentromeres in Drosophila and plants 300. However, the mechanism by which 
PfCENH3 remains confined to these sharply defined regions remains unknown. For 
other eukaryotes, it has been proposed that heterochromatic domains neighboring 
the centromere are favorable towards centromere formation and might aid to 
confine it to a specific region 51, 286. In the case of P. falciparum, however, neither of 
the heterochromatin marks H3K9me3 156, 166 or heterochromatin protein 1 (PfHP1) 157 
have been detected on pericentromeric regions. Accordingly, our ChIP-seq analysis 
also reveals the absence of H3K9me2/3 in these regions (figure 3b), providing 
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additional evidence for the lack of pericentric heterochromatin in P. falciparum. 
One alternative explanation for the strict confinement of PfCENH3-coverage 
might be the presence of unknown boundary elements that stop the spread of 
this nucleosome subtype. Notwithstanding extensive bioinformatic analysis we 
were unable to identify a common motif at or surrounding the boundaries of the 
PfCENH3-covered regions that could substantiate this theory. A third plausible 
mechanism, which is consistent with the uniform extension of PfCENH3 occupancy 
on either side of the AT-rich core on all P. falciparum chromosomes, is that spreading 
of centromeric chromatin is limited to few nucleosomes until the placement 
machinery is exhausted (‘runs out of steam’). 
In conclusion, we show that P. falciparum centromeric chromatin on all chromosomes 
consist of a conserved size and structure. Based on this observation and data 
from the literature we hypothesize that PfCENH3-containing nucleosomes have a 
preference towards AT-rich sequences (either nucleosome-inherent or chaperone-
mediated) and require an AT-rich stretch of minimally 2kb in order to be targeted 
to the centromeres and/or to establish centromeric chromatin. Once established, 
PfCENH3 chromatin might spread for up to 1kb on either side of the core resulting 
in a rather strictly confined 4-4.5kb centromeric domain. This attractive model 
(summarized on figure 3D) now needs to be challenged by targeted experimental 
verification in future studies and will fuel our understanding of centromere biology 
in malaria parasites.
P. falciparum centromeres are demarcated by PfCenH3 throughout intra-
erythrocytic development and associate into a single centromere cluster
As discussed above, Plasmodium centromere identity could potentially be 
sequence-mediated. Accordingly, epigenetic marking of centromeres may very well 
be restricted to replicative stages and consequently might relieve the necessity for 
continuous centromere occupancy by PfCENH3. Therefore, we set out to determine 
PfCENH3 occupancy at multiple intraerythrocytic stages using targeted ChIP 
(xChIP-qPCR). As shown in figure 4A, PfCENH3 enrichment at centromeres can be 
clearly observed in ring, trophozoite and schizont stages indicating that epigenetic 
marking of centromeres continues throughout intraerythrocytic development. 
In many eukaryotes, centromeres are distributed throughout the nuclear space 
and only captured by the mitotic spindle during cell division. Interestingly, a recent 
study in the related apicomplexan parasite Toxoplasma gondii demonstrated 
sequestration of centromeres to a single nuclear location and association with the 
centrocone throughout the cell cycle 305. 
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figure 4: P. falciparum centromeres are demarcated by PfCenH3 throughout intraerythrocytic 
development and are sequestered to a single nuclear location from early trophozoites to mature 
schizont. (A) PfCENH3 occupancy in synchronized ring, trophozoite and schizont P. falciparum cultures 
by cross-linked ChIP-qPCR. Occupancy of six centromeric (black bars) or six control (white bars) regions 
was averaged (mean +/- SD). (b) 3D7 wild-type parasites of all intra-erythrocytic stages were probed 
with anti-PfCENH3 antibody. Representative pictures are shown for ring (i), trophozoites (ii), early to 
mid schizont (iii-v) and mature schizont (vi) (~24 n). From early trophozoite to mature schizont (ii-vi) 
the PfCENH3 signal is concentrated to one focus per nucleus. In ring stage parasites (i) the PfCENH3 IFA 
signal is substantially weaker and multiple foci can be observed. (C) Live cell fluorescence microscopy 
on transgenic parasites expressing a GFP-CENH3 fusion protein confirms the presence of a single 
CENH3 focus per nucleus in trophozoite (vii) and schizont stage parasites (viii, ix) (construct above the 
pictures). Live cell imaging pictures of GFP in ring stage GFP-CENH3 parasites are not included as the 
GFP signal was below detection limit, potentially due to dissociation of centromere clusters or limited 
expression of the transgene. (D) The number of CENH3 foci per nucleus was counted in 100 ring stage 
parasites by three researchers independently. The percentage of parasites with different numbers of 
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signals per nucleus has been calculated, averaged, and is displayed in a bar graph. A close-up view 
of a ring stage parasite with multiple CENH3 foci is shown within the graph. (e) Double staining 
immunofluorescence pictures obtained from the transgenic parasite line 3D7/HP1-HA expressing HA-
tagged PfHP1 (construct above the pictures). Trophozoite (x), early schizont (xi) and late schizont stage 
parasites (xii) were simultaneously probed with aHA and aPfCENH3 antibodies. PfCENH3 foci do not 
overlap with PfHP1-marked chromosome end clusters. GFP live fluorescence and aPfCENH3 antibody 
(green), aHA antibody (red), DAPI nuclear stain (blue), DIC (differential interference contrast). Scalebars 
are 5 µm long. 
To determine whether a similar phenomenon occurs in P. falciparum we performed 
indirect immunofluoresence assays (IFA) using anti-PfCENH3 antibody on 3D7 
wild-type parasites and live cell imaging on a transfectant parasite line expressing 
a GFP-CENH3 fusion protein from an episome. These assays revealed that prior to 
replication, in late ring stages and young trophozoites, PfCENH3 localizes to a single 
nuclear focus (figure 4b,C), providing a strong indication that centromeres in P. 
falciparum are indeed clustered. Later during mitosis and cytokinesis the number 
of PfCENH3 foci increased proportionally to the observed number of nuclei per 
cell (figure 4b,C). This suggests that in every nucleus the centromeres remain 
clustered in a single spot that most likely continues to be attached to the mitotic 
spindle until the end of schizogony and the intraerythrocytic developmental cycle, 
similar to that observed in T. gondii 305. Intriguingly, in ring stage parasites subjected 
to IFA we did not observe a single cluster per nucleus, but rather multiple spots 
with substantially weaker PfCENH3 signal compared to the other stages (figure 
4D, supplementary figure 3). Assuming that all these CENH3 foci represent 
centromeres as CENH3 localizes to centromeres in ring stages as well (figure 
4A), we reason that centromeres at this early stage of development might form 
few clusters (figure 4D) containing a couple of centromeres each. Alternatively, 
centromeres might completely dissociate and no longer congregate in a single 
cluster. In this case the brighter spots observed in early ring stages may potentially 
be due to coincidental co-localization of few of the 14 centromeres or starting 
of the ‘clustering process’ as ring development progresses. Notably in ring stage 
parasites of the GFP-CENH3 line GFP signal was too weak to detect (data not shown), 
likely due to dissociation of centromere clusters and ‘dilution’ of the signal below 
detection limit. Alternatively, the absence of detectable GFP signal might be due 
to technical limitations, as the promoter driving transgene expression is not active 
at early stage of development and only a portion of total CENH3 is GFP-tagged. 
Importantly, data from an recent study in P. falciparum showed that centromeres 
2 and 3 do not co-localize in ring stage parasite 312, thereby substantiating our 
findings. Hence, in contrast to what has recently been reported for T. gondii, P. 
falciparum centromeres do not remain associated throughout the cell cycle, but 
specifically cluster prior to and throughout mitosis and cytokinesis.
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Centromeric regions of most eukaryotes reside within silent pericentric 
heterochromatic domains 319. As Plasmodium centromeres do not display 
enrichment of heterochromatic marks (figure 3b) on linear chromosomes we 
performed 2-colour IFA on parasites expressing an hemagglutinin(HA)-tagged 
version of PfHP1 157 to determine whether P. falciparum centromeres co-localize 
with heterochromatic domains at the nuclear periphery that are benchmarked 
by the presence of PfHP1 157. IFA of trophozoite and schizont stage parasites 
revealed a clear separation between centromeric and heterochromatic clusters 
(figure 4e) suggesting that P. falciparum centromeres function independent of 
heterochromatin.
In conclusion, we showed that i) PfCENH3 demarcates P. falciparum centromeres 
throughout intra-erythrocytic development; ii) that PfCENH3 localizes to a single 
nuclear location for most of the cell cycle except at early ring stages; and iii) that P. 
falciparum centromeres do not reside within heterochromatic domains neither on 
linear chromosomes nor in the nuclear space.
MATeRiAls & MeTHoDs
Parasite culture, synchronization and transfection:
Parasites were cultured in 20ml standard RPMI medium, supplemented with 10% human 
serum and 0.2% NaHCO3 and 2.5% human 0
+ blood cells in candle jars. Cultures were 
synchronized with multiple rounds of sorbitol treatment and Percoll gradient centrifugation. 
A last Percoll gradient centrifugation was applied in the cycle prior to collection. 2.5% red 
blood cells were added with a 1-2 hour delay after synchronisation, 40 hours after which 
schizont-stage parasites were collected. 
For generation of the GFP-CENH3 line the coding sequence of CENH3 was fused to the 
end of GFP and placed under the control of calmodulin promoter. This construct has 
been transfected to 3D7 parasites and transfectants growing in the presence of 2.5ug/ml 
blasticidine were used for fluorescent microscopy.
Chromatin immunoprecipitation (ChiP-seq, ChiP-qPCR):
Native immunoprecipitation from schizont stage parasites (~35-40 hours post-invasion, 
3D7) was carried out as described in 161 using an affinity purified aPfCENH3 313, aH3K9me2 
(Millipore 07-441) and aH3K9me3 (Millipore 07-442). PfH2A.Z and Ty1-H2A tracks were 
generated earlier 161. Sequencing libraries from immunoprecipitated DNA were prepared 
using the LADS method 225 and sequenced on the Illumina GAIIx platform (Standard Cluster 
Generation Kit V4). 76bp sequence reads were mapped against the P. falciparum genome 
assembly (PlasmoDB v6.4) and coverage plots were generated by counting the number of 
uniquely mapped 76bp tags in 10bp windows and visualized in SignalMap (NimbleGen). 
Ratio-tracks were obtained by dividing the ChIP tag counts with the corresponding tag 
counts of a mononucleosomal input from a previous experiment 161, smoothened by moving 
average (in a 150bp window) and displayed on a log2 scale. PfCENH3 covered regions were 
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manually defined where the CENH3 enrichment over input was higher than 4 fold. 
As native ChIP was inefficient in ring stage parasites, comparison of the PfCENH3 
occupancy in different lifecycle stages (ring, trophozoite, schizont) was performed using 
formaldehyde cross-linked chromatin as in 320. Enrichment over-input DNA has been assayed 
at six centomeric regions (chr 1,2,3,4,9,12) and the promoters as well as coding bodies of 
three genes (hrp3, kahrp, rhoph3) using real-time quantitative PCR (BioRad MyIQ) in two 
independent biological replicate experiments. The primers used are listed in below:
Region Forward primer (5’-3’) Reverse primer (5’-3’)
centromere 1 acacattggaaatttatgct gttatttaatgtataataatttccg
centromere 2 cgatataacaccatatgtg ccttcacaagtatgaaatg
centromere 3 cgacaaaaatcatacacatc gaatgtgaaaaactattatgg
centromere 4 gatacaaaactttatacacaac cattaagaatttcataatacatg
centromere 9 tatatattgtctttttattattttg ctatttaataatacttagtttatg
centromere 12 aagtgtaggtaacatataaac catattatcctagaaaatctatc
kahrp_promoter aaactgcatgtagtgtagt tagtagttatgttttgtcgt
kahrp_coding caggagcaagtactaatg gttgcttctttagaagtac
hrp3_promoter ttgtgtacattagaaatcac aagatacataagatagatgg
hrp3_coding atgtgcttgactttcgtg ccgaatttaacaataacttg
rhoph3_promoter gtgaataaatctaaatacagg taatacatccttagtgcag
rhoph3_coding catggaatgataagaagatc tggaatgtacctatattcg
PCR amplification of the centromere gap on chromosome 10:
Two primer pairs complementary to the sequence surrounding the small AT-rich core within 
the PfCENH3-covered region of chromosome 10 were designed (supplementary figure 
2). PCR was performed on genomic DNA isolated from three different P. falciparum strains 
(3D7, NF54 and NF135, a kind gift from R. Sauerwein, A. Teirlinck & B. Van Schaijk) using 
Advantage cDNA PCR Kit (Clontech). Amplification conditions were as follows: 5min 95°C, 
30 times: 10sec 95°C, 30sec 52°C, 90sec 65°C followed by 1min 65°C. PCR products were 
separated on a 1% agarose gel  (0.5xTBE buffer and Ethidium Bromide) alongside a 1kb DNA 
ladder (Invitrogen). 
Assembly of the centromeric sequence for chromosome 10:
The missing part of the centromeric sequence was assembled from those 76bp PfCENH3 
ChIP-seq reads that did not match to the current genome annotation. The assembly was 
carried out on an iterative manner starting from the “left” arm of the gap. ChIP-seq reads 
were first shortened to 25 bp and mapped against the last 100 bp of “left” arm using BWA 236. 
Reads that mapped uniquely in the forward direction were extended to their original length 
(76bp) and were assembled to a contig with ABYSS 321 using default settings. In the case 
multiple contigs were generated the one with the highest coverage was used. This contig 
was aligned against the last known end with Clustal 322 and used to extend the centromeric 
sequence. This procedure was repeated eight times before the last assembled contig 
bridged the left and right ends of the gap. The assembled sequence was fully confirmed 
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with capillary sequencing using a PCR fragment as a template. Primers used for sequencing 
are underlined on supplementary figure 2. Tandem repeats within this sequence were 
identified using Tandem Repeats Finder 323.
Mononucleosomal fragment length analysis:
Nuclei from 3D7 schizont stage parasites (~35-40 hours post-invasion) were collected and 
subjected to micrococcal nuclease digestion as described before 161. The nearly complete 
digestion of the chromatin to mononucleosomal DNA fragments was confirmed by 
agarose gel electrophoresis. A sequencing library was prepared using the LADS method 
225 and sequenced on the Illumina GAIIx platform from both ends. 50bp paired-end reads 
were mapped against the P. falciparum genome assembly (PlasmoDB v6.4, plus the extra 
sequence for the centromere of chromosome 10) using BWA 236. The length of each fragment 
was calculated as the distance between the most extreme bases of the forward and reverse 
reads. Sequences mapping to the AT-rich cores of the centromeres (150bp was subtracted 
from each side to avoid “contamination” from neighboring non PfCENH3-containing 
nucleosomes) were selected and the number of fragments belonging to the different size 
categories were counted using a self-written Linux script.
immunofluorescence assay (ifA) and live cell imaging:
Blood smears from asexual P. falciparum cultures (3D7 or 3D7/HP1-HA 157) were air-dried and 
fixed for two minutes in 100% methanol (-20°C). (Notably, glutaraldehyde/paraformaldehyde 
fixation leads to a less clear CENH3 localization pattern 313). Slides were washed in PBS for five 
minutes and incubated with affinity-purified rabbit aPfCENH3 313 or monoclonal rat aHA 
3F10 (Roche) for O/N or 30 minutes, respectively. Both antibodies were used at a dilution of 
1:100 in 3% BSA in PBS. After three PBS washes, secondary antibodies were applied; Alexa-
Fluor® 488-conjugated arabbit IgG (1:500) and/or Alexa-Fluor® 568-conjugated arat IgG 
(1:500). After five PBS washes, slides were dried and mounted using Vectashield® with DAPI 
(Vectorlabs). For live imaging, a small volume of pelleted 3D7/pGFP-CENH3 parasites was 
mixed with Vectashield® containing DAPI on a glass slide and covered with a cover slip.
Images were taken on a Leica DM 5000B microscope with a Leica DFC 300 FX camera, 
acquired via the Leica IM 1000 software and processed using Adobe Photoshop CS2. The 
number of CENH3 foci has been counted in 100 ring stage nuclei has been counted by three 
researchers independently. The percentage of parasites with different number of CENH3 foci 
per nucleus was calculated, averaged and displayed in a bar graph.  
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supplementary figure 1: PfCenH3 occupies a 4-4.5kb region on every P. falciparum chromosome. 
(A-b) Screenshots of ~12kb surrounding the single PfCENH3-covered region on each P. falciparum 
chromosome. Enrichment of PfCENH3-over-input (purple), GC-content in every 100bp (grey) and coding 
regions (blue boxes) are depicted. Reads were mapped against the P. falciparum genome sequence 
(version 6.1) (A) or the newly assembled centromeric region of chromosome 10 (b).
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Supplementary Figure 2: chapter 7 
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TATATTGTTATATAATTTTAATATATTAAAATTAAATAAATAATAATAAATAAATATAATTTTAATAAAGTATAT
ATAAAATAAATAAAATATATATTATATAATTTAAACATGATATTAATAAAAGATAAATACAATATTATAGCATTA
AAATATAATTTAATATAAAAATAAATAATAATACACATTATATATTTAAATATAATAAAAATAAATAATAAAATA
AATAATAATACATATTATATTATTTAAATATAATAAAAATAAATAATAAAATAAATAAATAATAATACAAATAAT
ATTTATTTAAATATAATAAAAATAAATAATAAAATAAATAAATAATAATACAAATATTATTTATTTAAATATAAT
AATAATAAATAATAAAATAAATAAATAATAATACAAATAATATTTATTTAAATATAATAAAAATAAATAATAATA
AATATTAATATAATAAAATTAATTAAAAATAAAATTAAAATAATAAAAATATTAAATTAATATATTAAATTTAAT
TAAACAAAATAATAATTAAATAAATTATATTATTAAATTAATATATTAATTTAAAAAATGAATAAATAATATACT
ATAATTAATATAAAATTAAATTAAATAAAAATAAATATAATGTATATAATTTAAATATTATAAATAAATAATATA
ATTTAATAAAAAAATTAATTAAATAATTAATTAATTAAATTAAAATAATATAATAAAATATATATAATTATTTTA
TTATAATTGTTTAATAATAATATTTTTAATGATATATTAATTTAATATAATAAATAAAATAATTATATTTATTAA
TTACTTATGATATTATTAATTTAATTAATTTAATATAATAAATAAAATAATTATATTTATTAATTACTTATGATA
TTGTTAATTTAATTAATTTAATATAATAATAAAATAATTATATTTATTAaTTACTTATGATATTATTAATTTAAT
TAATTTAATTTTAATAAATATAATTTTATAATTTAAAATTAAAAATAATATTATTAATATATTATTTAAATAATG
GCATATTAATTAATTTTATTAATATATAATTATTTATTTACATTATAATATATATTTATTTTATTTTAAACTTAA
AATTATTTATTAATTTATTATATTTATTAAAATAAAATTATTTGATAATTAATTTAATATAATATGTTTATTAAT
TAATTTTAAATATTAATTCTCTATTTTATTTATTAAATTAATATTGATTTATTAATTTATATTAATTTAATTATT
ATTATGTTATTAAATAAATTTAAATATTAATTATATTTCTTATTTATTAAATTAATATTTATTTATTAATTTATA
AATAATTTAATTATTATTTAAATATGTTTATTTTTTACAAATAATTTAATTTATATATATATATATTTATTTTAT
CATTTATTTATAAATAATTTAATTATTATAATTAAATTAATATATTTATTTATTTATTATTTTATTTATTTATAA
ATAATTTAATTATTATTTATATATTTTTAATTATTATAATTAAATTAATATATATATATATATTTATTTATTTAT
TATATTATTTTTTTATTTATTTATAAATAATTTAATTATTTAAATATTTTTAATTATTAATAATTAAATTAATAA
ATATATATATTTATATTATTTTTAATTAATTTATATAATATATTTATTTATATTATTTCTTATTTATTTATAATT
TATTTAATTTTATATAAATATATTTAAATATAAATAAATATATATATTATTTTAAATTATTATATTTTTATTTTA
ATAATTAATATTTAAATATATATAATAATTTAAAATAATATATATATTTTATTTATTATATTTTATATTTATTTA
ATTAAATTATTATTATTATATTATTTTATTAATTAATTTTAAATAAAAAATAATTTATTAATTTAAAATTATATA
AATATATATTATATTGTTATATTATATTTAAAATTAATATATTATTTATATTTTTTAAATTAATAAATAATTTTT
ATTTAAATATTAATATATAAAATAATTGTGTGTAAATATATATATAAATTTAATATAAAATTTAATTAATATAAT
AATTATTATTAAATTATTTTATTTATTATCAATATTAATTTATTATTTTTATTTATTAAATTAAAGAATTATAAT
TAATATATATATTTTAAAATTTATTTAATTTAATAATATAAAATATAATTATAAATAATTAATAATTTTATTTTA
TAATAGAAATAGTAAAATAAAATAAATGTATAATTTATAATTTAAATTAATTATTATATTTAATTAAATAAAAAT
AATTTTCTTAAATTATTAAAATAAATAATAAATATATATTAAATAAATATATATTTTTTAAATAATATATATATT
AATTACAGAGTTATCCATAATTAAAAATATAAAATATATTATATTTATTTGATTGTGTAAAATATTAATTATCAG
ATTTTAATTTATTAATTATTTTGAAAAATTTTTTGTCTTCTAAAATATATATATATTATAAAAATATTTATTTAT
GAAGTAAATATTTTATGAATACATTATTATTTGATTATTTTAATTTTTATTATTGATAGTAAATAATTATATTCT
AATATTAACGTTCTATAATTTATATATTTTTTGTGAATTGACTTAAAATATATTAAAATTTATTTGAATCGAATT
ATTTAGATGTTTACATTTTTATTAATATGTAAAATTTATATTATATTGGATTTTGTAGGATAAATTATG 
 
 
Previously known sequence is highlighted yellow. 
 
Primer sequences used for amplification and/or sequencing are underlined. 
supplementary figure 2: sequence of the newly assembled AT-rich core of the centromere on 
chromosome.  Fasta file containing the sequence of the newly assembled  P. falciparum chromosome 
10 centromeric sequence. Previously known sequence is highlighted in yellow.
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Supplementary Figure 3: chapter 7
DIC anti-CENH3 DAPI merge merge all
supplementary figure 3: PfCenH3 localization in ring stage parasites. 3D7 wild-type parasites of 
ring stages were subjected to immunofluorescence assay with aPfCENH3. At this stage the PfCENH3 
signal is substantially weaker and seldom concentrated to a single focus, suggesting that centromeres 
do not congregate into a single cluster at this stage. 3-6 distinct foci could typically be observed per 
nuclei potentially indicating subclustering of centromeres in ring stage nuclei.
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Malaria is a devastating infectious disease caused by parasites of the genus 
Plasmodium. A strictly regulated gene expression program underlies parasite 
development and reproduction. Nevertheless, the mechanisms regulating gene 
expression in this important human pathogen are poorly understood. Epigenetic 
processes play an important role in gene expression regulation as well as all other DNA-
associated processes. Therefore, the aim of this thesis was to explore the epigenome of 
the human malaria parasite P. falciparum. In order to study the parasite’s epigenome 
and transcriptome, we developed a method for the use of next-generation sequencing. 
Our genome-wide epifeature maps show that histone variants and modifications index 
the P. falciparum epigenome into functionally distinct domains. While some of these 
epifeatures are static during parasite development, others are dynamic and correlate 
with gene expression or parasite development. These epigenome maps significantly 
extend to the first insights gained by genome-wide localization of 3 epifeatures using 
ChIP-on-chip in our laboratory (by Adriana Salcedo-Amaya) and provide a solid 
foundation on which we can build to explore the mechanisms underlying Plasmodium 
gene expression and genome organization.
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neW insigHTs inTo THe PlAsModiuM ePigenoMe gAineD in THis 
THesis
Technological advancement
At the start of this thesis, revolutionizing next generation sequencing technologies 
215 had not been applied to Plasmodium. Hence, epigenome datasets generated 
by our 156, 157, 175 and other laboratories 166, 171, 262, relied on micro-array technology. 
However, micro-array approaches suffer from various technical limitations 
(discussed in 102, 263 and chapter 1, 4 and 5) and, most importantly, are exceptionally 
prone to hybridization artefacts for the extremely AT-rich probes that cover the P. 
falciparum intergenic regions, thereby hampering analysis of these key regulatory 
regions of the genome. Similarly, standard library preparation protocols for next-
generation sequencing results in severe underrepresentation or even complete 
loss of P. falciparum intergenic signal (chapter 3 and 5). As a consequence, 
these protocols cannot be applied to study epigenetic features in Plasmodium 
in a genome-wide fashion nor will they result in high-quality, quantitative full-
transcriptome analysis. In contrast, the Linear Amplification for Deep sequencing 
(LADS) protocol described in chapter 3 allows reliable and highly quantitative 
analysis of both coding and intergenic regions. So far, we combined LADS with 
chromatin immunoprecipitation (ChIP-seq) (chapter 5, 6, 7) and transcriptome 
analysis (RNA-seq) (chapter 4, 5) to obtain over 95% genome coverage at single-
base resolution. However, LADS can also be merged with a whole repertoire of 
state-of-the-art NGS applications, such as GRO-seq 189, ribosome footprinting 190, 
ChIA-PET 88 or Hi-C 87, and therefore will likely contribute to the future exploration 
of numerous aspects of the Plasmodium biology (e.g. RNA transcription, processing 
and translation, DNA replication, chromatin organisation)  and beyond.
Histone variants index the Plasmodium epigenome
In this thesis we present findings on the genome-wide localization of P. falciparum 
histone variants H2A.Z (chapter 5), H2Bv (chapter 6) and CenH3 (chapter 7) 
and histone PTMs H3K9ac and H3K4me3 (chapter 5). Collectively, these findings 
indicate that histone variants are rather stable features of the Plasmodium falciparum 
epigenome and index chromatin into functionally distinct domains (summarized 
in the updated model of figure 1). Histone variants H2A.Z and H2Bv form a double-
variant nucleosome subtype that demarcates euchromatic intergenic regions and 
displays a preference for long promoter regions with elevated AT-content. This 
double-variant nucleosome might be involved in the dynamic recruitment of the 
histone modifying and chromatin remodelling machinery as H3K9ac and H3K4me3 
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are dynamically placed on these nucleosomes at euchromatic regulatory regions 
during intraerythrocytic cycle progression. Whether H2A.Z and/or H2Bv histone 
variants are essential for parasite survival remains to be determined but seems 
plausible considering the demarcation of these critical regulatory regions and their 
potential key role in transcriptional control. 
Figure 1: General Discussion
Heterochromatic ‘readers’
Heterochromatic PTMs
Euchromatic histone variants & PTMs
E
H
var rifin constitutive schizont ringtrophozoite
K4 K9 K4 K9 K4 K4 K9 K4 K4 K4 K9K9 K9 K9 K9 K9 K9 K9
HP1 HP1 HP1 HP1 HP1
centromere
K9
var rifin constitutive schizont ringtrophozoite
K4 K9 K4 K9 K4 K9 K4 K4 K9 K4 K4 K9K9 K9 K9 K9 K9 K9 K9
HP1 HP1 HP1 HP1 HP1
centromere
var rifin constitutive schizont ringtrophozoite
K9 K9K9 K9 K9 K9 K9 K9 K9
HP1 HP1 HP1 HP1 HP1
centromere
CENH3 marks 
centromeres
H2A.Z/H2Bv double-variant nucleosomes demarcate euchromatic intergenic regions
figure 1: Histone variants index the Plasmodium falciparum epigenome. About 10% of 
the P. falciparum genome is packaged in the form of heterochromatin, hallmarked by the 
presence of H3K9 tri-methylation (black circles) 156 and heterochromatin protein 1 (HP1, 
yellow ovales) 157 and is largely devoid of histone variants (this thesis). This heterochromatin 
resides in the nuclear periphery 336, 337 and predominantly locates towards subtelomeric in 
chromosome-internal antigenic variation gene clusters 156. Within the euchromatic domain, 
intergenic regulatory regions are ubiquitously marked by the H2A.Z/H2Bv double-variant 
nucleosome subtype (orange/green) throughout intraerythrocytic development (161 and 
chapter 6), which bear dynamic H3K4 tri-methylation (pink circles) and H3K9 acetylation 
(blue circles) in a stage-specifi c or transcription-coupled manner, respectively 161. Finally, P. 
falciparum centromeres are delineated by CENH3-containing nucleosomes (purple) 283 and 
display modest enrichment of histone variants H2A.Z and H2Bv (283 and data not shown), 
although at the moment it is unclear whether these form a triple-variant nucleosome 
(orange/green/purple), or alternate with the CENH3-containing nucleosome particle. In 
conclusion, P. falciparum histone variants stably index the parasites epigenome into distinct 
functional domains and might play a key role in the structural organization of the genome 
of this important human pathogen. 
Similarly, histone variant CenH3 delineates P. falciparum centromeres throughout 
intraerythrocytic development, potentially assisted by histone variants H2A.Z 
(chapter 7) and H2Bv (data not shown). Whether these variants reside in the 
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same nucleosome particle or alternate with CenH3-containing nucleosomes at 
centromere regions remains to be determined. We hypothesize that the CenH3-
containing nucleosomes might be “seeded” at the AT-rich core domain from 
where they spread for about 1kb on either side of this core. Similar to what has 
been reported for other organisms 286, it seems likely that these CenH3-containing 
nucleosomes provide the scaffold for recruitment of other kinetochore components 
that are essential for centromere function.
A striking observation resulting from chapters 5, 6 & 7 is that all three identified 
histone variants remarkably locate to AT-rich regions of the P. falciparum genome 
(H2A.Z/H2Bv localizes to euchromatic intergenic regions of average 86% AT 
whereas CenH3 resides on extraordinary >97% AT-rich centromere cores). This is in 
contrast to reports claiming that high AT-content is disfavourable for nucleosome 
formation 170, 324, whereas GC-rich regions display higher nucleosome occupancies 
293. Although it is in theory possible that even though histone variants specifically 
occupy these regions, the overall nucleosome occupancy is reduced; in practice 
we do not observe significant drops in nucleosome occupancy for these AT-rich 
domains (supplementary figure 3 of chapter 5). Consequently, P. falciparum 
histone variants might have specifically evolved to wrap DNA with high AT-content 
and to inhabit these extreme regions of the genome. Whatever the mechanisms 
underlying preferential occupancy of high-AT regions by Pf histone variants, our 
data indicate that genomic AT-content might be a driving force of P. falciparum 
epigenome organisation. Accordingly, heterochromatic (~73% AT), euchromatic 
coding (~76% AT), euchromatic intergenic (~86% AT) and centromeric (~97% AT) 
regions might be differentially recognized based on their base-composition as 
distinct epigenetic entities resulting in their different functions. The mechanisms 
by which AT-content might drive this epigenome speciation is unknown, but 
subject to current investigations. Potentially, high AT-content in combination with 
specific nucleosome composition might result in reduced nucleosome stability 
and thereby higher accessibility of regulatory regions. Alternatively, the specific 
nucleosome subtypes inhabiting distinct regions of the epigenome might serve 
as a platform for the differential recruitment of histone modifying and chromatin 
remodelling complexes to their site of action. 
The fourth variant of the Plasmodium histones, H3.3 154, so far remains 
uncharacterized. Therefore, it still needs to be determined whether this variant, 
like the others, stably indexes specific regions of the P. falciparum epigenome and 
has evolved to occupy AT-richer sequences. Although, literature on H3.3 function 
in other organisms 50, 325 would imply a dynamic marking of the coding body of 
active genes and their active promoter regions, the P. falciparum epigenome seems 
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distinct from common model organisms in various aspects and might utilize its 
histone variants in an alternative fashion.
The data presented in this thesis reveals the genome-wide localization of 5 
epigenetic features in the P. falciparum epigenome and extends the very first Pf 
epigenome characterization by H3K4me3, H3K9ac & H3K9me3 post-translational 
histone modifications performed in our laboratory (156 and thesis Adriana Salcedo-
Amaya). This data provided very important insights into Plasmodium epigenome 
organisation and laid the foundation for targeted hypothesis-driving research. 
ReCenT PRogRess in PlAsModiuM ePigeneTiCs
Our genome-wide localization studies reveal the distribution of P. falciparum 
histone variants and several PTMs, however, we have so far ‘neglected’ the proteins 
that write, read or erase these modifications. Genome annotations revealed 
the presence of several chromatin modifier enzymes, including 4 HATs 144, 3 
HDACs and 2 Sirs HDACs 144, 13 HMTs (of which 10 putative lysine and 3 arginine 
methyltransferases), 3 HDMs and numerous proteins containing well-recognized 
reader-domains (reviewed in 326). As the HMTs, HDMs and reader-proteins are 
extensively discussed in an excellent recent review by Cui et. al. 326, they will not be 
covered here.
Of the 4 HATs identified in the P. falciparum genome, PfGCN5 was shown to 
preferentially acetylate the K9 and K14 residues of histone H3 in vitro 327 and is 
essential for parasite viability 326. In addition, curcumin treatment (a broad range 
inhibitor, inhibiting GCN5 amongst others) resulted in reduction of H3K9 and K14 
acetylation levels in P. falciparum parasites 328. Another Plasmodium HAT, PfMYST, 
was recently shown to acetylate multiple histone H4 residues in vitro and resulted 
in increased H4 acetylation in vivo when overexpressed. Furthermore, also this HAT 
was reported to be essential for parasite viability 329. Interestingly, PfMYST associated 
with the promoter of active var2csa, but not of poised or silent var promoter 329 (see 
below for an extensive discussion on var gene control), suggesting a role of H4 
acetylation in gene expression.
Plasmodium sirtuins have received a lot of attention with respect to var gene 
control (see discussion below), but of the other HDACs only PfHDAC1 has been 
characterized to some extent 330, 331 and is predominantly expressed in asexual 
and sexual intraerythocytic stages where it localizes to the parasite nucleus 332. 
In addition, multiple class I/II HDAC inhibitors were recently shown to possess 
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anti-malarial activity by several laboratories (179, 262, 333-335 and A. Salcedo-Amaya 
unpublished observations) although the underlying mechanisms are still 
unresolved. Nonetheless, these studies highlight that the Plasmodium epigenome 
is a very promising target for therapeutic intervention. In addition to histone 
acetylation, exploration of other epifeatures and the factors involved with their 
deposition, removal and/or recognition will likely uncover more high-profile 
targets for drug developments.
Previous studies revealed the presence of heterochromatic chromatin in the 
nuclear periphery of the nucleus. These studies subsequently showed that these 
regions harboured members of silent gene families and that upon activation these 
genes relocate to a distinct, transcription-permissive peripheral expression site 336-
339. Moreover, a study reporting the nuclear localisation of 12 proteins (including 
various SET-type HMTs, a putative HDM and several potential reader proteins) 
revealed specific localization of each factor to either the nuclear periphery, the 
central nuclear domain or the border of these regions 313. Recently, an elegant 
study from the Dzikowski lab using state-of-the-art electron microscopy provided 
more insight in the 3D nuclear organisation during intraerythrocytic development 
340. They show that nuclear pore complexes are poorly abundant and display a 
polarized distribution in ring and schizont stage parasites, but are plentiful present 
and uniformly distributed over the nuclear envelope in trophozoites. Furthermore, 
nuclear pore complexes coincide with euchromatic chromatin in both trophozoite 
and schizont stages supporting their role in the direct transport of newly 
generated transcripts from the nucleus to the cytoplasm. Interestingly, chromatin 
organisation appears highly dynamic during intraerythrocytic development. Ring 
stages exhibit a rather diffuse chromatin without clear distinction between eu- and 
heterochromatic domains, whereas heterochromatin is distributed in small patches 
throughout the nucleus of trophozoite stage parasites. Contrary, in schizonts, large 
clusters of compact heterochromatin are observed 340. These data are in line with 
the dynamic chromatin marking described in chapter 5. The relative depletion of 
active H3K4me3 and H3K9ac marks 161 and the very low transcriptional activity 161, 
169 of ring stage parasites might indicate that ‘true’ active euchromatin is scarce at 
this stage of development. In contrast, trophozoite stage parasites exhibit massive 
transcriptional activity 161, 169 and undergo multiple rounds of DNA replication, which 
might be responsible for the patchy distribution of heterochromatin throughout 
the nucleus 340. Late stage schizont parasites reveal clustering of heterochromatic 
domains and clearly distinctive euchromatin 340, coinciding with the presence of 
active marks 161 and abundant, but reduced transcriptional activity reported for this 
stage compared to trophozoite stage parasites 161, 169.
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Var genes have always received special attention in malaria research given their 
importance in antigenic variation and immune escape. The var gene family is 
composed of about 60 genes 133, which are localized at mainly subtelomeric and 
some chromosome-internal islands of P. falciparum genome 341. These genes are 
expressed in a mutually exclusive manner 342. Expression of full-length transcripts 
from a single var gene in each parasite is regulated at the level of transcription 
initiation 343 and results in the production and exposure of a single PfEMP1 variant 
on the surface of the infected red blood cell. This is essential for parasite immune 
evasion by sequestration in internal organs 344 and results in obstruction of blood 
flow in vital organs, giving rise to severe malaria typical to P. falciparum infections 
345. As PfEMP1 is immunogenic, switching towards different PfEMP1 variants (of 
the 60 proteins encoded by the var genes) sustains chronic infection of humans 
infected with P. falciparum 345. Importantly, mutually exclusive expression of 
the singular active var gene is maintained over several generations and is likely 
subject to epigenetic memory. Moreover, individual var genes display varying 
rates of switching and follow a non-random switching hierarchy 346-348, indicating 
that (epigenetic) mechanisms exist to influence var gene choice and expression 
stability.  Although extensively studied by several groups 339, 349-353, the (epigenetic) 
mechanism(s) regulating expression of a single family-member while silencing all 
others are still largely unknown. Only ~10% of the P. falciparum epigenome resides 
in a heterochromatic state 156, 166, hallmarked by the presence of H3K9me3 156, 166 
and heterochromatin protein 1 (HP1) 157, 172. Heterochromatin is almost exclusive 
located to the subtelomeric and chromosome-internal islands encoding var and 
other (suspected) antigenic variants families 156, 166, indicating that the majority of 
(silent) var genes posses an inactive epigenetic signature. In contrast, the single 
active var gene is devoid of H3K9me3 173 or HP1 172, and displays enrichment of 
H3K4me2, -me3 and H3K9ac 173 at the 5’ UTR 173. 
The P. falciparum genome encodes two class III histone deacetylases (PfSir2A, 
PfSir2B). PfSir2A (PF13_0152) was shown to localize to electron-dense 
heterochromatic regions in the nuclear periphery 337. Furthermore, it occupies 
telomeric and subtelomeric repeats and is enriched on the inactive, but not an 
active copy of the subtelomeric var2csa gene 337, suggesting a role in deacetylation 
of histone tails in the heterochromatic domain and silencing of var gene expression. 
Accordingly, knock-out of PfSir2A 176, 338, 354 or Sir2B 176 results in loss of mutual 
exclusive expression for different subsets of var genes. Besides histone post-
translational modifications, a recent study revealed a role for histone variant H2A.Z 
in var gene expression 287. This study shows that H2A.Z marks the transcription start 
site of the active var gene, but not of poised or silent family members. Interestingly, 
increased H2A.Z occupancy is detected on the TSS of derepressed var genes in 
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Sir2A or Sir2B KO parasites suggesting a role for H2A.Z in var gene activation 287.  As 
our study 161 on the genome-wide localization of PfH2A.Z was performed on non-
selected parasites where multiple var genes are active in subsets of the population 
and consequently every var is ‘on average’ silent, active marking was not detected 
on or surrounding var transcription start sites. However, we did observe clear ring-
stage specific marking of SPE2 arrays located upstream of upsB type subtelomeric 
var genes (figure s10 of 161). Interestingly, these regions were recently shown 
to bind an AP2-type transcription factor PfSIP2 in schizont stage parasites 175. Of 
particular relevance, a recently identified family of long non-coding RNAs (lncRNA-
TARE 158) was detected in the vicinity of these SPE2 arrays and was synthesized 
towards the telomere specifically in schizont stage parasites. As non-coding RNAs 
are frequently involved in gene silencing and assembly of large silent chromatin 
domains (reviewed in 79-81), PfSIP2 might very well activate transcription of this non-
coding RNA family thereby contributing (indirectly) to heterochromatin formation/
maintenance (also discussed in 158). These data show that various epigenetic 
processes work together to orchestrate var gene expression. Dissecting those 
mechanisms will be a daunting task that might require combining experiments 
from various different angles before insights in the regulatory processes are 
obtained. 
fuTuRe ouTlooK & DiReCTions
Five years ago, epigenetics in Plasmodium was still in its infancy. Now, we and 
others provided a solid base by exploration of the (genome-wide) localization of 
various epifeatures and an initial characterization of singular ‘epi’factors. Even so, 
one histone variant (PfH3.3) and numerous histone PTMs remain to be explored in 
respect to their genomic localization profiles. Some of these features most likely 
will coincide (as they do in model organisms) and therefore might not directly bring 
new insights. However, in light of the various ‘unique’ features displayed by this 
parasites epigenome (e.g. H3K4me3 and K9ac coincide almost without exception 
in model eukaryotes, but not in Plasmodium) it will be difficult to predict which 
factors will be most rewarding to profile. Nonetheless, explorations of acetylations 
found on PfH2A.Z and PfH2Bv might be attractive targets as 1) this double-variant 
nucleosome subtype occupies key regulatory regions of the Plasmodium genome, 
2) stably demarcates these regions in contrast to the dynamic occupancy observed 
in model eukaryotes and 3) contains component(s) specific to the parasite over 
its human host. Additionally, exploration of epigenomes from other stages of 
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the life cycle (e.g. sexual or liver-stage parasites), although challenging, would be 
extremely interesting from a medical perspective.
In addition to progress made in epigenetic research, the past 5 years brought 
marked advancement in the field of gene expression regulation by transcription 
factors (TFs). Despite identification of ~27 ApiAP2 proteins 145 and >30 other 
potential TFs 146, 147, very few studies so far targeted the genome-wide localization 175 
or the functional relevance of these factors 146, 244, 245. One promising area of research 
for the coming years will be the examination of genome-wide signatures of the TF 
network. In addition, generation of high-quality and high-resolution nucleosome 
position maps will allow to explore the interplay between epigenetic and TF-
mediated transcription regulation through the accessibility of transcription factor 
binding sites and might provide a mechanism underlying regulated TF binding that 
cannot be explained by the simple absence or presence of transcription factors.
It has been discussed above that a very recent study 340 revealed a highly fascinating 
and dynamic 3D nuclear organization during intraerythrocytic development. 
Although this is a big leap forward in a so far virtually unexplored area of research, 
it does not reveal which regions of the genome inhabit the different nuclear 
domains. In my opinion, current microscopic technologies do not provide sufficient 
resolution to gain significant more insights. Therefore I believe that adaptation to 
state-of-the-art NGS applications such as ChIA-PET 88 and Hi-C 87 will be inevitable 
to gain deeper insights into the 3-dimensional organization of the Plasmodium 
epigenome. 
Another subject that I already touched upon above is the writer, reader and eraser 
component of the parasites epigenome. Although several studies have targeted 
mostly isolated HATs and HDACs (see above), epigenetic enzymes are known to 
most commonly reside in large multi-subunit complexes that bring together various 
epigenetic activities. A recent groundbreaking study by Bantscheff and co-workers 
355 disclosed that specificity of drugs targeting singular complex components (e.g. 
HDACs) is greatly influenced by the complex composition. The astonishing result 
from this study was that inhibitors targeting a single HDAC component target this 
HDAC while it resides in one complex, but not in the other. Therefore, it will be 
crucial for Plasmodium research (especially in light of the ongoing studies aiming 
at developing HDACi’s for therapeutic use) to identify the components of the multi-
subunit complexes in Plasmodium, and to test potential epidrugs in the context 
of these large multi-subunit structures instead of singular HDAC molecules. 
Furthermore, targeted functional studies to dissect the causal relation between 
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these complexes and epigenetic marks will be vital to dissect the regulation of 
DNA-associates processes by components of the parasites epigenome.
Above I listed several tasks that lay ahead of us. Although these are many, the 
greatest challenge that lies ahead of us is to translate descriptive knowledge of TF or 
epifeature localization maps and 3D location into the mechanisms that orchestrate 
the parasites epigenome. Currently, we lack the experimental systems to perform 
functional experiments to translate ‘descriptive’ epigenetics into mechanisms and 
functions. A big investment of resources will be needed to generate/develop tools 
that will allow this translation. Without those it will be impossible to proceed to the 
next level and to make the transit from ‘observing’ towards ‘understanding’. 
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suMMARY
Malaria is still one of the most threatening infectious diseases responsible for 
~225 million clinical cases and almost 1 million deaths annually. It is caused by 
unicellular parasites of the genus Plasmodium, of which P. falciparum is accountable 
for the most deadly form of the disease. Despite decades of research, a malaria-
vaccine is lacking and drug resistance against commonly used anti-malarials 
is spreading. Therefore, there is an urgent need to identify novel pathways for 
therapeutic intervention. Epidrugs, successfully used in the treatment of cancer, 
also display anti-malarial activity. However, their molecular mechanisms of action 
remain enigmatic. Epigenetic pathways regulate all DNA-associated processes 
and are believed to play a key role in the strict regulation of gene expression that 
is observed throughout the Plasmodium life cycle. However, the proteins and 
mechanisms involved in epigenetic regulation are currently largely unexplored. 
This thesis aims to unravel the fundamental composition of the P. falciparum 
epigenome in order to unravel its organization and importance in regulation of 
DNA-associated processes.
Chapter 1 summarizes our current knowledge on epigenetic processes from 
studies in commonly used model organisms and introduces Plasmodium parasites. 
The state-of-the-art in Plasmodium epigenetics at the start of this PhD project is 
described in chapter 2. The development of a method that enables application of 
top-notch next-generation-sequencing technology for the analysis of the extremely 
AT-rich P. falciparum genome and transcriptome are extensively described in 
chapter 3 & 4 and form the technological cornerstone of this thesis. In chapter 5 
we uncover the genome-wide localization of the very first histone variant and two 
histone post-translational modifications during intraerythrocytic development of 
this deadly human pathogen. Our study reveals that PfH2A.Z stably demarcates 
euchromatic intergenic regions throughout development. Moreover, histone PTMs 
are dynamically placed onto these nucleosomes, indicating that H2A.Z-containing 
nucleosomes might provide a ‘scaffold’ for the dynamic recruitment of histone 
modifying components of the parasites epigenome. H3K9ac marking is most 
abundant in the transcriptionally most active stages of development and its levels 
correlate with expression profiles of genes at all of the stages examined. On the 
contrary, H3K4me3 predominantly demarcates euchromatic intergenic regions at 
the trophozoite and schizont stages, while it is generally absent in rings. Further 
explorations in chapter 6 reveal that PfH2A.Z and another histone variant PfH2Bv 
form a double-variant nucleosome subtype, which is most highly enriched on 
long promoter regions and positively correlate with AT-content indicating that the 
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genomic sequence composition might be instructive in histone variant deposition. 
This double-variant nucleosome seems to display reduced stability, potentially 
promoting a transcription permissive environment. Chapter 7 uncovers the 
epigenetic signature of P. falciparum centromeres. These key regions are delineated 
by histone variant PfCENH3, contain H2A.Z and are hallmarked by the presence of 
a 2-2.5kb exceptionally AT-rich core. Our data demonstrates that all Pf centromeres 
confer to the same size and structure and suggest that genomic AT-content might 
be instructive to centromere formation as well.
Taken together, the data presented in this thesis reveal that histone variants index 
the P. falciparum epigenome in functionally distinct domains and play a key role in 
the epigenome organization of this important human pathogen.
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sAMenVATTing
Malaria is een van de dodelijkste infectieuze ziektes en veroorzaakt zo’n 225 
miljoen ziektegevallen per jaar. Deze ziekte wordt veroorzaakt door eencellige 
parasieten van het geslacht Plasmodium en wordt op mensen overgebracht door 
malariamuggen van het geslacht Anopheles. Er zijn voor de mens 5 infectieuze 
soorten van Plasmodium nl. P. vivax, P. ovale, P. malariae, P. falciparum en P. knowlesi. 
De meest dodelijke parasietensoort is P. falciparum waaraan jaarlijks bijna 1 miljoen 
mensen overlijden, het overgrote deel waarvan Afrikaanse kinderen jonger dan 5 
jaar.
Ondanks vele jaren van wetenschappelijk onderzoek is er nog steeds geen vaccin 
tegen malaria ontwikkeld. De bestrijding van de ziekte vindt op dit moment met 
name plaats door het gebruik van medicijnen en door de bestrijding van de mug 
(met behulp van muskietennetten en door het droogleggen van broedplaatsen 
voor de mug). Echter, de resistentie van parasieten tegen de meest gebruikte 
medicijnen neemt schrikbarende vormen aan en limiteert onze enige optie om 
mensen die besmet zijn met Plasmodium te genezen. Het is daarom van zeer groot 
belang om nieuwe methodes te ontwikkelen ter bestrijding van de malariaparasiet. 
De epigenetica bestudeerd nucleosomen en vele andere factoren die de functie 
en toegankelijkheid van ons genoom reguleren. Epigenetische mechanismen 
beïnvloeden namelijk alle processen die werkzaam zijn op DNA zonder de DNA 
sequentie zelf te veranderen. Op dit moment worden epigenetische mechanismen 
gezien als één van de belangrijkste regulatoren van genexpressie in de malaria 
parasiet. Medicijnen die deze epigenetische processen remmen, zogenaamde 
‘epidrugs’, worden op dit moment met succes gebruikt in de kliniek ten behoeve 
van kankertherapie. Recent onderzoek toont aan dat deze ‘epidrugs’ ook werkzaam 
zijn tegen de malariaparasiet en daarom mogelijk gebruikt kunnen worden als 
anti-malaria medicijn. Het is echter tot nu toe onbekend op welke epigenetische 
processen in de parasiet deze medicijnen aangrijpen en welke factoren en 
mechanismen daarbij betrokken zijn.
 Het doel van het onderzoek dat beschreven staat in dit proefschrift, is om inzicht 
te krijgen in de organisatie van het epigenoom van de dodelijke Plasmodium 
falciparum parasiet en de rol die epigenetische processen spelen bij regulatie van 
verschillende essentiële processen zoals genexpressie.
In hoofdstuk 1 van dit proefschrift wordt onze huidige kennis op het gebied 
van de epigenetica en een introductie van de parasitaire veroorzaker van malaria 
uiteengezet. Een overzicht van de kennis betreffende epigenetica in Plasmodium 
voorzover deze bekend was aan het begin van het in dit proefschrift beschreven 
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onderzoek wordt weergegeven in hoofdstuk 2. In de hoofdstukken 3 & 4 worden 
de methoden beschreven die zijn ontwikkeld om die nieuwste technologische 
ontwikkeling, het ‘next generation sequencing’, toe te kunnen passen in het 
malariaonderzoek om meer inzicht te krijgen in het transcriptoom en de organisatie 
van het epigenoom van deze dodelijke ziekteverwekker. Aanpassing van bestaande 
protocollen was noodzakelijk vanwege de zeer afwijkende samenstelling van het 
genoom van deze parasiet. De hoofdstukken 3 & 4 vormen de technologische 
basis van dit proefschrift. In hoofdstuk 5 wordt de ontrafeling van de genoom-
brede lokalisatie van histon variant H2A.Z en twee histon-modificaties beschreven. 
We laten zien dat H2A.Z bijna uniform verdeeld is over euchromatische intergene 
gebieden tijdens verschillende stadia van de ontwikkeling in rode bloedcellen. 
Bovendien blijken deze gebieden dynamisch te worden gemarkeerd met 
twee verschillende histon-modificaties: H3K9 acetylatie profielen tijdens de 
ontwikkelingscyclus correleren met patronen van genexpressie, terwijl H3K4 
methylatie (drie-me) alleen in de latere ontwikkelingsstadia op deze regio’s 
aanwezig is. Deze data suggereren dat H2A.Z-nucleosomen een platform vormen 
voor de dynamische rekrutering van enzymen die deze ‘barcodes’ aanbrengen of 
verwijderen. In hoofdstuk 6 tonen we aan dat H2A.Z samen met histon variant 
H2Bv een dubbel-variant nucleosoom vormt. Deze speciale nucleosomen zijn 
verrijkt op lange promoter regio’s en correleren met de hoge locale concentraties 
van de adenine en thymine basen. Dit suggereert dat de basen-compositie 
van verschillende gebieden in het genoom mogelijk instructies bevatten die 
bepalend zijn bij de plaatsing van dubbel-variante nucleosomen. Tot slot laten we 
in hoofdstuk 7 van dit proefschrift zien dat centromeren in de malaria-parasiet 
gemarkeerd worden door een derde histon variant: CENH3. Deze centromeer 
gebieden worden gekenmerkt door een extreem A + T rijke sequentie van 2 tot 2.5 
kilobase en bevatten naast CENH3 ook histon variant H2A.Z. Onze data suggereert 
dat alle P. falciparum centromeren een vergelijkbare opbouw en structuur bezitten. 
Bovendien is ook hier de basen-compositie van het genoom mogelijk bepalend 
voor de werving en/of plaatsing van CENH3-nucleosomen.
Samenvattend, in dit proefschrift hebben wij aangetoond dat histon varianten 
in de malaria parasiet Plasmodium falciparum het genoom opdelen in diverse 
gebieden met verschillende biologische functies. Hiermee verschaffen we als 
één van de eersten inzicht in de basale opbouw van het epigenoom van deze 
dodelijke ziekteverwekker en maken we de weg vrij voor meer onderzoek naar de 
mechanismen die ten grondslag liggen aan deze epigenetische organisatie.
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your master. A decision that turned out to be fantastic for us (and hopefully also 
for you)! Basically, you seem to be extremely good in whatever you want to do 
and our histone variant mapping project greatly benefited from your involvement. 
You were captured by the project and even came to the lab in the middle of the 
night to collect batches of synchronous parasites with me. Furthermore, you were 
fantastic with the bioinformatic analysis of the large amounts of ChIP-seq data that 
we produced, and often you knew how to do these things faster and better than 
Richard and I did. You more than deserve the co-authorship on many of the papers/
manuscripts that are included in this thesis. I really enjoyed the year that you were 
a part of our group and want to thank you (and also Annika) for the great time. I 
hope we keep in contact! 
Till, also you came to the lab for the FG2 course/bachelor internship, but long 
before you started we already received an email from you indicating that you really 
wanted to work on malaria. And so you joined our group! You were very eager to 
learn about all the work that was ongoing and with you we performed a project on 
culturing parasites and testing a set epidrugs. A difficult project, but you handled 
it well. I still did not manage to continue as much with your work as I would like 
to, but I’m still planning to do so, don’t worry. Till, you are a very social person and 
a real pleasure to have around! Also, you were a driving force behind many of our 
social activities and as you keep on saying, yes we still should go out for a drink 
or a fun activity in the city center soonish! I’m glad you found the project of your 
dreams, and I really hope you get the PhD position and your grant. It is great that 
you will be located at the 5th floor, as that means I will see you around (hopefully 
often)!
Robert, you were our last student so far. And although you really wanted to do 
research and a PhD, I think we soon figured out it might not really be your ‘piece 
of cake’. However, you turned out to be a marvellous house-constructer and were 
working very hard to get the house done in time. I hope your house is ready now 
and you are enjoying every bit of it. And I also hope you managed to find a job 
more of your liking!
Waar zou ik zijn zonder de fantastische hulp vanuit de Malaria Cultering Facility 
(ofwel de ‘unit’)?! Daar heb ik zoveel uren van mijn PhD doorgebracht! Maar saai 
was het nooit (behalve ‘s nachts), want er was altijd wel iemand aanwezig om mee 
te kletsen en de tijd te vullen als ik op de centrifuge of mijn slides moest wachten. 
Het was/is fantastisch om in een faciliteit te werken waar zoveel ervaring aanwezig 
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is. Marga en Geert Jan, bedankt voor al jullie adviezen, hulp en vooral ook jullie 
gezelligheid! Ook wil ik heel graag Wouter, Ben, Martijn, Sanna, Matthew, Maarten, 
Marta en Helmi, met wie ik in verschillende fasen van mijn PhD samen in de unit 
heb gekweekt, bedanken. Heel erg bedankt voor jullie gezelligheid, collegialiteit of 
gewoon voor een luisterend oor. Zonder jullie had ik het niet zo naar mijn zin gehad 
en me niet zo thuis gevoeld op het kweeklab! En natuurlijk kan een bedankje voor 
de unit niet zonder een BIG THANK YOU voor Rianne! Rianne, we zijn rond min-of-
meer dezelfde tijd begonnen en hebben samen het kweken, synchroniseren en 
ook de misdragingen van de parasieten leren kennen (jij wat sneller dan ik). En die 
vele uren samen in de unit hebben er voor gezorgd dat we goede vriendinnen zijn 
geworden! Ik kijk altijd erg uit naar onze ‘thee-sessies’ (zeker nu ik niet meer zo vaak 
in de unit te vinden ben en jij naar de andere unit bent verhuisd) en ik hoop dat we 
die er nog lang in kunnen houden (en hopelijk wat vaker dan dat we nu doen!). Ik 
heb een fantastische tijd gehad en hoop nog lang op jou advies en gezelligheid te 
mogen steunen!
At ‘my’ department of Molecular Biology there are so many people I would like to 
thank and this is probably too much to write down in detail, so I will try to do with 
a summary. But first I just want to thank everyone who contributed to the very 
friendly environment that made me feel at home at the department, thanks to all 
of you for being such great colleagues!!! Maria & Josephine, jullie stonden altijd 
klaar om me te helpen, dingen te regelen, of gewoon om gezellig te kletsen aan de 
koffietafel of in het kantoortjes als ik op Henk moest wachten, iets moest printen, 
kopieren of faxen. Zonder jullie zou het hele lab compleet in het honderd lopen. 
Heel erg bedankt voor jullie steun en gezelligheid gedurende de afgelopen 4,5 
jaar! Anita, ik wil je graag bedanken voor de gezelligheid, maar vooral ook voor 
het cloneren van mijn KO-constructen voor Australië en het pimpen van de Dutch 
Summary in deze thesis. Zonder jou waren de laatste paar maanden van 2012 een 
stuk stressvoller geweest! Hendrik & Rike, naast de gezelligheid en het feit dat jullie 
gewoon hele leuke collega’s zijn/waren, wil ik jullie speciaal bedanken voor jullie 
input en het delen van jullie ervaring met de RNA-sequencing! En natuurlijk was 
mijn thesis nooit gevuld zonder de fantastische zorg van het Solexa-sequencing-
team en support van het bioinformatica-team, Eva, Anita, Yan, Simon, Marc, Kees-
Jan, Hinri, Blaise, Enrique, Abishek en Renske, BEDANKT! Stefanie & Sadia, my 
fellow-PhD labmates! We started about the same time and could share our concerns 
about the ups and downs of being a PhD-student together. Thanks for the nice 
time in the lab, the things we did together (amongst which Helsinki-meeting, PhD 
retreate, PhD program components), the nice chats and the comfort of talking to 
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you! Both of you, good luck with the finalization of your own thesises and up to 
your defenses! Ik heb het geluk gehad door de jaren heen te kunnen steunen op 
heel veel ervaring en kennis van (senior) onderzoekers op het lab. Blanca, Arjen, 
Hendrik, Joost en Marcel, ik heb heel veel bewondering voor de manier waarop 
jullie altijd opbouwende kritiek leveren tijdens labmeetings en fantastisch slimme 
vragen stellen of suggesties doen tijdens presentaties, besprekingen etc. Ik hoop 
net zo’n scherpe, ervaren wetenschapper te worden als jullie zijn! In het begin met 
de voorbereiding voor mijn NWO-TopTalent interview (Blanca), of later zowel tijdens 
werkbesprekingen als in het lab kon ik altijd bij jullie terecht. Heel erg bedankt 
daarvoor! Natuurlijk wil ik ook de staff (de ‘oude’ garde, die ik me herinner van toen 
ik als 3e jaars student voor het eerst hier in het lab kwam) bedanken. Colin, Gert-Jan 
en Marion, ik heb altijd heel veel bewondering gehad voor jullie enthousiasme en 
de inspirerende manier waarop jullie bergen aan kennis op andere mensen kunnen 
overbrengen. Ik heb heel erg genoten van de cursussen die ik als student bij jullie 
heb gevolgd! Ook wil ik jullie bedanken voor al jullie suggesties en adviezen door 
de jaren heen en voor al jullie steun en inzet ten behoeve van het lab! I also would 
like to thank Roberta and Gigi for the great chats and good atmosphere in our 
shared “U”. It is a shame that I had to move to the other side of the lab, as now I 
will have to miss your uplifting comments and chats! Joke, ook jou wil ik graag 
bedanken. Ondanks dat we er uiteindelijk niet meer in zijn geslaagd de coole in 
vitro experimenten die we wilden doen met malaria-histonen samen uit te voeren, 
wil ik je wel bedanken voor je goede ideeen, enthousiasme en gezelligheid! Marion 
(Bussemakers), ook jou wil ik graag bedanken voor je enthousiasme, je gezelligheid 
maar vooral ook je interesse en hulp met onze beursaanvragen. Ik weet niet hoe 
je het voor elkaar krijgt zo efficiënt te zijn, we hoeven je niets eens te vragen om 
iets voor ons te doen of het is al gebeurd. Fantastisch! Dankjewel daarvoor! My 
many other colleagues I want to thank for the nice chats in the lab or at the coffee 
table, the nice ‘lab-uitjes’, discussions, support or just the great company! Robert, 
Willem, Max, Leonie (Smeenk), Femke, Ozren, Adalberto, Melysia, Evelien, Fiona, 
Xi, Dik, Sergei, Mena, Floriana, Wasseem, Vikram, Pascal, Mark, Annemarie, Armen, 
Eshan, Lusy, Koen, Tanya, Amit, Sarita, Emese, Saartje, Asif, Nagesha en Leonie 
(Kamminga), THANKS!!! En ‘last but not least’, wil ik natuurlijk Eva en Kim bedanken! 
Kim, wat ben ik blij dat je bij ons op de afdeling bent begonnen! En dat je in het “U”-
tje naast me kwam zitten, zodat we gezellig konden kleppen. Je bent zo’n gezellige, 
optimistische en behulpzame meid en ik hoop dat je die positieve eigenschappen 
nog lang voor het lab kan inzetten! Jammer dat we nu verhuisd zijn naar de andere 
kant van het lab, maar we moeten maar gewoon proberen samen te lunchen en 
thee te drinken en dan blijft het vast net zo gezellig als het nu is! Eva, de afgelopen 
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4,5 jaar hebben we naast elkaar gezeten op het lab en ik had me geen gezelliger 
persoon kunnen wensen om in het “U”-tje naast me te hebben. Ik kon altijd bij je 
terecht, om iets te vragen, te overleggen, mijn hart te luchten of gewoon te kletsen 
over van alles en nogwat. We zijn in de loop van de tijd erg close geworden en ik 
heb erg veel geluk gehad een collega te treffen waarmee het zo goed klikt! Ik mis 
je wel, nu je al een tijdje niet meer op het lab bent en ik hoop van harte dat jij en 
Geert-Jan over een paar maanden twee fantastische en gezonde baby’s in jullie 
armen en hart mogen sluiten. Geert-Jan, heel erg bedankt voor de goede adviezen 
voor ons huis en de gezelligheid aan de koffietafel als je hier kwam lunchen. Eva, 
heel erg bedankt voor de supertijd die ik tot nu toe op het lab heb gehad, en ik 
hoop dat we nog lang vriendinnen zullen blijven. 
Ook wil ik graag de mensen ‘van beneden’, van de afdeling Medische Microbiologie, 
bedanken. Robert, bedankt dat je Richard en mij hebt verwelkomd en behandeld 
als deel van jou groep. Het voelt heel fijn om onderdeel uit te maken van zo’n 
gezellige en hechte afdeling en ik voel me echt thuis bij jullie op de verdieping. En 
natuurlijk wil ik iedereen bedanken die bijdraagt aan die warme, verwelkomende 
atmosfeer! Rob, Adrian, Will, Matthew, Meta, Ben, Martijn, Anne, Krystelle, Anja, Ivo, 
Maarten, Karina, Marga, Geert-Jan, Rianne, Wouter, Helmi, Guido, Else, Sanna en 
Edwin, BEDANKT! Bedankt voor alle gezelligheid, interesse of goede opmerkingen 
tijdens labmeetings!
Furthermore, I would like to thank all the many people with whom I collaborated 
for including and trusting me with your projects. The P. berghei group: Aga, Jannik, 
Chris & Andy, thank you so much for your early interest in our RNA-seq, for letting 
me work on your precious samples and all your very positive input, enthousiasm 
and friendliness. The P. knowlesi group: Erica, Tjeerd & Clemens, thanks for trusting 
me with your very dear samples, for your positive attitute and just for being the 
friendly people that you are, even though I know that I’m the one that causes the 
slow progress of the project. The PlasmoDB-team, Omar & Brian, thanks for the 
nice interactions over the years! I think/hope the EuPathDB collaboration will turn 
out to be great fun! Also, I would like to thank Christian, Till & Tim (although more 
Richards collaborators then mine) for all the very nice interactions over the years! 
Furthermore, I would very much like to thank Alan (Cowman) for giving me the 
opportunity to spend four wonderfull weeks in your lab and I would like to thank 
all the fantastic people in the lab who helped me out where ever possible and for 
the incredibly friendly and welcoming atmosphere they created! Alan (Yap), Dejan, 
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Neta, Danny, Sash, Tony, Lin, Waihong, Xavier, Sara, Justin, Wilson, Andreea, Chris, 
Jake, Kelly & Joan, thanks for being such wonderfully nice people! I hope to meet 
you again some day! Also, I would like to thank Noa for the great company while 
both being away from home in Australia!
Wilbert, mijn NCMLS-mentor. Ook jou wil ik graag bedanken voor je interesse en 
steun. Ik keek altijd uit naar onze gezellige mentorgesprekken (die niet alleen 
over werk, maar ook over vakanties en allerlei andere zaken gingen). Dank je wel 
daarvoor! 
Daarnaast wil ik mijn ouders heel erg bedanken.
Lieve paps, jij hebt me met het wetenschappelijk onderzoek ik aanraking gebracht. 
En het zijn jou drive, jou nieuwsgierigheid en doorzettingsvermogen die me al 
op de basisschool enthousiast maakten voor de biologie, hoe het leven en de 
natuur in elkaar zitten en voor ‘onderzoek doen’. Deze fascinatie is gebleven en 
door de jaren gegroeid. Het is niet voor niets dat mijn hart toch echt ligt bij DNA-
gerelateerde processen. Ik wil je heel erg bedanken voor je onvoorwaardelijke 
steun, je enthousiasme voor het werk dat ik doe en je ondersteuning, suggesties 
en adviezen voor projecten, beursaanvragen en of ik wel de juiste keuzes maak (en 
voor de tijd, die je altijd weet te vinden om mijn dingen te lezen, ondanks dat je 
het zelf ook verschrikkelijk druk hebt). Het spijt me dat ik de laatste jaren, eigenlijk 
sinds het begin van mijn PhD, steeds minder in het weekend in 7-huizen ben 
langsgekomen. Ik hoop dat als dit boekje eindelijk klaar is, Jelle en ik weer meer tijd 
hebben om gewoon eens relaxed een weekendje in 7-huizen te zijn. Pap, zonder 
jou inspiratie was ik misschien wel nooit in de wetenschap terecht gekomen en 
had ik nooit dit boekje af kunnen schrijven. Ik hou van je, heel erg BEDANKT!
Lieve mam, jij staat altijd voor me klaar. Jij bent de steun en toeverlaat op wie ik 
al mijn hele leven heb kunnen rekenen. Ik heb zoveel aan je te danken. Al zo lang 
ik me kan herinneren heb je me gestimuleerd mijn best te doen om al die dingen 
te leren die ik zo interessant vind (en ook dingen die ik minder interessant vond, 
zoals engels, waarvoor ik je ook heel dankbaar moet zijn!). Jou zorg en opvoeding 
hebben me gemaakt tot wie ik ben. Mam, mijn liefde voor de biologie en mijn 
leergierigheid komen ook van jou, net als het belang dat ik hecht aan de band met 
mijn familie. En ondanks dat ik ook jou de laatste tijd niet zo vaak heb gezien en 
gesproken als ik graag zou willen, voel je nog steeds feilloos aan wanneer ik je hulp 
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nodig heb en kan ik altijd op je rekenen. Mam, ook jou wil ik heel erg bedanken, 
want zonder jou steun was ik nooit zo ver gekomen. Ik hou van je!
Ik wil ook graag mijn grote broer, zus en zusjes bedanken. Mathijs, Janneke, Marieke 
en Lineke, jullie zijn de fijnste broers en zussen die ik me kan wensen en door jullie 
voelt thuis echt als ‘thuis’. Bedankt voor jullie interesse, steun en gezelligheid!!! 
Speciaal wil ik mijn paranymf, Janneke, bedanken. Ik vind het zo leuk dat jij, Klaas 
Jan en Thijs in Nijmegen zijn komen wonen en dat ik mijn grote zus, (die ook haar 
PhD doet!) zo dicht in de buurt heb. Bedankt voor jullie gezelligheid, het samen 
eten, je steun, de up-en-downs van een PhD samen delen en dat je mijn paranymf 
wilt zijn!
Opa & Oma van Dommelen en Oma Hoeijmakers, heel erg bedankt voor jullie 
steun en dat ik altijd welkom ben bij jullie! Hopelijk heb ik straks wat meer tijd 
en kan ik wat vaker eens bij jullie langskomen! Ook wil ik graag mijn vriendinnen 
van de middelbare school (Daniëlle, Angela, Martine en Nelleke) en vrienden 
en vriendinnen van de studie (Sas, Marcel, Karlien & Ghaith) bedanken voor 
de gezelligheid door de jaren heen. En natuurlijk de familie Faber, de gezellige 
ooms en tantes, neef & nicht en specifiek Gusta, Auke & Sanne, die mij hebben 
opgenomen in deze fijne familie, BEDANKT!
Tot slot wil ik jou, mijn allerliefste Jelle, helemaal aan het eind van deze thesis 
bedanken! Jij hebt me het hele traject bijgestaan en gesteund. Vanaf het eerste 
moment dat ik de beursaanvraag ging schrijven (‘je moet juist doen wat je leuk vind 
en dan sta ik erachter’) tot aan het eind waarin ik teveel weekenden heb moeten 
werken om alles op tijd af te krijgen. Deze thesis is niet alleen mijn ‘achievement’, 
maar ook die van jou. Zonder jou liefde en steun was deze thesis er niet geweest! Jij 
was degene die moest lijden onder mijn bij vlagen te drukke werkschema, teveel 
stress, nachtelijke parasieten synchronisatie en collecties of negative reviews en 
wist me dan toch weer op te vrolijken. En jij bent de reden dat ik er aan het eind 
van de werkdag naar uitkijk om weer thuis te zijn en er naar verlang om jou weer 
te zien! Wij zijn een goed team, en ik ben zo gelukkig met jou aan mijn zijde. Ik hou 
heel veel van je, Jel! En ik wil je bedanken voor alle leuke, lieve, vrolijke, verdrietige, 
relaxte, sportieve, romantische, mooie en fijne momenten en de prachtige verre 
reizen die ik met jou heb gedeeld!
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CuRRiCuluM ViTAe
Wieteke Anna Maria Hoeijmakers werd op 18 augustus 1984 geboren te 
Zevenhuizen (ZH). In 2002 behaalde ze cum laude haar VWO diploma aan het 
Coenecoop College te Waddinxveen, waarna ze begon aan een bachelor studie 
Biologie aan de Radboud Universiteit Nijmegen (toentertijd Katholieke Universiteit 
Nijmegen). Tevens startte ze in 2004 aan het 2-jarige extra-curriculaire Honours 
Programma van de Radboud Universiteit en in 2005 doorliep ze een korte stage 
aan de afdeling Moleculaire Biologie, gericht op de biochemische karakterisatie 
van de MBD2/NuRD en MBD3/NuRD complexen, onder begeleiding van dr. Michiel 
Vermeulen, dr. Xavier LeGeuzennec en Prof. Henk Stunnenberg. Ze behaalde cum 
laude haar bachelor diploma en startte in 2005 als 1 van de eerste 3 studenten 
aan de nieuwe onderzoeksmaster van het Nijmegen Center for Molecular Life 
Sciences (NCMLS), genaamd Molecular Mechanisms of Disease. Twee stages 
vormden onderdeel van deze opleiding. In 2006 deed ze onderzoek bij de afdeling 
Eiwitbiochemie (thans Biomoleculaire Chemie) onder begeleiding van dr. John 
den Engelsman en dr. Wilbert Boelens, waar ze zich richtte op het ontrafelen van 
mogelijk oncogene activiteiten van het kleine heatshock eiwit aB-crystalline. In 
2007 deed ze stage aan het Ernest Orlando Lawrence Berkeley National Laboratory 
(LBNL) in Berkeley, Californie (Verenigde Staten van Amerika), onder begeleiding 
van dr. Francis Rodier en dr. Judith Campisi. Deze stage was gericht op het 
ontrafelen van de mechanismen die ten grondslag liggen aan het verouderings- en 
kankergerelateerde senescence-geassocieerde secretoire fenotype (SASP).
In 2007 studeerde ze summa cum laude af als Master of Science en startte als 
promovendus bij de afdeling Moleculaire Biologie aan de Radboud Universiteit, 
onder begeleiding van Prof. Henk Stunnenberg, aan een promotietraject dat 
werd gefinancierd uit een persoonlijk beurs vanuit het TopTalent programma 
van NWO. De resultaten daarvan zijn beschreven in dit proefschrift. Gedurende 
dit promotietraject begeleide ze diverse studenten en werkte nauw samen 
met dr. Adriana Salcedo-Amaya, dr. Richárd Bártfai en de afdeling Medische 
Microbiologie / Parasitologie van het UMC St Radboud onder leiding van Prof. 
Robert Sauerwein. Verder onderhield ze in het kader van haar promotieonderzoek 
samenwerkingsverbanden met verschillende nationale en internationale 
laboratoria, inclusief de groepen van Dr. Chris Janse (LUMC, Leiden), Dr. Clemens 
Kocken (BPRC, Rijswijk) en Prof. Andy Waters (University of Glasgow, Glasgow, 
Verenigd Koninkrijk) en bracht ze 4 weken door op het laboratorium van Prof. 
Alan Cowman in het Walter and Eliza Hall Institute for Biomedical Research in 
Melbourne, Australië. 
Hoeijmakers.indd   218 20-04-12   14:43
Hoeijmakers_PROEF (all).ps Back - 109     T1 -    Black CyanMagentaYellow
Publication list
219
PubliCATion lisT 
Plasmodium falciparum centromeres display a unique epigenetic makeup and 
cluster prior to and during schizogony
Hoeijmakers WAM, Flueck C, Françoijs K-J, Smits AH, Wetzel J, Volz JC, Cowman AF, 
Voss T, Stunnenberg HG *, Bártfai R *
Cellular Microbiology, in press
Transcriptome analysis using RnA-seq
Hoeijmakers WAM*, Bártfai R*, Stunnenberg HG.
Methods in Molecular Biology, in press
linear Amplification for Deep sequencing 
Hoeijmakers WAM*, Bártfai R*, Françoijs K-J, Stunnenberg HG.
Nature Protocols (2011) 6: 1026-1036
H2A.Z Demarcates intergenic regions of the Plasmodium falciparum 
epigenome that are Dynamically Marked by H3K9ac and H3K4me3
Bártfai R*, Hoeijmakers WAM*, Salcedo-Amaya AM, Smits AH, Janssen-Megens E, 
Kaan A, Treeck M, Gilberger T-W, Françoijs K-J, Stunnenberg HG.
PLoS Pathogens (2010) 6: e1001223
Malaria: Could its unusual epigenome be the weak spot?
Salcedo-Amaya AM, Hoeijmakers WAM, Bártfai R, Stunnenberg HG.
The International Journal of Biochemistry & Cell Biology (2010) 42: 781-784 Review
Persistent DnA damage signalling triggers senescence-associated 
inflammatory cytokine secretion
Rodier F, Coppé JP, Patil CK, Hoeijmakers WAM, Muñoz DR, Raza SR, Freund A, 
Campeau E, Davalos AR, Campisi J.
Nature Cell Biology (2009) 11: 973-979
MDb2/nuRD and MbD3/nuRD, Two Distinct Complexes with Different 
biochemical and functional Properties
Le Guezennec X*, Vermeulen M*, Brinkman AB, Hoeijmakers WAM, Cohen A, 
Lasonder E, Stunnenberg HG.
Molecular and Cellular Biology (2006) 26: 843-851 
* authors contributed equally
Hoeijmakers.indd   219 20-04-12   14:43
Hoeijmakers_PROEF (all).ps Front - 110     T1 -    Black CyanMagentaYellow
Hoeijmakers.indd   220 20-04-12   14:43
Hoeijmakers_PROEF (all).ps Back - 110     T1 -    Black CyanMagentaYellow
